NZ709801B2 - Compositions and methods for controlling head blight disease - Google Patents
Compositions and methods for controlling head blight disease Download PDFInfo
- Publication number
- NZ709801B2 NZ709801B2 NZ709801A NZ70980112A NZ709801B2 NZ 709801 B2 NZ709801 B2 NZ 709801B2 NZ 709801 A NZ709801 A NZ 709801A NZ 70980112 A NZ70980112 A NZ 70980112A NZ 709801 B2 NZ709801 B2 NZ 709801B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- plant
- leu
- ala
- gly
- glu
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title claims abstract description 87
- 241000233647 Phytophthora nicotianae var. parasitica Species 0.000 title claims abstract description 73
- 239000000203 mixture Substances 0.000 title claims description 142
- 230000001276 controlling effect Effects 0.000 title description 9
- 230000000813 microbial Effects 0.000 claims abstract description 113
- 230000012010 growth Effects 0.000 claims abstract description 37
- 239000002689 soil Substances 0.000 claims abstract description 30
- 230000018109 developmental process Effects 0.000 claims abstract description 28
- 241000223195 Fusarium graminearum Species 0.000 claims abstract description 27
- 238000011161 development Methods 0.000 claims abstract description 27
- 239000001963 growth media Substances 0.000 claims abstract description 19
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 13
- 230000001629 suppression Effects 0.000 claims abstract description 12
- 241000056137 Variovorax sp. Species 0.000 claims abstract description 9
- 241000196324 Embryophyta Species 0.000 claims description 123
- 240000008529 Triticum aestivum Species 0.000 claims description 73
- 210000004027 cells Anatomy 0.000 claims description 48
- 230000001717 pathogenic Effects 0.000 claims description 40
- 210000004215 spores Anatomy 0.000 claims description 38
- 244000052769 pathogens Species 0.000 claims description 35
- 229920003013 deoxyribonucleic acid Polymers 0.000 claims description 26
- 230000000855 fungicidal Effects 0.000 claims description 26
- 239000000417 fungicide Substances 0.000 claims description 23
- 239000000969 carrier Substances 0.000 claims description 22
- 238000009472 formulation Methods 0.000 claims description 19
- 239000000575 pesticide Substances 0.000 claims description 18
- 238000000576 coating method Methods 0.000 claims description 17
- 239000011248 coating agent Substances 0.000 claims description 16
- 240000005979 Hordeum vulgare Species 0.000 claims description 14
- 210000001519 tissues Anatomy 0.000 claims description 14
- 229920001850 Nucleic acid sequence Polymers 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 13
- 239000000839 emulsion Substances 0.000 claims description 8
- 239000008188 pellet Substances 0.000 claims description 8
- 239000007921 spray Substances 0.000 claims description 8
- 239000008199 coating composition Substances 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 235000007319 Avena orientalis Nutrition 0.000 claims description 5
- 244000075850 Avena orientalis Species 0.000 claims description 5
- 230000000749 insecticidal Effects 0.000 claims description 5
- 239000002917 insecticide Substances 0.000 claims description 4
- 239000005645 nematicide Substances 0.000 claims description 4
- 235000007558 Avena sp Nutrition 0.000 claims description 3
- 239000000428 dust Substances 0.000 claims description 3
- 241000602080 Dracaena fragrans Species 0.000 claims description 2
- 230000000895 acaricidal Effects 0.000 claims description 2
- 239000000642 acaricide Substances 0.000 claims description 2
- 230000003641 microbiacidal Effects 0.000 claims description 2
- 239000002855 microbicide agent Substances 0.000 claims description 2
- 230000001850 reproductive Effects 0.000 claims description 2
- 239000000084 colloidal system Substances 0.000 claims 1
- 230000001747 exhibiting Effects 0.000 claims 1
- 244000005700 microbiome Species 0.000 description 85
- 230000003042 antagnostic Effects 0.000 description 78
- 239000005557 antagonist Substances 0.000 description 56
- 235000021307 wheat Nutrition 0.000 description 54
- 238000000034 method Methods 0.000 description 52
- 235000013339 cereals Nutrition 0.000 description 46
- 230000001580 bacterial Effects 0.000 description 45
- 241000894007 species Species 0.000 description 32
- 239000000126 substance Substances 0.000 description 30
- 239000003795 chemical substances by application Substances 0.000 description 27
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 23
- -1 isoprenoid quinones Chemical class 0.000 description 22
- 239000007788 liquid Substances 0.000 description 22
- 241000223218 Fusarium Species 0.000 description 21
- 238000004458 analytical method Methods 0.000 description 21
- 150000007523 nucleic acids Chemical class 0.000 description 21
- 238000003752 polymerase chain reaction Methods 0.000 description 21
- 150000002500 ions Chemical class 0.000 description 20
- 108020004707 nucleic acids Proteins 0.000 description 20
- 239000000725 suspension Substances 0.000 description 18
- 230000002538 fungal Effects 0.000 description 17
- 239000002609 media Substances 0.000 description 17
- 108020004465 16S Ribosomal RNA Proteins 0.000 description 16
- 241000233866 Fungi Species 0.000 description 15
- VYZAGTDAHUIRQA-WHFBIAKZSA-N L-alanyl-L-glutamic acid Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O VYZAGTDAHUIRQA-WHFBIAKZSA-N 0.000 description 15
- 241001646398 Pseudomonas chlororaphis Species 0.000 description 15
- UPJONISHZRADBH-XPUUQOCRSA-N Val-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O UPJONISHZRADBH-XPUUQOCRSA-N 0.000 description 15
- 108010015792 glycyllysine Proteins 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 15
- 102000004169 proteins and genes Human genes 0.000 description 15
- 108090000623 proteins and genes Proteins 0.000 description 15
- 241000894006 Bacteria Species 0.000 description 14
- 206010061217 Infestation Diseases 0.000 description 14
- NFNVDJGXRFEYTK-YUMQZZPRSA-N Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O NFNVDJGXRFEYTK-YUMQZZPRSA-N 0.000 description 14
- LESXFEZIFXFIQR-LURJTMIESA-N Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(O)=O LESXFEZIFXFIQR-LURJTMIESA-N 0.000 description 14
- 230000000443 biocontrol Effects 0.000 description 14
- YBAFDPFAUTYYRW-YUMQZZPRSA-N Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O YBAFDPFAUTYYRW-YUMQZZPRSA-N 0.000 description 13
- 235000007340 Hordeum vulgare Nutrition 0.000 description 12
- 241000500375 Microbacterium sp. Species 0.000 description 12
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 12
- 230000003321 amplification Effects 0.000 description 12
- 108010047857 aspartylglycine Proteins 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 108010089804 glycyl-threonine Proteins 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 238000003199 nucleic acid amplification method Methods 0.000 description 12
- 239000002773 nucleotide Substances 0.000 description 12
- 125000003729 nucleotide group Chemical group 0.000 description 12
- 239000001965 potato dextrose agar Substances 0.000 description 12
- 108010061238 threonyl-glycine Proteins 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- FRYULLIZUDQONW-IMJSIDKUSA-N Asp-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FRYULLIZUDQONW-IMJSIDKUSA-N 0.000 description 11
- 241000193830 Bacillus <bacterium> Species 0.000 description 11
- DKEXFJVMVGETOO-LURJTMIESA-N Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CN DKEXFJVMVGETOO-LURJTMIESA-N 0.000 description 11
- 241000880493 Leptailurus serval Species 0.000 description 11
- XGDCYUQSFDQISZ-BQBZGAKWSA-N Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O XGDCYUQSFDQISZ-BQBZGAKWSA-N 0.000 description 11
- JKHXYJKMNSSFFL-IUCAKERBSA-N Val-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN JKHXYJKMNSSFFL-IUCAKERBSA-N 0.000 description 11
- 241001478283 Variovorax Species 0.000 description 11
- 108010047495 alanylglycine Proteins 0.000 description 11
- 108010062796 arginyllysine Proteins 0.000 description 11
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 11
- 108010038633 aspartylglutamate Proteins 0.000 description 11
- 244000052616 bacterial pathogens Species 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 201000009910 diseases by infectious agent Diseases 0.000 description 11
- 108010050848 glycylleucine Proteins 0.000 description 11
- 230000002906 microbiologic Effects 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 108010026333 seryl-proline Proteins 0.000 description 11
- 108010073969 valyllysine Proteins 0.000 description 11
- 229920001817 Agar Polymers 0.000 description 10
- JSIQVRIXMINMTA-ZDLURKLDSA-N Glu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O JSIQVRIXMINMTA-ZDLURKLDSA-N 0.000 description 10
- 241000238631 Hexapoda Species 0.000 description 10
- WKXVAXOSIPTXEC-UHFFFAOYSA-N Isoleucyl-Aspartate Chemical compound CCC(C)C(N)C(=O)NC(C(O)=O)CC(O)=O WKXVAXOSIPTXEC-UHFFFAOYSA-N 0.000 description 10
- 241001467578 Microbacterium Species 0.000 description 10
- IBIDRSSEHFLGSD-YUMQZZPRSA-N Val-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IBIDRSSEHFLGSD-YUMQZZPRSA-N 0.000 description 10
- 239000008272 agar Substances 0.000 description 10
- 150000001413 amino acids Chemical group 0.000 description 10
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 10
- 108010049041 glutamylalanine Proteins 0.000 description 10
- STKYPAFSDFAEPH-LURJTMIESA-N gly-val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CN STKYPAFSDFAEPH-LURJTMIESA-N 0.000 description 10
- 108010034529 leucyl-lysine Proteins 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- KTGFOCFYOZQVRJ-UHFFFAOYSA-N 2-[(2-amino-3-methylpentanoyl)amino]pentanedioic acid Chemical compound CCC(C)C(N)C(=O)NC(C(O)=O)CCC(O)=O KTGFOCFYOZQVRJ-UHFFFAOYSA-N 0.000 description 9
- XUUXCWCKKCZEAW-YFKPBYRVSA-N 2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)[C@@H](N)CCCN=C(N)N XUUXCWCKKCZEAW-YFKPBYRVSA-N 0.000 description 9
- CXISPYVYMQWFLE-VKHMYHEASA-N Ala-Gly Chemical compound C[C@H]([NH3+])C(=O)NCC([O-])=O CXISPYVYMQWFLE-VKHMYHEASA-N 0.000 description 9
- IEFJWDNGDZAYNZ-BYPYZUCNSA-N Gly-Glu Chemical compound NCC(=O)N[C@H](C(O)=O)CCC(O)=O IEFJWDNGDZAYNZ-BYPYZUCNSA-N 0.000 description 9
- OTXBNHIUIHNGAO-UWVGGRQHSA-N Leu-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN OTXBNHIUIHNGAO-UWVGGRQHSA-N 0.000 description 9
- LRKCBIUDWAXNEG-CSMHCCOUSA-N Leu-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LRKCBIUDWAXNEG-CSMHCCOUSA-N 0.000 description 9
- 101710002875 TYRO3 Proteins 0.000 description 9
- 108010044940 alanylglutamine Proteins 0.000 description 9
- 108010087924 alanylproline Proteins 0.000 description 9
- 108010013835 arginine glutamate Proteins 0.000 description 9
- 108010060035 arginylproline Proteins 0.000 description 9
- 238000004166 bioassay Methods 0.000 description 9
- 108010037850 glycylvaline Proteins 0.000 description 9
- 108010012581 phenylalanylglutamate Proteins 0.000 description 9
- IOUPEELXVYPCPG-UHFFFAOYSA-N val-gly Chemical compound CC(C)C(N)C(=O)NCC(O)=O IOUPEELXVYPCPG-UHFFFAOYSA-N 0.000 description 9
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 9
- 230000035899 viability Effects 0.000 description 9
- SITLTJHOQZFJGG-XPUUQOCRSA-N α-Glu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O SITLTJHOQZFJGG-XPUUQOCRSA-N 0.000 description 9
- 101700037792 AURKB Proteins 0.000 description 8
- RDIKFPRVLJLMER-BQBZGAKWSA-N Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)N RDIKFPRVLJLMER-BQBZGAKWSA-N 0.000 description 8
- WPWUFUBLGADILS-WDSKDSINSA-N Ala-Pro Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O WPWUFUBLGADILS-WDSKDSINSA-N 0.000 description 8
- BUQICHWNXBIBOG-LMVFSUKVSA-N Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)N BUQICHWNXBIBOG-LMVFSUKVSA-N 0.000 description 8
- JHFNSBBHKSZXKB-VKHMYHEASA-N Asp-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(O)=O JHFNSBBHKSZXKB-VKHMYHEASA-N 0.000 description 8
- DWBZEJHQQIURML-IMJSIDKUSA-N Asp-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O DWBZEJHQQIURML-IMJSIDKUSA-N 0.000 description 8
- SJUXYGVRSGTPMC-UHFFFAOYSA-N Asparaginyl-Alanine Chemical compound OC(=O)C(C)NC(=O)C(N)CC(N)=O SJUXYGVRSGTPMC-UHFFFAOYSA-N 0.000 description 8
- NTQDELBZOMWXRS-UHFFFAOYSA-N Aspartyl-Threonine Chemical compound CC(O)C(C(O)=O)NC(=O)C(N)CC(O)=O NTQDELBZOMWXRS-UHFFFAOYSA-N 0.000 description 8
- SCCPDJAQCXWPTF-VKHMYHEASA-N Gly-Asp Chemical compound NCC(=O)N[C@H](C(O)=O)CC(O)=O SCCPDJAQCXWPTF-VKHMYHEASA-N 0.000 description 8
- OLIFSFOFKGKIRH-WUJLRWPWSA-N Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CN OLIFSFOFKGKIRH-WUJLRWPWSA-N 0.000 description 8
- QOOWRKBDDXQRHC-BQBZGAKWSA-N L-lysyl-L-alanine Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN QOOWRKBDDXQRHC-BQBZGAKWSA-N 0.000 description 8
- VTJUNIYRYIAIHF-IUCAKERBSA-N Leu-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O VTJUNIYRYIAIHF-IUCAKERBSA-N 0.000 description 8
- FELJDCNGZFDUNR-WDSKDSINSA-N Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 FELJDCNGZFDUNR-WDSKDSINSA-N 0.000 description 8
- 206010039509 Scab Diseases 0.000 description 8
- WOUIMBGNEUWXQG-VKHMYHEASA-N Ser-Gly Chemical compound OC[C@H](N)C(=O)NCC(O)=O WOUIMBGNEUWXQG-VKHMYHEASA-N 0.000 description 8
- BIYXEUAFGLTAEM-WUJLRWPWSA-N Thr-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(O)=O BIYXEUAFGLTAEM-WUJLRWPWSA-N 0.000 description 8
- GIAZPLMMQOERPN-YUMQZZPRSA-N Val-Pro Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O GIAZPLMMQOERPN-YUMQZZPRSA-N 0.000 description 8
- 102000004965 antibodies Human genes 0.000 description 8
- 108090001123 antibodies Proteins 0.000 description 8
- 108010077245 asparaginyl-proline Proteins 0.000 description 8
- 108010092854 aspartyllysine Proteins 0.000 description 8
- 230000003115 biocidal Effects 0.000 description 8
- 239000006285 cell suspension Substances 0.000 description 8
- 230000009089 cytolysis Effects 0.000 description 8
- 231100000676 disease causative agent Toxicity 0.000 description 8
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine zwitterion Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 8
- 108010040030 histidinoalanine Proteins 0.000 description 8
- 108010057821 leucylproline Proteins 0.000 description 8
- 230000002934 lysing Effects 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- FAQVCWVVIYYWRR-WHFBIAKZSA-N (2S)-2-[[(2S)-2,5-diamino-5-oxopentanoyl]amino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O FAQVCWVVIYYWRR-WHFBIAKZSA-N 0.000 description 7
- QXRNAOYBCYVZCD-BQBZGAKWSA-N (2S)-6-amino-2-[[(2S)-2-aminopropanoyl]amino]hexanoic acid Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN QXRNAOYBCYVZCD-BQBZGAKWSA-N 0.000 description 7
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 7
- ZSOICJZJSRWNHX-ACZMJKKPSA-N Ala-Ile Chemical compound CC[C@H](C)[C@@H](C([O-])=O)NC(=O)[C@H](C)[NH3+] ZSOICJZJSRWNHX-ACZMJKKPSA-N 0.000 description 7
- IJYZHIOOBGIINM-WDSKDSINSA-N Arg-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N IJYZHIOOBGIINM-WDSKDSINSA-N 0.000 description 7
- XNSKSTRGQIPTSE-UHFFFAOYSA-N Arginyl-Threonine Chemical compound CC(O)C(C(O)=O)NC(=O)C(N)CCCNC(N)=N XNSKSTRGQIPTSE-UHFFFAOYSA-N 0.000 description 7
- DVUFTQLHHHJEMK-IMJSIDKUSA-N Asp-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O DVUFTQLHHHJEMK-IMJSIDKUSA-N 0.000 description 7
- PSZNHSNIGMJYOZ-WDSKDSINSA-N Asp-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PSZNHSNIGMJYOZ-WDSKDSINSA-N 0.000 description 7
- ARPVSMCNIDAQBO-UHFFFAOYSA-N Glutaminyl-Leucine Chemical compound CC(C)CC(C(O)=O)NC(=O)C(N)CCC(N)=O ARPVSMCNIDAQBO-UHFFFAOYSA-N 0.000 description 7
- JLXVRFDTDUGQEE-YFKPBYRVSA-N Gly-Arg Chemical compound NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N JLXVRFDTDUGQEE-YFKPBYRVSA-N 0.000 description 7
- UCGDDTHMMVWVMV-FSPLSTOPSA-N Ile-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(O)=O UCGDDTHMMVWVMV-FSPLSTOPSA-N 0.000 description 7
- JYOAXOMPIXKMKK-UHFFFAOYSA-N Leucyl-Glutamine Chemical compound CC(C)CC(N)C(=O)NC(C(O)=O)CCC(N)=O JYOAXOMPIXKMKK-UHFFFAOYSA-N 0.000 description 7
- NPBGTPKLVJEOBE-IUCAKERBSA-N Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N NPBGTPKLVJEOBE-IUCAKERBSA-N 0.000 description 7
- ATIPDCIQTUXABX-UWVGGRQHSA-N Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN ATIPDCIQTUXABX-UWVGGRQHSA-N 0.000 description 7
- 108010079364 N-glycylalanine Proteins 0.000 description 7
- HYLXOQURIOCKIH-VQVTYTSYSA-N Thr-Arg Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N HYLXOQURIOCKIH-VQVTYTSYSA-N 0.000 description 7
- WITCOKQIPFWQQD-FSPLSTOPSA-N Val-Asn Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O WITCOKQIPFWQQD-FSPLSTOPSA-N 0.000 description 7
- STTYIMSDIYISRG-WDSKDSINSA-N Val-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(O)=O STTYIMSDIYISRG-WDSKDSINSA-N 0.000 description 7
- 108010008355 arginyl-glutamine Proteins 0.000 description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 7
- 238000011081 inoculation Methods 0.000 description 7
- 108010000761 leucylarginine Proteins 0.000 description 7
- 108010009298 lysylglutamic acid Proteins 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 229920000023 polynucleotide Polymers 0.000 description 7
- 239000002157 polynucleotide Substances 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 229920001670 16S ribosomal RNA Polymers 0.000 description 6
- CCUAQNUWXLYFRA-IMJSIDKUSA-N Ala-Asn Chemical compound C[C@H]([NH3+])C(=O)N[C@H](C([O-])=O)CC(N)=O CCUAQNUWXLYFRA-IMJSIDKUSA-N 0.000 description 6
- SITWEMZOJNKJCH-UHFFFAOYSA-N Alanyl-Arginine Chemical compound CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 6
- OMLWNBVRVJYMBQ-YUMQZZPRSA-N Arg-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O OMLWNBVRVJYMBQ-YUMQZZPRSA-N 0.000 description 6
- JQFZHHSQMKZLRU-IUCAKERBSA-N Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N JQFZHHSQMKZLRU-IUCAKERBSA-N 0.000 description 6
- CKAJHWFHHFSCDT-WHFBIAKZSA-N Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O CKAJHWFHHFSCDT-WHFBIAKZSA-N 0.000 description 6
- ZVDPYSVOZFINEE-UHFFFAOYSA-N Aspartyl-Leucine Chemical compound CC(C)CC(C(O)=O)NC(=O)C(N)CC(O)=O ZVDPYSVOZFINEE-UHFFFAOYSA-N 0.000 description 6
- 101710044578 At3g10140 Proteins 0.000 description 6
- 241000190633 Cordyceps Species 0.000 description 6
- KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 description 6
- MRVYVEQPNDSWLH-UHFFFAOYSA-N Glutaminyl-Valine Chemical compound CC(C)C(C(O)=O)NC(=O)C(N)CCC(N)=O MRVYVEQPNDSWLH-UHFFFAOYSA-N 0.000 description 6
- KGVHCTWYMPWEGN-FSPLSTOPSA-N Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CN KGVHCTWYMPWEGN-FSPLSTOPSA-N 0.000 description 6
- BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 description 6
- FRJIAZKQGSCKPQ-FSPLSTOPSA-N His-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CN=CN1 FRJIAZKQGSCKPQ-FSPLSTOPSA-N 0.000 description 6
- HYXQKVOADYPQEA-CIUDSAMLSA-N Ile-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HYXQKVOADYPQEA-CIUDSAMLSA-N 0.000 description 6
- BCVIOZZGJNOEQS-XKNYDFJKSA-N Ile-Ile Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)[C@@H](C)CC BCVIOZZGJNOEQS-XKNYDFJKSA-N 0.000 description 6
- BBIXOODYWPFNDT-CIUDSAMLSA-N Ile-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O BBIXOODYWPFNDT-CIUDSAMLSA-N 0.000 description 6
- 241000229754 Iva xanthiifolia Species 0.000 description 6
- SENJXOPIZNYLHU-IUCAKERBSA-N Leu-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-IUCAKERBSA-N 0.000 description 6
- OAPNERBWQWUPTI-YUMQZZPRSA-N Lys-Gln Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O OAPNERBWQWUPTI-YUMQZZPRSA-N 0.000 description 6
- ZOKVLMBYDSIDKG-CSMHCCOUSA-N Lys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN ZOKVLMBYDSIDKG-CSMHCCOUSA-N 0.000 description 6
- SSJMZMUVNKEENT-IMJSIDKUSA-N Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CO SSJMZMUVNKEENT-IMJSIDKUSA-N 0.000 description 6
- VBKBDLMWICBSCY-IMJSIDKUSA-N Ser-Asp Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O VBKBDLMWICBSCY-IMJSIDKUSA-N 0.000 description 6
- LAFKUZYWNCHOHT-WHFBIAKZSA-N Ser-Glu Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O LAFKUZYWNCHOHT-WHFBIAKZSA-N 0.000 description 6
- NFDYGNFETJVMSE-BQBZGAKWSA-N Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CO NFDYGNFETJVMSE-BQBZGAKWSA-N 0.000 description 6
- WBAXJMCUFIXCNI-WDSKDSINSA-N Ser-Pro Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O WBAXJMCUFIXCNI-WDSKDSINSA-N 0.000 description 6
- BWUHENPAEMNGQJ-ZDLURKLDSA-N Thr-Gln Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O BWUHENPAEMNGQJ-ZDLURKLDSA-N 0.000 description 6
- GXDLGHLJTHMDII-WISUUJSJSA-N Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(O)=O GXDLGHLJTHMDII-WISUUJSJSA-N 0.000 description 6
- DSGIVWSDDRDJIO-ZXXMMSQZSA-N Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DSGIVWSDDRDJIO-ZXXMMSQZSA-N 0.000 description 6
- OBTCMSPFOITUIJ-FSPLSTOPSA-N Val-Asp Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O OBTCMSPFOITUIJ-FSPLSTOPSA-N 0.000 description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 6
- 108010068380 arginylarginine Proteins 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 244000038559 crop plants Species 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000003337 fertilizer Substances 0.000 description 6
- 230000035784 germination Effects 0.000 description 6
- 101700013200 gyrB1 Proteins 0.000 description 6
- 108010025306 histidylleucine Proteins 0.000 description 6
- 108010064235 lysylglycine Proteins 0.000 description 6
- 108010017391 lysylvaline Proteins 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 108010056582 methionylglutamic acid Proteins 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- QLROSWPKSBORFJ-BQBZGAKWSA-N pro glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 QLROSWPKSBORFJ-BQBZGAKWSA-N 0.000 description 6
- 108010090894 prolylleucine Proteins 0.000 description 6
- 108010053725 prolylvaline Proteins 0.000 description 6
- 238000005507 spraying Methods 0.000 description 6
- LQJAALCCPOTJGB-YUMQZZPRSA-N (2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carboxylic acid Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O LQJAALCCPOTJGB-YUMQZZPRSA-N 0.000 description 5
- 244000215068 Acacia senegal Species 0.000 description 5
- FUESBOMYALLFNI-VKHMYHEASA-N Gly-Asn Chemical compound NCC(=O)N[C@H](C(O)=O)CC(N)=O FUESBOMYALLFNI-VKHMYHEASA-N 0.000 description 5
- 229920000084 Gum arabic Polymers 0.000 description 5
- CNPNWGHRMBQHBZ-ZKWXMUAHSA-N Ile-Gln Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O CNPNWGHRMBQHBZ-ZKWXMUAHSA-N 0.000 description 5
- TWVKGYNQQAUNRN-ACZMJKKPSA-N Ile-Ser Chemical compound CC[C@H](C)[C@H]([NH3+])C(=O)N[C@@H](CO)C([O-])=O TWVKGYNQQAUNRN-ACZMJKKPSA-N 0.000 description 5
- UWBDLNOCIDGPQE-UHFFFAOYSA-N Isoleucyl-Lysine Chemical compound CCC(C)C(N)C(=O)NC(C(O)=O)CCCCN UWBDLNOCIDGPQE-UHFFFAOYSA-N 0.000 description 5
- DRCKHKZYDLJYFQ-UHFFFAOYSA-N Isoleucyl-Threonine Chemical compound CCC(C)C(N)C(=O)NC(C(C)O)C(O)=O DRCKHKZYDLJYFQ-UHFFFAOYSA-N 0.000 description 5
- HFKJBCPRWWGPEY-BQBZGAKWSA-N L-arginyl-L-glutamic acid Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O HFKJBCPRWWGPEY-BQBZGAKWSA-N 0.000 description 5
- MLTRLIITQPXHBJ-BQBZGAKWSA-N Leu-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O MLTRLIITQPXHBJ-BQBZGAKWSA-N 0.000 description 5
- XWOBNBRUDDUEEY-UWVGGRQHSA-N Leu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 XWOBNBRUDDUEEY-UWVGGRQHSA-N 0.000 description 5
- CIOWSLJGLSUOME-BQBZGAKWSA-N Lys-Asp Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O CIOWSLJGLSUOME-BQBZGAKWSA-N 0.000 description 5
- HGNRJCINZYHNOU-LURJTMIESA-N Lys-Gly Chemical compound NCCCC[C@H](N)C(=O)NCC(O)=O HGNRJCINZYHNOU-LURJTMIESA-N 0.000 description 5
- JPNRPAJITHRXRH-UHFFFAOYSA-N Lysyl-Asparagine Chemical compound NCCCCC(N)C(=O)NC(C(O)=O)CC(N)=O JPNRPAJITHRXRH-UHFFFAOYSA-N 0.000 description 5
- 241000131448 Mycosphaerella Species 0.000 description 5
- JXWLMUIXUXLIJR-QWRGUYRKSA-N Phe-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 JXWLMUIXUXLIJR-QWRGUYRKSA-N 0.000 description 5
- GLUBLISJVJFHQS-VIFPVBQESA-N Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 GLUBLISJVJFHQS-VIFPVBQESA-N 0.000 description 5
- 229920001213 Polysorbate 20 Polymers 0.000 description 5
- 108020001027 Ribosomal DNA Proteins 0.000 description 5
- 229920002288 RpoB Polymers 0.000 description 5
- ILVGMCVCQBJPSH-WDSKDSINSA-N Ser-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CO ILVGMCVCQBJPSH-WDSKDSINSA-N 0.000 description 5
- BQBCIBCLXBKYHW-CSMHCCOUSA-N Thr-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@@H]([NH3+])[C@@H](C)O BQBCIBCLXBKYHW-CSMHCCOUSA-N 0.000 description 5
- GVRKWABULJAONN-UHFFFAOYSA-N Valyl-Threonine Chemical compound CC(C)C(N)C(=O)NC(C(C)O)C(O)=O GVRKWABULJAONN-UHFFFAOYSA-N 0.000 description 5
- 241000209149 Zea Species 0.000 description 5
- 235000010489 acacia gum Nutrition 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 108010011559 alanylphenylalanine Proteins 0.000 description 5
- 108010093581 aspartyl-proline Proteins 0.000 description 5
- 150000001768 cations Chemical class 0.000 description 5
- 235000005822 corn Nutrition 0.000 description 5
- 235000005824 corn Nutrition 0.000 description 5
- 108010078144 glutaminyl-glycine Proteins 0.000 description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 5
- 235000019341 magnesium sulphate Nutrition 0.000 description 5
- 108010005942 methionylglycine Proteins 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 101700072042 parE Proteins 0.000 description 5
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 description 5
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 5
- 108010070643 prolylglutamic acid Proteins 0.000 description 5
- 108010029020 prolylglycine Proteins 0.000 description 5
- 101700034421 rpoB Proteins 0.000 description 5
- 101700002805 rpoB2 Proteins 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- GJSURZIOUXUGAL-UHFFFAOYSA-N 2-((2,6-Dichlorophenyl)imino)imidazolidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 4
- SNFUTDLOCQQRQD-UHFFFAOYSA-N 2-[(2-amino-4-carboxybutanoyl)amino]-3-methylpentanoic acid Chemical compound CCC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SNFUTDLOCQQRQD-UHFFFAOYSA-N 0.000 description 4
- RLMISHABBKUNFO-WHFBIAKZSA-N 2-[[(2S)-2-[[(2S)-2-azaniumylpropanoyl]amino]propanoyl]amino]acetate Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 4
- XMBSYZWANAQXEV-UHFFFAOYSA-N 4-amino-5-[(1-carboxy-2-phenylethyl)amino]-5-oxopentanoic acid Chemical compound OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 4
- MGHKSHCBDXNTHX-UHFFFAOYSA-N 4-amino-5-[(4-amino-1-carboxy-4-oxobutyl)amino]-5-oxopentanoic acid Chemical compound OC(=O)CCC(N)C(=O)NC(CCC(N)=O)C(O)=O MGHKSHCBDXNTHX-UHFFFAOYSA-N 0.000 description 4
- IPWKGIFRRBGCJO-IMJSIDKUSA-N Ala-Ser Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](CO)C([O-])=O IPWKGIFRRBGCJO-IMJSIDKUSA-N 0.000 description 4
- BNODVYXZAAXSHW-UHFFFAOYSA-N Arginyl-Histidine Chemical compound NC(=N)NCCCC(N)C(=O)NC(C(O)=O)CC1=CN=CN1 BNODVYXZAAXSHW-UHFFFAOYSA-N 0.000 description 4
- QCWJKJLNCFEVPQ-WHFBIAKZSA-N Asn-Gln Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O QCWJKJLNCFEVPQ-WHFBIAKZSA-N 0.000 description 4
- NPDLYUOYAGBHFB-UHFFFAOYSA-N Asparaginyl-Arginine Chemical compound NC(=O)CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N NPDLYUOYAGBHFB-UHFFFAOYSA-N 0.000 description 4
- MQLZLIYPFDIDMZ-UHFFFAOYSA-N Asparaginyl-Isoleucine Chemical compound CCC(C)C(C(O)=O)NC(=O)C(N)CC(N)=O MQLZLIYPFDIDMZ-UHFFFAOYSA-N 0.000 description 4
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 4
- OWOFCNWTMWOOJJ-WDSKDSINSA-N Gln-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O OWOFCNWTMWOOJJ-WDSKDSINSA-N 0.000 description 4
- FYYSIASRLDJUNP-WHFBIAKZSA-N Glu-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FYYSIASRLDJUNP-WHFBIAKZSA-N 0.000 description 4
- BBBXWRGITSUJPB-YUMQZZPRSA-N Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O BBBXWRGITSUJPB-YUMQZZPRSA-N 0.000 description 4
- SXGAGTVDWKQYCX-BQBZGAKWSA-N Glu-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O SXGAGTVDWKQYCX-BQBZGAKWSA-N 0.000 description 4
- YBTCBQBIJKGSJP-BQBZGAKWSA-N Glu-Pro Chemical compound OC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O YBTCBQBIJKGSJP-BQBZGAKWSA-N 0.000 description 4
- UQHGAYSULGRWRG-WHFBIAKZSA-N Glu-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CO)C(O)=O UQHGAYSULGRWRG-WHFBIAKZSA-N 0.000 description 4
- YSWHPLCDIMUKFE-QWRGUYRKSA-N Glu-Tyr Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 YSWHPLCDIMUKFE-QWRGUYRKSA-N 0.000 description 4
- IKAIKUBBJHFNBZ-LURJTMIESA-N Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CN IKAIKUBBJHFNBZ-LURJTMIESA-N 0.000 description 4
- PFMUCCYYAAFKTH-YFKPBYRVSA-N Gly-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)CN PFMUCCYYAAFKTH-YFKPBYRVSA-N 0.000 description 4
- MMFKFJORZBJVNF-UWVGGRQHSA-N His-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 MMFKFJORZBJVNF-UWVGGRQHSA-N 0.000 description 4
- FMIIKPHLJKUXGE-GUBZILKMSA-N Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN FMIIKPHLJKUXGE-GUBZILKMSA-N 0.000 description 4
- YQAIUOWPSUOINN-IUCAKERBSA-N Lys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN YQAIUOWPSUOINN-IUCAKERBSA-N 0.000 description 4
- DZMGFGQBRYWJOR-YUMQZZPRSA-N Met-Pro Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O DZMGFGQBRYWJOR-YUMQZZPRSA-N 0.000 description 4
- WEDDFMCSUNNZJR-WDSKDSINSA-N Met-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(O)=O WEDDFMCSUNNZJR-WDSKDSINSA-N 0.000 description 4
- 241001633954 Microbacterium oxydans Species 0.000 description 4
- 241000364057 Peoria Species 0.000 description 4
- MIDZLCFIAINOQN-WPRPVWTQSA-N Phe-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 MIDZLCFIAINOQN-WPRPVWTQSA-N 0.000 description 4
- BXNGIHFNNNSEOS-UWVGGRQHSA-N Phe-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 BXNGIHFNNNSEOS-UWVGGRQHSA-N 0.000 description 4
- WEQJQNWXCSUVMA-RYUDHWBXSA-N Phe-Pro Chemical compound C([C@H]([NH3+])C(=O)N1[C@@H](CCC1)C([O-])=O)C1=CC=CC=C1 WEQJQNWXCSUVMA-RYUDHWBXSA-N 0.000 description 4
- NYQBYASWHVRESG-MIMYLULJSA-N Phe-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 NYQBYASWHVRESG-MIMYLULJSA-N 0.000 description 4
- ZKQOUHVVXABNDG-IUCAKERBSA-N Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 ZKQOUHVVXABNDG-IUCAKERBSA-N 0.000 description 4
- RVQDZELMXZRSSI-IUCAKERBSA-N Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 RVQDZELMXZRSSI-IUCAKERBSA-N 0.000 description 4
- XZKQVQKUZMAADP-IMJSIDKUSA-N Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(O)=O XZKQVQKUZMAADP-IMJSIDKUSA-N 0.000 description 4
- RZEQTVHJZCIUBT-UHFFFAOYSA-N Serinyl-Arginine Chemical compound OCC(N)C(=O)NC(C(O)=O)CCCNC(N)=N RZEQTVHJZCIUBT-UHFFFAOYSA-N 0.000 description 4
- BXLYSRPHVMCOPS-UHFFFAOYSA-N Serinyl-Isoleucine Chemical compound CCC(C)C(C(O)=O)NC(=O)C(N)CO BXLYSRPHVMCOPS-UHFFFAOYSA-N 0.000 description 4
- LDEBVRIURYMKQS-UHFFFAOYSA-N Serinyl-Threonine Chemical compound CC(O)C(C(O)=O)NC(=O)C(N)CO LDEBVRIURYMKQS-UHFFFAOYSA-N 0.000 description 4
- PDSLRCZINIDLMU-QWRGUYRKSA-N Tyr-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PDSLRCZINIDLMU-QWRGUYRKSA-N 0.000 description 4
- HPYDSVWYXXKHRD-VIFPVBQESA-N Tyr-Gly Chemical compound [O-]C(=O)CNC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 HPYDSVWYXXKHRD-VIFPVBQESA-N 0.000 description 4
- QJKMCQRFHJRIPU-XDTLVQLUSA-N Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 QJKMCQRFHJRIPU-XDTLVQLUSA-N 0.000 description 4
- 241000607479 Yersinia pestis Species 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 108010070944 alanylhistidine Proteins 0.000 description 4
- 230000001488 breeding Effects 0.000 description 4
- 239000004927 clay Substances 0.000 description 4
- 229910052570 clay Inorganic materials 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- VPZXBVLAVMBEQI-VKHMYHEASA-N gly ala Chemical compound OC(=O)[C@H](C)NC(=O)CN VPZXBVLAVMBEQI-VKHMYHEASA-N 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical class [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 108010078274 isoleucylvaline Proteins 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000006011 modification reaction Methods 0.000 description 4
- 239000000123 paper Substances 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 108010048818 seryl-histidine Proteins 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000004450 types of analysis Methods 0.000 description 4
- OPINTGHFESTVAX-UHFFFAOYSA-N γ-glutamyl-Arginine Chemical compound NC(=O)CCC(N)C(=O)NC(C(O)=O)CCCNC(N)=N OPINTGHFESTVAX-UHFFFAOYSA-N 0.000 description 4
- CXRCVCURMBFFOL-FXQIFTODSA-N (2S)-1-[(2S)-2-[[(2S)-2-azaniumylpropanoyl]amino]propanoyl]pyrrolidine-2-carboxylate Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O CXRCVCURMBFFOL-FXQIFTODSA-N 0.000 description 3
- ZJZNLRVCZWUONM-JXUBOQSCSA-N (2S)-2-[[(2S,3R)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]propanoic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O ZJZNLRVCZWUONM-JXUBOQSCSA-N 0.000 description 3
- XPJBQTCXPJNIFE-ZETCQYMHSA-N (2S)-2-[[2-[(2-azaniumylacetyl)amino]acetyl]amino]-4-methylpentanoate Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)CN XPJBQTCXPJNIFE-ZETCQYMHSA-N 0.000 description 3
- AUTNXSQEVVHSJK-YVNDNENWSA-N (2S,3S)-2-[[(2S)-2-[[(2S)-2-amino-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoic acid Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O AUTNXSQEVVHSJK-YVNDNENWSA-N 0.000 description 3
- KIUYPHAMDKDICO-WHFBIAKZSA-N (3S)-3-[[(2S)-2-aminopropanoyl]amino]-4-(carboxymethylamino)-4-oxobutanoic acid Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O KIUYPHAMDKDICO-WHFBIAKZSA-N 0.000 description 3
- MPZWMIIOPAPAKE-UHFFFAOYSA-N 4-amino-5-[[1-carboxy-4-(diaminomethylideneamino)butyl]amino]-5-oxopentanoic acid Chemical compound OC(=O)CCC(N)C(=O)NC(C(O)=O)CCCN=C(N)N MPZWMIIOPAPAKE-UHFFFAOYSA-N 0.000 description 3
- OMNVYXHOSHNURL-WPRPVWTQSA-N Ala-Phe Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OMNVYXHOSHNURL-WPRPVWTQSA-N 0.000 description 3
- PMGDADKJMCOXHX-BQBZGAKWSA-N Arg-Gln Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O PMGDADKJMCOXHX-BQBZGAKWSA-N 0.000 description 3
- QYLJIYOGHRGUIH-CIUDSAMLSA-N Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCNC(N)=N QYLJIYOGHRGUIH-CIUDSAMLSA-N 0.000 description 3
- JSLGXODUIAFWCF-UHFFFAOYSA-N Arginyl-Asparagine Chemical compound NC(N)=NCCCC(N)C(=O)NC(CC(N)=O)C(O)=O JSLGXODUIAFWCF-UHFFFAOYSA-N 0.000 description 3
- KLKHFFMNGWULBN-VKHMYHEASA-N Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)NCC(O)=O KLKHFFMNGWULBN-VKHMYHEASA-N 0.000 description 3
- SONUFGRSSMFHFN-IMJSIDKUSA-N Asn-Ser Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O SONUFGRSSMFHFN-IMJSIDKUSA-N 0.000 description 3
- GSMPSRPMQQDRIB-WHFBIAKZSA-N Asp-Gln Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O GSMPSRPMQQDRIB-WHFBIAKZSA-N 0.000 description 3
- OAMLVOVXNKILLQ-BQBZGAKWSA-N Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O OAMLVOVXNKILLQ-BQBZGAKWSA-N 0.000 description 3
- BSWHERGFUNMWGS-UHFFFAOYSA-N Aspartyl-Isoleucine Chemical compound CCC(C)C(C(O)=O)NC(=O)C(N)CC(O)=O BSWHERGFUNMWGS-UHFFFAOYSA-N 0.000 description 3
- UKGGPJNBONZZCM-WDSKDSINSA-N Aspartyl-L-proline Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O UKGGPJNBONZZCM-WDSKDSINSA-N 0.000 description 3
- 239000002028 Biomass Substances 0.000 description 3
- 229940041514 Candida albicans extract Drugs 0.000 description 3
- 238000007400 DNA extraction Methods 0.000 description 3
- 229940088598 Enzyme Drugs 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- VLDVBZICYBVQHB-IUCAKERBSA-N His-Val Chemical compound CC(C)[C@@H](C([O-])=O)NC(=O)[C@@H]([NH3+])CC1=CN=CN1 VLDVBZICYBVQHB-IUCAKERBSA-N 0.000 description 3
- IDXZDKMBEXLFMB-UHFFFAOYSA-N Histidinyl-Isoleucine Chemical compound CCC(C)C(C(O)=O)NC(=O)C(N)CC1=CN=CN1 IDXZDKMBEXLFMB-UHFFFAOYSA-N 0.000 description 3
- JWBXCSQZLLIOCI-GUBZILKMSA-N Ile-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CC(C)C JWBXCSQZLLIOCI-GUBZILKMSA-N 0.000 description 3
- MUFXDFWAJSPHIQ-XDTLVQLUSA-N Ile-Tyr Chemical compound CC[C@H](C)[C@H]([NH3+])C(=O)N[C@H](C([O-])=O)CC1=CC=C(O)C=C1 MUFXDFWAJSPHIQ-XDTLVQLUSA-N 0.000 description 3
- BCXBIONYYJCSDF-CIUDSAMLSA-N Ile-Val Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(O)=O BCXBIONYYJCSDF-CIUDSAMLSA-N 0.000 description 3
- RNKSNIBMTUYWSH-YFKPBYRVSA-N L-prolylglycine Chemical compound [O-]C(=O)CNC(=O)[C@@H]1CCC[NH2+]1 RNKSNIBMTUYWSH-YFKPBYRVSA-N 0.000 description 3
- JXNRXNCCROJZFB-RYUDHWBXSA-N L-tyrosyl-L-arginine Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JXNRXNCCROJZFB-RYUDHWBXSA-N 0.000 description 3
- AZLASBBHHSLQDB-GUBZILKMSA-N Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(C)C AZLASBBHHSLQDB-GUBZILKMSA-N 0.000 description 3
- UGTZHPSKYRIGRJ-YUMQZZPRSA-N Lys-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O UGTZHPSKYRIGRJ-YUMQZZPRSA-N 0.000 description 3
- ADHNYKZHPOEULM-BQBZGAKWSA-N Met-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O ADHNYKZHPOEULM-BQBZGAKWSA-N 0.000 description 3
- QXOHLNCNYLGICT-YFKPBYRVSA-N Met-Gly Chemical compound CSCC[C@H](N)C(=O)NCC(O)=O QXOHLNCNYLGICT-YFKPBYRVSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241001655310 Microbacteriaceae Species 0.000 description 3
- 241001557906 Mycosphaerella sp. Species 0.000 description 3
- 231100000678 Mycotoxin Toxicity 0.000 description 3
- 241000244206 Nematoda Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 240000005158 Phaseolus vulgaris Species 0.000 description 3
- HWMGTNOVUDIKRE-UWVGGRQHSA-N Phe-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 HWMGTNOVUDIKRE-UWVGGRQHSA-N 0.000 description 3
- JWBLQDDHSDGEGR-DRZSPHRISA-N Phe-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 JWBLQDDHSDGEGR-DRZSPHRISA-N 0.000 description 3
- PYOHODCEOHCZBM-RYUDHWBXSA-N Phe-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 PYOHODCEOHCZBM-RYUDHWBXSA-N 0.000 description 3
- KLAONOISLHWJEE-UHFFFAOYSA-N Phenylalanyl-Glutamine Chemical compound NC(=O)CCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 KLAONOISLHWJEE-UHFFFAOYSA-N 0.000 description 3
- FADYJNXDPBKVCA-UHFFFAOYSA-N Phenylalanyl-Lysine Chemical compound NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- HMNSRTLZAJHSIK-YUMQZZPRSA-N Pro-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 HMNSRTLZAJHSIK-YUMQZZPRSA-N 0.000 description 3
- RWCOTTLHDJWHRS-YUMQZZPRSA-N Pro-Pro Chemical compound OC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 RWCOTTLHDJWHRS-YUMQZZPRSA-N 0.000 description 3
- PPQRSMGDOHLTBE-UWVGGRQHSA-N Ser-Phe Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PPQRSMGDOHLTBE-UWVGGRQHSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfizole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 description 3
- IOWJRKAVLALBQB-IWGUZYHVSA-N Thr-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O IOWJRKAVLALBQB-IWGUZYHVSA-N 0.000 description 3
- BECPPKYKPSRKCP-ZDLURKLDSA-N Thr-Glu Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O BECPPKYKPSRKCP-ZDLURKLDSA-N 0.000 description 3
- WXVIGTAUZBUDPZ-DTLFHODZSA-N Thr-His Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 WXVIGTAUZBUDPZ-DTLFHODZSA-N 0.000 description 3
- UQTNIFUCMBFWEJ-UHFFFAOYSA-N Threoninyl-Asparagine Chemical compound CC(O)C(N)C(=O)NC(C(O)=O)CC(N)=O UQTNIFUCMBFWEJ-UHFFFAOYSA-N 0.000 description 3
- YKRQRPFODDJQTC-UHFFFAOYSA-N Threoninyl-Lysine Chemical compound CC(O)C(N)C(=O)NC(C(O)=O)CCCCN YKRQRPFODDJQTC-UHFFFAOYSA-N 0.000 description 3
- CKHWEVXPLJBEOZ-UHFFFAOYSA-N Threoninyl-Valine Chemical compound CC(C)C(C(O)=O)NC(=O)C(N)C(C)O CKHWEVXPLJBEOZ-UHFFFAOYSA-N 0.000 description 3
- BNQVUHQWZGTIBX-IUCAKERBSA-N Val-His Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@H](C([O-])=O)CC1=CN=CN1 BNQVUHQWZGTIBX-IUCAKERBSA-N 0.000 description 3
- PNVLWFYAPWAQMU-CIUDSAMLSA-N Val-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)C(C)C PNVLWFYAPWAQMU-CIUDSAMLSA-N 0.000 description 3
- 241001478284 Variovorax paradoxus Species 0.000 description 3
- LINOMUASTDIRTM-LZTLOYDTSA-N Vomitoxin Chemical compound C([C@]12[C@@]3(C[C@@H](O)[C@H]1O[C@@H]1C=C(C([C@@H](O)[C@@]13CO)=O)C)C)O2 LINOMUASTDIRTM-LZTLOYDTSA-N 0.000 description 3
- 239000000205 acacia gum Substances 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000001464 adherent Effects 0.000 description 3
- 108010041407 alanylaspartic acid Proteins 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000000844 anti-bacterial Effects 0.000 description 3
- 108010036533 arginylvaline Proteins 0.000 description 3
- 210000004666 bacterial spores Anatomy 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 238000006065 biodegradation reaction Methods 0.000 description 3
- 229920001222 biopolymer Polymers 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 229930002954 deoxynivalenol Natural products 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 150000004676 glycans Polymers 0.000 description 3
- 108010010147 glycylglutamine Proteins 0.000 description 3
- 108010087823 glycyltyrosine Proteins 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 230000002363 herbicidal Effects 0.000 description 3
- 108010036413 histidylglycine Proteins 0.000 description 3
- 108010028295 histidylhistidine Proteins 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 3
- 108010053037 kyotorphin Proteins 0.000 description 3
- 108010044056 leucyl-phenylalanine Proteins 0.000 description 3
- 244000144972 livestock Species 0.000 description 3
- 239000002636 mycotoxin Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 108010024607 phenylalanylalanine Proteins 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000004804 polysaccharides Polymers 0.000 description 3
- 229920002689 polyvinyl acetate Polymers 0.000 description 3
- 108010079317 prolyl-tyrosine Proteins 0.000 description 3
- 108010004914 prolylarginine Proteins 0.000 description 3
- 108010015796 prolylisoleucine Proteins 0.000 description 3
- 238000007790 scraping Methods 0.000 description 3
- 150000004760 silicates Chemical class 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 239000008247 solid mixture Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 238000003971 tillage Methods 0.000 description 3
- 108010078580 tyrosylleucine Proteins 0.000 description 3
- 239000010455 vermiculite Substances 0.000 description 3
- 229910052902 vermiculite Inorganic materials 0.000 description 3
- 235000019354 vermiculite Nutrition 0.000 description 3
- 239000012138 yeast extract Chemical class 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- XITLYYAIPBBHPX-UHFFFAOYSA-N γ-glutamyl-Isoleucine Chemical compound CCC(C)C(C(O)=O)NC(=O)C(N)CCC(N)=O XITLYYAIPBBHPX-UHFFFAOYSA-N 0.000 description 3
- NJMYZEJORPYOTO-UHFFFAOYSA-N γ-glutamyl-Proline Chemical compound NC(=O)CCC(N)C(=O)N1CCCC1C(O)=O NJMYZEJORPYOTO-UHFFFAOYSA-N 0.000 description 3
- ZRLUISBDKUWAIZ-CIUDSAMLSA-N (2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]propanoyl]amino]butanedioic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O ZRLUISBDKUWAIZ-CIUDSAMLSA-N 0.000 description 2
- YYSWCHMLFJLLBJ-ZLUOBGJFSA-N (2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]propanoyl]amino]-3-hydroxypropanoic acid Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 2
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3aR,7aS)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 description 2
- INGJLBQKTRJLFO-UKJIMTQDSA-N (4S)-4-amino-5-[[(2S,3S)-1-[[(1S)-1-carboxy-2-methylpropyl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O INGJLBQKTRJLFO-UKJIMTQDSA-N 0.000 description 2
- 229920000160 (ribonucleotides)n+m Polymers 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N 1-[(1S,2R,3R,4S,5R,6R)-3-carbamimidamido-6-{[(2R,3R,4R,5S)-3-{[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy}-2,4,5-trihydroxycyclohexyl]guanidine Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- RFCVXVPWSPOMFJ-UHFFFAOYSA-N 2-[(2-azaniumyl-3-phenylpropanoyl)amino]-4-methylpentanoate Chemical compound CC(C)CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 RFCVXVPWSPOMFJ-UHFFFAOYSA-N 0.000 description 2
- AAKRWBIIGKPOKQ-ONGXEEELSA-N 2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]acetic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AAKRWBIIGKPOKQ-ONGXEEELSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- TUTIHHSZKFBMHM-UHFFFAOYSA-N 4-amino-5-[(3-amino-1-carboxy-3-oxopropyl)amino]-5-oxopentanoic acid Chemical compound OC(=O)CCC(N)C(=O)NC(CC(N)=O)C(O)=O TUTIHHSZKFBMHM-UHFFFAOYSA-N 0.000 description 2
- XZWXFWBHYRFLEF-FSPLSTOPSA-N Ala-His Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 XZWXFWBHYRFLEF-FSPLSTOPSA-N 0.000 description 2
- ROWCTNFEMKOIFQ-YUMQZZPRSA-N Arg-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCNC(N)=N ROWCTNFEMKOIFQ-YUMQZZPRSA-N 0.000 description 2
- PQBHGSGQZSOLIR-RYUDHWBXSA-N Arg-Phe Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PQBHGSGQZSOLIR-RYUDHWBXSA-N 0.000 description 2
- XTWSWDJMIKUJDQ-RYUDHWBXSA-N Arg-Tyr Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 XTWSWDJMIKUJDQ-RYUDHWBXSA-N 0.000 description 2
- DAQIJMOLTMGJLO-YUMQZZPRSA-N Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCNC(N)=N DAQIJMOLTMGJLO-YUMQZZPRSA-N 0.000 description 2
- 240000002922 Armillaria mellea Species 0.000 description 2
- RJUHZPRQRQLCFL-IMJSIDKUSA-N Asn-Asn Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O RJUHZPRQRQLCFL-IMJSIDKUSA-N 0.000 description 2
- IIFDPDVJAHQFSR-WHFBIAKZSA-N Asn-Glu Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O IIFDPDVJAHQFSR-WHFBIAKZSA-N 0.000 description 2
- FFMIYIMKQIMDPK-BQBZGAKWSA-N Asn-His Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 FFMIYIMKQIMDPK-BQBZGAKWSA-N 0.000 description 2
- HSPSXROIMXIJQW-BQBZGAKWSA-N Asp-His Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 HSPSXROIMXIJQW-BQBZGAKWSA-N 0.000 description 2
- HXWUJJADFMXNKA-UHFFFAOYSA-N Asparaginyl-Leucine Chemical compound CC(C)CC(C(O)=O)NC(=O)C(N)CC(N)=O HXWUJJADFMXNKA-UHFFFAOYSA-N 0.000 description 2
- OMSMPWHEGLNQOD-UHFFFAOYSA-N Asparaginyl-Phenylalanine Chemical compound NC(=O)CC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 OMSMPWHEGLNQOD-UHFFFAOYSA-N 0.000 description 2
- DYDKXJWQCIVTMR-UHFFFAOYSA-N Aspartyl-Methionine Chemical compound CSCCC(C(O)=O)NC(=O)C(N)CC(O)=O DYDKXJWQCIVTMR-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Chemical class OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000005745 Captan Substances 0.000 description 2
- 229940117949 Captan Drugs 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 2
- WXOFKRKAHJQKLT-UHFFFAOYSA-N Cysteinyl-Lysine Chemical compound NCCCCC(C(O)=O)NC(=O)C(N)CS WXOFKRKAHJQKLT-UHFFFAOYSA-N 0.000 description 2
- 108010090461 DFG peptide Proteins 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 108020000161 EC 2.7.4.1 Proteins 0.000 description 2
- 229940096118 Ella Drugs 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- 240000006775 Enicostema verticillatum Species 0.000 description 2
- 241001529716 Entomophaga Species 0.000 description 2
- 241001058146 Erium Species 0.000 description 2
- OPMNROCQHKJDAQ-FKSUSPILSA-N Festucine Chemical compound C1C[C@@H]2O[C@H]3[C@H](NC)[C@@H]2N1C3 OPMNROCQHKJDAQ-FKSUSPILSA-N 0.000 description 2
- 241000122692 Fusarium avenaceum Species 0.000 description 2
- 241000896533 Gliocladium Species 0.000 description 2
- JEFZIKRIDLHOIF-BYPYZUCNSA-N Gln-Gly Chemical compound NC(=O)CC[C@H](N)C(=O)NCC(O)=O JEFZIKRIDLHOIF-BYPYZUCNSA-N 0.000 description 2
- JZDHUJAFXGNDSB-WHFBIAKZSA-N Glu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O JZDHUJAFXGNDSB-WHFBIAKZSA-N 0.000 description 2
- VHLZDSUANXBJHW-UHFFFAOYSA-N Glutaminyl-Phenylalanine Chemical compound NC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 VHLZDSUANXBJHW-UHFFFAOYSA-N 0.000 description 2
- HHSJMSCOLJVTCX-UHFFFAOYSA-N Glutaminyl-Threonine Chemical compound CC(O)C(C(O)=O)NC(=O)C(N)CCC(N)=O HHSJMSCOLJVTCX-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000143459 Hirsutella Species 0.000 description 2
- LNCFUHAPNTYMJB-IUCAKERBSA-N His-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CN=CN1 LNCFUHAPNTYMJB-IUCAKERBSA-N 0.000 description 2
- NIKBMHGRNAPJFW-UHFFFAOYSA-N Histidinyl-Arginine Chemical compound NC(=N)NCCCC(C(O)=O)NC(=O)C(N)CC1=CN=CN1 NIKBMHGRNAPJFW-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241000282619 Hylobates lar Species 0.000 description 2
- RCFDOSNHHZGBOY-ACZMJKKPSA-N Ile-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(O)=O RCFDOSNHHZGBOY-ACZMJKKPSA-N 0.000 description 2
- WMDZARSFSMZOQO-DRZSPHRISA-N Ile-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WMDZARSFSMZOQO-DRZSPHRISA-N 0.000 description 2
- 206010022114 Injury Diseases 0.000 description 2
- 229920001204 Intergenic region Polymers 0.000 description 2
- 229920002424 Internal transcribed spacer Polymers 0.000 description 2
- 239000005909 Kieselgur Substances 0.000 description 2
- DVCSNHXRZUVYAM-BQBZGAKWSA-N Leu-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O DVCSNHXRZUVYAM-BQBZGAKWSA-N 0.000 description 2
- QCZYYEFXOBKCNQ-STQMWFEESA-N Lys-Phe Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QCZYYEFXOBKCNQ-STQMWFEESA-N 0.000 description 2
- MUMXFARPYQTTSL-BQBZGAKWSA-N Met-Gln Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O MUMXFARPYQTTSL-BQBZGAKWSA-N 0.000 description 2
- OGGRSJFVXREKOR-CIUDSAMLSA-N Met-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCSC OGGRSJFVXREKOR-CIUDSAMLSA-N 0.000 description 2
- KAKJTZWHIUWTTD-VQVTYTSYSA-N Met-Thr Chemical compound CSCC[C@H]([NH3+])C(=O)N[C@@H]([C@@H](C)O)C([O-])=O KAKJTZWHIUWTTD-VQVTYTSYSA-N 0.000 description 2
- PESQCPHRXOFIPX-RYUDHWBXSA-N Met-Tyr Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PESQCPHRXOFIPX-RYUDHWBXSA-N 0.000 description 2
- BJFJQOMZCSHBMY-YUMQZZPRSA-N Met-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(O)=O BJFJQOMZCSHBMY-YUMQZZPRSA-N 0.000 description 2
- 239000005807 Metalaxyl Substances 0.000 description 2
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N Metalaxyl Chemical compound COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 description 2
- JMEWFDUAFKVAAT-UHFFFAOYSA-N Methionyl-Asparagine Chemical compound CSCCC(N)C(=O)NC(C(O)=O)CC(N)=O JMEWFDUAFKVAAT-UHFFFAOYSA-N 0.000 description 2
- 206010027626 Milia Diseases 0.000 description 2
- 241000108056 Monas Species 0.000 description 2
- UQOFGTXDASPNLL-XHNCKOQMSA-N Muscarine Chemical compound C[C@@H]1O[C@H](C[N+](C)(C)C)C[C@H]1O UQOFGTXDASPNLL-XHNCKOQMSA-N 0.000 description 2
- 241001645776 Muscodor Species 0.000 description 2
- 241000186359 Mycobacterium Species 0.000 description 2
- 241000344256 Mycosphaerellaceae Species 0.000 description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 2
- 108010066427 N-valyltryptophan Proteins 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 108010013639 Peptidoglycan Proteins 0.000 description 2
- OZILORBBPKKGRI-RYUDHWBXSA-N Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 OZILORBBPKKGRI-RYUDHWBXSA-N 0.000 description 2
- GKZIWHRNKRBEOH-HOTGVXAUSA-N Phe-Phe Chemical compound C([C@H]([NH3+])C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)C1=CC=CC=C1 GKZIWHRNKRBEOH-HOTGVXAUSA-N 0.000 description 2
- SHAQGFGGJSLLHE-BQBZGAKWSA-N Pro-Gln Chemical compound NC(=O)CC[C@@H](C([O-])=O)NC(=O)[C@@H]1CCC[NH2+]1 SHAQGFGGJSLLHE-BQBZGAKWSA-N 0.000 description 2
- OCYROESYHWUPBP-CIUDSAMLSA-N Pro-Ile Chemical compound CC[C@H](C)[C@@H](C([O-])=O)NC(=O)[C@@H]1CCC[NH2+]1 OCYROESYHWUPBP-CIUDSAMLSA-N 0.000 description 2
- IWIANZLCJVYEFX-RYUDHWBXSA-N Pro-Phe Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 IWIANZLCJVYEFX-RYUDHWBXSA-N 0.000 description 2
- STJLVHWMYQXCPB-UHFFFAOYSA-N Propiconazole Chemical compound O1C(CCC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 STJLVHWMYQXCPB-UHFFFAOYSA-N 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- YZMPDHTZJJCGEI-BQBZGAKWSA-N Ser-His Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 YZMPDHTZJJCGEI-BQBZGAKWSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 240000001016 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- PXMNMQRDXWABCY-UHFFFAOYSA-N Tebuconazole Chemical compound C1=NC=NN1CC(O)(C(C)(C)C)CCC1=CC=C(Cl)C=C1 PXMNMQRDXWABCY-UHFFFAOYSA-N 0.000 description 2
- APIDTRXFGYOLLH-VQVTYTSYSA-N Thr-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)[C@@H](C)O APIDTRXFGYOLLH-VQVTYTSYSA-N 0.000 description 2
- IQHUITKNHOKGFC-MIMYLULJSA-N Thr-Phe Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IQHUITKNHOKGFC-MIMYLULJSA-N 0.000 description 2
- QOLYAJSZHIJCTO-VQVTYTSYSA-N Thr-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O QOLYAJSZHIJCTO-VQVTYTSYSA-N 0.000 description 2
- WCRFXRIWBFRZBR-GGVZMXCHSA-N Thr-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 WCRFXRIWBFRZBR-GGVZMXCHSA-N 0.000 description 2
- 229940035295 Ting Drugs 0.000 description 2
- 231100000765 Toxin Toxicity 0.000 description 2
- 241000223259 Trichoderma Species 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- OHGNSVACHBZKSS-KWQFWETISA-N Trp-Ala Chemical compound C1=CC=C2C(C[C@H]([NH3+])C(=O)N[C@@H](C)C([O-])=O)=CNC2=C1 OHGNSVACHBZKSS-KWQFWETISA-N 0.000 description 2
- PWIQCLSQVQBOQV-AAEUAGOBSA-N Trp-Glu Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CNC2=C1 PWIQCLSQVQBOQV-AAEUAGOBSA-N 0.000 description 2
- DZHDVYLBNKMLMB-ZFWWWQNUSA-N Trp-Lys Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCCCN)C(O)=O)=CNC2=C1 DZHDVYLBNKMLMB-ZFWWWQNUSA-N 0.000 description 2
- KBUBZAMBIVEFEI-UHFFFAOYSA-N Tryptophyl-Histidine Chemical compound C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CN=CN1 KBUBZAMBIVEFEI-UHFFFAOYSA-N 0.000 description 2
- NLKUJNGEGZDXGO-XVKPBYJWSA-N Tyr-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NLKUJNGEGZDXGO-XVKPBYJWSA-N 0.000 description 2
- AUEJLPRZGVVDNU-STQMWFEESA-N Tyr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AUEJLPRZGVVDNU-STQMWFEESA-N 0.000 description 2
- ONWMQORSVZYVNH-UHFFFAOYSA-N Tyrosyl-Asparagine Chemical compound NC(=O)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 ONWMQORSVZYVNH-UHFFFAOYSA-N 0.000 description 2
- ZSXJENBJGRHKIG-UHFFFAOYSA-N Tyrosyl-Serine Chemical compound OCC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 ZSXJENBJGRHKIG-UHFFFAOYSA-N 0.000 description 2
- MFEVVAXTBZELLL-UHFFFAOYSA-N Tyrosyl-Threonine Chemical compound CC(O)C(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 MFEVVAXTBZELLL-UHFFFAOYSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Natural products O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- XXDVDTMEVBYRPK-XPUUQOCRSA-N Val-Gln Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O XXDVDTMEVBYRPK-XPUUQOCRSA-N 0.000 description 2
- MBMQEIFVQACCCH-QBODLPLBSA-N Zearalenone Chemical compound O=C1O[C@@H](C)CCCC(=O)CCC\C=C\C2=CC(O)=CC(O)=C21 MBMQEIFVQACCCH-QBODLPLBSA-N 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive Effects 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 108010001271 arginyl-glutamyl-arginine Proteins 0.000 description 2
- 108010059459 arginyl-threonyl-phenylalanine Proteins 0.000 description 2
- 108010068265 aspartyltyrosine Proteins 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt Chemical class [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 229910052803 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Chemical class 0.000 description 2
- 230000001332 colony forming Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000003967 crop rotation Methods 0.000 description 2
- 239000012531 culture fluid Substances 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 230000004059 degradation Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000001809 detectable Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N edta Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 230000002349 favourable Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 244000053095 fungal pathogens Species 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000002068 genetic Effects 0.000 description 2
- 108010079547 glutamylmethionine Proteins 0.000 description 2
- 108010077515 glycylproline Proteins 0.000 description 2
- 108010084389 glycyltryptophan Proteins 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 108010085325 histidylproline Proteins 0.000 description 2
- 108010018006 histidylserine Proteins 0.000 description 2
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 108010077158 leucinyl-arginyl-tryptophan Proteins 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000012139 lysis buffer Substances 0.000 description 2
- 108010054155 lysyllysine Proteins 0.000 description 2
- 108010044655 lysylproline Proteins 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N manganese Chemical class [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Chemical class 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N n-butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 230000001069 nematicidal Effects 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 230000000361 pesticidal Effects 0.000 description 2
- 239000000447 pesticide residue Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108010084525 phenylalanyl-phenylalanyl-glycine Proteins 0.000 description 2
- 108010018625 phenylalanylarginine Proteins 0.000 description 2
- 230000000885 phytotoxic Effects 0.000 description 2
- 101710007479 pkk2A Proteins 0.000 description 2
- 239000003375 plant hormone Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000011118 polyvinyl acetate Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 101700063125 ppk Proteins 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 108010077112 prolyl-proline Proteins 0.000 description 2
- 230000001737 promoting Effects 0.000 description 2
- 238000000163 radioactive labelling Methods 0.000 description 2
- 238000003044 randomized block design Methods 0.000 description 2
- 230000002829 reduced Effects 0.000 description 2
- 229920002973 ribosomal RNA Polymers 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 238000007480 sanger sequencing Methods 0.000 description 2
- 108010071207 serylmethionine Proteins 0.000 description 2
- 230000001568 sexual Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 108010031491 threonyl-lysyl-glutamic acid Proteins 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 108010029384 tryptophyl-histidine Proteins 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 108010020532 tyrosyl-proline Proteins 0.000 description 2
- 229960000200 ulipristal Drugs 0.000 description 2
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- XERJKGMBORTKEO-VZUCSPMQSA-N (1E)-2-(ethylcarbamoylamino)-N-methoxy-2-oxoethanimidoyl cyanide Chemical compound CCNC(=O)NC(=O)C(\C#N)=N\OC XERJKGMBORTKEO-VZUCSPMQSA-N 0.000 description 1
- JSZMKEYEVLDPDO-ACZMJKKPSA-N (2R)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]-3-sulfanylpropanoic acid Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CS)C(O)=O JSZMKEYEVLDPDO-ACZMJKKPSA-N 0.000 description 1
- OAIGZYFGCNNVIE-ZPFDUUQYSA-N (2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylbutanoyl]amino]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(O)=O OAIGZYFGCNNVIE-ZPFDUUQYSA-N 0.000 description 1
- VNYDHJARLHNEGA-RYUDHWBXSA-N (2S)-1-[(2S)-2-azaniumyl-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylate Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=C(O)C=C1 VNYDHJARLHNEGA-RYUDHWBXSA-N 0.000 description 1
- QBJCJWAZOPCNIX-JPLJXNOCSA-N (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-3-methylbutanoic acid Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=CC=C1 QBJCJWAZOPCNIX-JPLJXNOCSA-N 0.000 description 1
- VGMNWQOPSFBBBG-XUXIUFHCSA-N (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]butanedioic acid Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O VGMNWQOPSFBBBG-XUXIUFHCSA-N 0.000 description 1
- BUZMZDDKFCSKOT-CIUDSAMLSA-N (2S)-2-[[(2S)-2-[[(2S)-2-amino-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]pentanedioic acid Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O BUZMZDDKFCSKOT-CIUDSAMLSA-N 0.000 description 1
- VKVDRTGWLVZJOM-DCAQKATOSA-N (2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O VKVDRTGWLVZJOM-DCAQKATOSA-N 0.000 description 1
- ZAVCJRJOQKIOJW-KKUMJFAQSA-N (2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]butanedioic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CC=CC=C1 ZAVCJRJOQKIOJW-KKUMJFAQSA-N 0.000 description 1
- KYPMKDGKAYQCHO-RYUDHWBXSA-N (2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylsulfanylbutanoic acid Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 KYPMKDGKAYQCHO-RYUDHWBXSA-N 0.000 description 1
- LZDNBBYBDGBADK-KBPBESRZSA-N (2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 LZDNBBYBDGBADK-KBPBESRZSA-N 0.000 description 1
- NIZKGBJVCMRDKO-KWQFWETISA-N (2S)-2-[[2-[[(2S)-2-aminopropanoyl]amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoic acid Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NIZKGBJVCMRDKO-KWQFWETISA-N 0.000 description 1
- NBTGEURICRTMGL-WHFBIAKZSA-N (2S)-2-[[2-[[(2S)-2-aminopropanoyl]amino]acetyl]amino]-3-hydroxypropanoic acid Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O NBTGEURICRTMGL-WHFBIAKZSA-N 0.000 description 1
- BIZNDKMFQHDOIE-KKUMJFAQSA-N (2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-4-oxobutanoic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(O)=O)CC1=CC=CC=C1 BIZNDKMFQHDOIE-KKUMJFAQSA-N 0.000 description 1
- BUDNAJYVCUHLSV-ZLUOBGJFSA-N (3S)-3-[[(2S)-2-aminopropanoyl]amino]-4-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-4-oxobutanoic acid Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O BUDNAJYVCUHLSV-ZLUOBGJFSA-N 0.000 description 1
- KXTAGESXNQEZKB-DZKIICNBSA-N (4S)-4-amino-5-[[(2S)-1-[[(1S)-1-carboxy-2-methylpropyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-oxopentanoic acid Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=CC=C1 KXTAGESXNQEZKB-DZKIICNBSA-N 0.000 description 1
- WTMZXOPHTIVFCP-QEWYBTABSA-N (4S)-4-amino-5-[[(2S,3S)-1-[[(1S)-1-carboxy-2-phenylethyl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WTMZXOPHTIVFCP-QEWYBTABSA-N 0.000 description 1
- LGXVIGDEPROXKC-UHFFFAOYSA-N 1,1-Dichloroethene Chemical compound ClC(Cl)=C LGXVIGDEPROXKC-UHFFFAOYSA-N 0.000 description 1
- AAILEWXSEQLMNI-UHFFFAOYSA-N 1H-pyridazin-6-one Chemical class OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 description 1
- SVPKNMBRVBMTLB-UHFFFAOYSA-N 2,3-dichloronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(Cl)=C(Cl)C(=O)C2=C1 SVPKNMBRVBMTLB-UHFFFAOYSA-N 0.000 description 1
- CGNBQYFXGQHUQP-UHFFFAOYSA-N 2,3-dinitroaniline Chemical class NC1=CC=CC([N+]([O-])=O)=C1[N+]([O-])=O CGNBQYFXGQHUQP-UHFFFAOYSA-N 0.000 description 1
- GQWWGRUJOCIUKI-UHFFFAOYSA-N 2-[3-(2-methyl-1-oxopyrrolo[1,2-a]pyrazin-3-yl)propyl]guanidine Chemical compound O=C1N(C)C(CCCN=C(N)N)=CN2C=CC=C21 GQWWGRUJOCIUKI-UHFFFAOYSA-N 0.000 description 1
- WNGVUZWBXZKQES-YUMQZZPRSA-N 2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]propanoyl]amino]acetic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O WNGVUZWBXZKQES-YUMQZZPRSA-N 0.000 description 1
- VWHGTYCRDRBSFI-ZETCQYMHSA-N 2-[[2-[[(2S)-2-amino-4-methylpentanoyl]amino]acetyl]amino]acetic acid Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)NCC(O)=O VWHGTYCRDRBSFI-ZETCQYMHSA-N 0.000 description 1
- LFSAPCRASZRSKS-UHFFFAOYSA-N 2-methylcyclohexan-1-one Chemical compound CC1CCCCC1=O LFSAPCRASZRSKS-UHFFFAOYSA-N 0.000 description 1
- CMLFRMDBDNHMRA-UHFFFAOYSA-N 2H-1,2-benzoxazine Chemical class C1=CC=C2C=CNOC2=C1 CMLFRMDBDNHMRA-UHFFFAOYSA-N 0.000 description 1
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2H-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 description 1
- AGIJRRREJXSQJR-UHFFFAOYSA-N 2H-thiazine Chemical compound N1SC=CC=C1 AGIJRRREJXSQJR-UHFFFAOYSA-N 0.000 description 1
- ZXVONLUNISGICL-UHFFFAOYSA-N 4,6-dinitro-o-cresol Chemical compound CC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O ZXVONLUNISGICL-UHFFFAOYSA-N 0.000 description 1
- QZHXKQKKEBXYRG-UHFFFAOYSA-N 4-N-(4-aminophenyl)benzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1NC1=CC=C(N)C=C1 QZHXKQKKEBXYRG-UHFFFAOYSA-N 0.000 description 1
- HKTRDWYCAUTRRL-UHFFFAOYSA-N 4-amino-5-[[1-carboxy-2-(1H-imidazol-5-yl)ethyl]amino]-5-oxopentanoic acid Chemical compound OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CN=CN1 HKTRDWYCAUTRRL-UHFFFAOYSA-N 0.000 description 1
- 108010036211 5-HT-moduline Proteins 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N AI2O3 Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N Acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- XAEWTDMGFGHWFK-IMJSIDKUSA-N Ala-Asp Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O XAEWTDMGFGHWFK-IMJSIDKUSA-N 0.000 description 1
- 108010040956 Ala-Asp-Glu-Leu Proteins 0.000 description 1
- 108010076441 Ala-His-His Proteins 0.000 description 1
- FSHURBQASBLAPO-WDSKDSINSA-N Ala-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](C)N FSHURBQASBLAPO-WDSKDSINSA-N 0.000 description 1
- WUGMRIBZSVSJNP-UFBFGSQYSA-N Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UFBFGSQYSA-N 0.000 description 1
- 241000251169 Alopias vulpinus Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- PZZYQPZGQPZBDN-UHFFFAOYSA-N Aluminium silicate Chemical compound O=[Al]O[Si](=O)O[Al]=O PZZYQPZGQPZBDN-UHFFFAOYSA-N 0.000 description 1
- 241000609240 Ambelania acida Species 0.000 description 1
- RZVHIXYEVGDQDX-UHFFFAOYSA-N Anthraquinone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C(=O)C2=C1 RZVHIXYEVGDQDX-UHFFFAOYSA-N 0.000 description 1
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- 241000239223 Arachnida Species 0.000 description 1
- SIFXMYAHXJGAFC-WDSKDSINSA-N Arg-Asp Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O SIFXMYAHXJGAFC-WDSKDSINSA-N 0.000 description 1
- 241001443610 Aschersonia Species 0.000 description 1
- HZYFHQOWCFUSOV-IMJSIDKUSA-N Asn-Asp Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O HZYFHQOWCFUSOV-IMJSIDKUSA-N 0.000 description 1
- GADKFYNESXNRLC-WDSKDSINSA-N Asn-Pro Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O GADKFYNESXNRLC-WDSKDSINSA-N 0.000 description 1
- KWBQPGIYEZKDEG-FSPLSTOPSA-N Asn-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(N)=O KWBQPGIYEZKDEG-FSPLSTOPSA-N 0.000 description 1
- YZQCXOFQZKCETR-UWVGGRQHSA-N Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YZQCXOFQZKCETR-UWVGGRQHSA-N 0.000 description 1
- NALWOULWGHTVDA-UWVGGRQHSA-N Asp-Tyr Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NALWOULWGHTVDA-UWVGGRQHSA-N 0.000 description 1
- CPMKYMGGYUFOHS-FSPLSTOPSA-N Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O CPMKYMGGYUFOHS-FSPLSTOPSA-N 0.000 description 1
- QJMCHPGWFZZRID-UHFFFAOYSA-N Asparaginyl-Lysine Chemical compound NCCCCC(C(O)=O)NC(=O)C(N)CC(N)=O QJMCHPGWFZZRID-UHFFFAOYSA-N 0.000 description 1
- VBKIFHUVGLOJKT-UHFFFAOYSA-N Asparaginyl-Threonine Chemical compound CC(O)C(C(O)=O)NC(=O)C(N)CC(N)=O VBKIFHUVGLOJKT-UHFFFAOYSA-N 0.000 description 1
- VGRHZPNRCLAHQA-UHFFFAOYSA-N Aspartyl-Asparagine Chemical compound OC(=O)CC(N)C(=O)NC(CC(N)=O)C(O)=O VGRHZPNRCLAHQA-UHFFFAOYSA-N 0.000 description 1
- FKBFDTRILNZGAI-UHFFFAOYSA-N Aspartyl-Cysteine Chemical compound OC(=O)CC(N)C(=O)NC(CS)C(O)=O FKBFDTRILNZGAI-UHFFFAOYSA-N 0.000 description 1
- 241000223651 Aureobasidium Species 0.000 description 1
- 101700051947 BACE2 Proteins 0.000 description 1
- 102100015648 BACE2 Human genes 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 240000008371 Bacillus subtilis Species 0.000 description 1
- 229940075615 Bacillus subtilis Drugs 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000006379 Bacillus weihenstephanensis Species 0.000 description 1
- 241001302652 Bassiana Species 0.000 description 1
- RIOXQFHNBCKOKP-UHFFFAOYSA-N Benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 241000555281 Brevibacillus Species 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 101710024722 CCT3 Proteins 0.000 description 1
- 102100004276 CCT3 Human genes 0.000 description 1
- 229960005069 Calcium Drugs 0.000 description 1
- 229960003563 Calcium Carbonate Drugs 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 240000000218 Cannabis sativa Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- JHRWWRDRBPCWTF-OLQVQODUSA-N Captafol Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)C(Cl)Cl)C(=O)[C@H]21 JHRWWRDRBPCWTF-OLQVQODUSA-N 0.000 description 1
- 210000002421 Cell Wall Anatomy 0.000 description 1
- 241001157813 Cercospora Species 0.000 description 1
- 240000001817 Cereus hexagonus Species 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 241000221955 Chaetomium Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- DJHJJVWPFGHIPH-OODMECLYSA-N Chitin Chemical compound O[C@@H]1C(NC(=O)C)[C@H](O)OC(CO)[C@H]1COC[C@H]1C(NC(C)=O)[C@@H](O)[C@H](COC[C@H]2C([C@@H](O)[C@H](O)C(CO)O2)NC(C)=O)C(CO)O1 DJHJJVWPFGHIPH-OODMECLYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 241000248757 Cordyceps brongniartii Species 0.000 description 1
- 241001264174 Cordyceps militaris Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 239000005756 Cymoxanil Substances 0.000 description 1
- HAYVTMHUNMMXCV-UHFFFAOYSA-N Cysteinyl-Alanine Chemical compound OC(=O)C(C)NC(=O)C(N)CS HAYVTMHUNMMXCV-UHFFFAOYSA-N 0.000 description 1
- RGTVXXNMOGHRAY-UHFFFAOYSA-N Cysteinyl-Arginine Chemical compound SCC(N)C(=O)NC(C(O)=O)CCCNC(N)=N RGTVXXNMOGHRAY-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101700061444 DDX25 Proteins 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 240000002860 Daucus carota Species 0.000 description 1
- 235000002243 Daucus carota subsp sativus Nutrition 0.000 description 1
- YRMLFORXOOIJDR-UHFFFAOYSA-N Dichlormid Chemical compound ClC(Cl)C(=O)N(CC=C)CC=C YRMLFORXOOIJDR-UHFFFAOYSA-N 0.000 description 1
- 102000016938 EC 1.11.1.6 Human genes 0.000 description 1
- 108010053835 EC 1.11.1.6 Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 229960002125 Enilconazole Drugs 0.000 description 1
- PZBPKYOVPCNPJY-UHFFFAOYSA-N Enilconazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=C)CN1C=NC=C1 PZBPKYOVPCNPJY-UHFFFAOYSA-N 0.000 description 1
- 241000237537 Ensis Species 0.000 description 1
- 241000147179 Entomophaga maimaiga Species 0.000 description 1
- XDBBZHXTFQZTEO-ZWNOBZJWSA-N Ergoline Chemical compound C1C([C]23)=CN=C3C=CC=C2[C@@H]2[C@@H]1NCCC2 XDBBZHXTFQZTEO-ZWNOBZJWSA-N 0.000 description 1
- DNVPQKQSNYMLRS-APGDWVJJSA-N Ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-APGDWVJJSA-N 0.000 description 1
- DNVPQKQSNYMLRS-LNHMRCHQSA-N Ergosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3C([C@H]4[C@@](C)([C@H]([C@@H](/C=C/[C@H](C(C)C)C)C)CC4)CC3)=CC=2)CC1 DNVPQKQSNYMLRS-LNHMRCHQSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 230000036809 Fabs Effects 0.000 description 1
- NHOWDZOIZKMVAI-UHFFFAOYSA-N Fenarimol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(Cl)C=C1 NHOWDZOIZKMVAI-UHFFFAOYSA-N 0.000 description 1
- FQKUGOMFVDPBIZ-UHFFFAOYSA-N Flusilazole Chemical compound C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 FQKUGOMFVDPBIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005789 Folpet Substances 0.000 description 1
- 208000004770 Fusariosis Diseases 0.000 description 1
- 241000223194 Fusarium culmorum Species 0.000 description 1
- 206010051919 Fusarium infection Diseases 0.000 description 1
- 241001489200 Fusarium poae Species 0.000 description 1
- 108060003107 GATC Proteins 0.000 description 1
- 101700032567 GATM Proteins 0.000 description 1
- 101700002510 GCAT Proteins 0.000 description 1
- 208000008665 Gastrointestinal Disease Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000626621 Geobacillus Species 0.000 description 1
- LOJYQMFIIJVETK-WDSKDSINSA-N Gln-Gln Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O LOJYQMFIIJVETK-WDSKDSINSA-N 0.000 description 1
- 241000235503 Glomus Species 0.000 description 1
- SSHIXEILTLPAQT-UHFFFAOYSA-N Glutaminyl-Aspartate Chemical compound NC(=O)CCC(N)C(=O)NC(CC(O)=O)C(O)=O SSHIXEILTLPAQT-UHFFFAOYSA-N 0.000 description 1
- JBCLFWXMTIKCCB-VIFPVBQESA-N Gly-Phe Chemical compound NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-VIFPVBQESA-N 0.000 description 1
- AJHCSUXXECOXOY-NSHDSACASA-N Gly-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-NSHDSACASA-N 0.000 description 1
- 240000007842 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 239000005562 Glyphosate Substances 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-O Glyphosate Chemical compound OC(=O)C[NH2+]CP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-O 0.000 description 1
- 240000006962 Gossypium hirsutum Species 0.000 description 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 1
- 229940093915 Gynecological Organic acids Drugs 0.000 description 1
- 240000006669 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- MDCTVRUPVLZSPG-BQBZGAKWSA-N His-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CNC=N1 MDCTVRUPVLZSPG-BQBZGAKWSA-N 0.000 description 1
- LYCVKHSJGDMDLM-LURJTMIESA-N His-Gly Chemical compound OC(=O)CNC(=O)[C@@H](N)CC1=CN=CN1 LYCVKHSJGDMDLM-LURJTMIESA-N 0.000 description 1
- KRBMQYPTDYSENE-BQBZGAKWSA-N His-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CNC=N1 KRBMQYPTDYSENE-BQBZGAKWSA-N 0.000 description 1
- HTOOKGDPMXSJSY-STQMWFEESA-N His-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CN=CN1 HTOOKGDPMXSJSY-STQMWFEESA-N 0.000 description 1
- MAJYPBAJPNUFPV-UHFFFAOYSA-N Histidinyl-Cysteine Chemical compound SCC(C(O)=O)NC(=O)C(N)CC1=CN=CN1 MAJYPBAJPNUFPV-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- HZYHBDVRCBDJJV-HAFWLYHUSA-N Ile-Asn Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O HZYHBDVRCBDJJV-HAFWLYHUSA-N 0.000 description 1
- TUYOFUHICRWDGA-CIUDSAMLSA-N Ile-Met Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CCSC TUYOFUHICRWDGA-CIUDSAMLSA-N 0.000 description 1
- 239000005795 Imazalil Substances 0.000 description 1
- RSAZYXZUJROYKR-UHFFFAOYSA-N Indophenol Chemical compound C1=CC(O)=CC=C1N=C1C=CC(=O)C=C1 RSAZYXZUJROYKR-UHFFFAOYSA-N 0.000 description 1
- 241000030456 Isaria farinosa Species 0.000 description 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
- 241000026993 Jeotgalibacillus Species 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 1
- 241001112724 Lactobacillales Species 0.000 description 1
- 229940039696 Lactobacillus Drugs 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- HIZYETOZLYFUFF-BQBZGAKWSA-N Leu-Cys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CS)C(O)=O HIZYETOZLYFUFF-BQBZGAKWSA-N 0.000 description 1
- KFKWRHQBZQICHA-STQMWFEESA-N Leu-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KFKWRHQBZQICHA-STQMWFEESA-N 0.000 description 1
- BQVUABVGYYSDCJ-ZFWWWQNUSA-N Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-ZFWWWQNUSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- NVGBPTNZLWRQSY-UWVGGRQHSA-N Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN NVGBPTNZLWRQSY-UWVGGRQHSA-N 0.000 description 1
- AIXUQKMMBQJZCU-IUCAKERBSA-N Lys-Pro Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O AIXUQKMMBQJZCU-IUCAKERBSA-N 0.000 description 1
- YSZNURNVYFUEHC-BQBZGAKWSA-N Lys-Ser Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(O)=O YSZNURNVYFUEHC-BQBZGAKWSA-N 0.000 description 1
- MYTOTTSMVMWVJN-STQMWFEESA-N Lys-Tyr Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 MYTOTTSMVMWVJN-STQMWFEESA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- YKSNLCVSTHTHJA-UHFFFAOYSA-L Maneb Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S YKSNLCVSTHTHJA-UHFFFAOYSA-L 0.000 description 1
- 241000908212 Mariannaea Species 0.000 description 1
- JHKXZYLNVJRAAJ-WDSKDSINSA-N Met-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(O)=O JHKXZYLNVJRAAJ-WDSKDSINSA-N 0.000 description 1
- UASDAHIAHBRZQV-YUMQZZPRSA-N Met-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N UASDAHIAHBRZQV-YUMQZZPRSA-N 0.000 description 1
- QTZXSYBVOSXBEJ-WDSKDSINSA-N Met-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O QTZXSYBVOSXBEJ-WDSKDSINSA-N 0.000 description 1
- IMTUWVJPCQPJEE-IUCAKERBSA-N Met-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN IMTUWVJPCQPJEE-IUCAKERBSA-N 0.000 description 1
- 241000223250 Metarhizium anisopliae Species 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N Methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- NDYNTQWSJLPEMK-UHFFFAOYSA-N Methionyl-Cysteine Chemical compound CSCCC(N)C(=O)NC(CS)C(O)=O NDYNTQWSJLPEMK-UHFFFAOYSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- VZUNGTLZRAYYDE-UHFFFAOYSA-N Methylnitronitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 1
- 108060004843 Mical Proteins 0.000 description 1
- 241000947859 Microdochium Species 0.000 description 1
- 241000223196 Microdochium nivale Species 0.000 description 1
- 210000004080 Milk Anatomy 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 241001645777 Muscodor albus Species 0.000 description 1
- 239000005811 Myclobutanil Substances 0.000 description 1
- HZJKXKUJVSEEFU-UHFFFAOYSA-N Myclobutanil Chemical compound C=1C=C(Cl)C=CC=1C(CCCC)(C#N)CN1C=NC=N1 HZJKXKUJVSEEFU-UHFFFAOYSA-N 0.000 description 1
- GRSMWKLPSNHDHA-UHFFFAOYSA-N Naphthalic anhydride Chemical class C1=CC(C(=O)OC2=O)=C3C2=CC=CC3=C1 GRSMWKLPSNHDHA-UHFFFAOYSA-N 0.000 description 1
- 241000366215 Neozygites floridana Species 0.000 description 1
- 241000157296 Nomuraea Species 0.000 description 1
- 229920000272 Oligonucleotide Polymers 0.000 description 1
- 241000855107 Ophiocordyceps entomorrhiza Species 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- 241001656390 Ophiocordyceps sphecocephala Species 0.000 description 1
- 241000530427 Ophiocordyceps variabilis Species 0.000 description 1
- 210000004681 Ovum Anatomy 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N Oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 229960000625 Oxytetracycline Drugs 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 241001236817 Paecilomyces <Clavicipitaceae> Species 0.000 description 1
- 241000179039 Paenibacillus Species 0.000 description 1
- 241001289563 Pandora <zygomycete> Species 0.000 description 1
- 241000520272 Pantoea Species 0.000 description 1
- LKPLKUMXSAEKID-UHFFFAOYSA-N Pentachloronitrobenzene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl LKPLKUMXSAEKID-UHFFFAOYSA-N 0.000 description 1
- IZUPBVBPLAPZRR-UHFFFAOYSA-N Pentachlorophenol Chemical compound OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl IZUPBVBPLAPZRR-UHFFFAOYSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- OHUXOEXBXPZKPT-STQMWFEESA-N Phe-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)C1=CC=CC=C1 OHUXOEXBXPZKPT-STQMWFEESA-N 0.000 description 1
- ROHDXJUFQVRDAV-UWVGGRQHSA-N Phe-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 ROHDXJUFQVRDAV-UWVGGRQHSA-N 0.000 description 1
- 229940067631 Phospholipids Drugs 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N Phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 240000000129 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 241001085205 Prenanthella exigua Species 0.000 description 1
- JQOHKCDMINQZRV-WDSKDSINSA-N Pro-Asn Chemical compound NC(=O)C[C@@H](C([O-])=O)NC(=O)[C@@H]1CCC[NH2+]1 JQOHKCDMINQZRV-WDSKDSINSA-N 0.000 description 1
- AFWBWPCXSWUCLB-WDSKDSINSA-N Pro-Ser Chemical compound OC[C@@H](C([O-])=O)NC(=O)[C@@H]1CCC[NH2+]1 AFWBWPCXSWUCLB-WDSKDSINSA-N 0.000 description 1
- 239000005820 Prochloraz Substances 0.000 description 1
- HXNYBZQLBWIADP-UHFFFAOYSA-N Prolyl-Cysteine Chemical compound OC(=O)C(CS)NC(=O)C1CCCN1 HXNYBZQLBWIADP-UHFFFAOYSA-N 0.000 description 1
- BEPSGCXDIVACBU-UHFFFAOYSA-N Prolyl-Histidine Chemical compound C1CCNC1C(=O)NC(C(=O)O)CC1=CN=CN1 BEPSGCXDIVACBU-UHFFFAOYSA-N 0.000 description 1
- 239000005822 Propiconazole Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 241000899394 Pseudocercospora Species 0.000 description 1
- 108010025216 RVF peptide Proteins 0.000 description 1
- 241000173767 Ramularia Species 0.000 description 1
- 241000589180 Rhizobium Species 0.000 description 1
- 229920002049 Ribosomal DNA Polymers 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 101710023380 S100A8 Proteins 0.000 description 1
- 101710042981 SHMT1 Proteins 0.000 description 1
- 101710044969 SLC18A1 Proteins 0.000 description 1
- 101710028729 SLC25A20 Proteins 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 240000002057 Secale cereale Species 0.000 description 1
- DUIOPKIIICUYRZ-UHFFFAOYSA-N Semicarbazide Chemical compound NNC(N)=O DUIOPKIIICUYRZ-UHFFFAOYSA-N 0.000 description 1
- 241001533598 Septoria Species 0.000 description 1
- LTFSLKWFMWZEBD-IMJSIDKUSA-N Ser-Asn Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O LTFSLKWFMWZEBD-IMJSIDKUSA-N 0.000 description 1
- UJTZHGHXJKIAOS-WHFBIAKZSA-N Ser-Gln Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O UJTZHGHXJKIAOS-WHFBIAKZSA-N 0.000 description 1
- PBUXMVYWOSKHMF-WDSKDSINSA-N Ser-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CO PBUXMVYWOSKHMF-WDSKDSINSA-N 0.000 description 1
- SBMNPABNWKXNBJ-UHFFFAOYSA-N Serinyl-Lysine Chemical compound NCCCCC(C(O)=O)NC(=O)C(N)CO SBMNPABNWKXNBJ-UHFFFAOYSA-N 0.000 description 1
- LZLREEUGSYITMX-UHFFFAOYSA-N Serinyl-Tryptophan Chemical compound C1=CC=C2C(CC(NC(=O)C(CO)N)C(O)=O)=CNC2=C1 LZLREEUGSYITMX-UHFFFAOYSA-N 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N Sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 241000222068 Sporobolomyces <Sporidiobolaceae> Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 229960005322 Streptomycin Drugs 0.000 description 1
- 101700078799 TCP1 Proteins 0.000 description 1
- 102100005486 TCP1 Human genes 0.000 description 1
- 241000228341 Talaromyces Species 0.000 description 1
- 239000005839 Tebuconazole Substances 0.000 description 1
- 239000005842 Thiophanate-methyl Substances 0.000 description 1
- 239000005843 Thiram Substances 0.000 description 1
- KUAZQDVKQLNFPE-UHFFFAOYSA-N Thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 description 1
- VPZKQTYZIVOJDV-LMVFSUKVSA-N Thr-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(O)=O VPZKQTYZIVOJDV-LMVFSUKVSA-N 0.000 description 1
- 235000015450 Tilia cordata Nutrition 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 1
- WURBVZBTWMNKQT-UHFFFAOYSA-N Triadimefon Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
- DQJCHOQLCLEDLL-UHFFFAOYSA-O Tricyclazole Chemical compound CC1=CC=CC2=C1N1C=N[NH+]=C1S2 DQJCHOQLCLEDLL-UHFFFAOYSA-O 0.000 description 1
- 235000019714 Triticale Nutrition 0.000 description 1
- HWKQNAWCHQMZHK-UHFFFAOYSA-N Trolnitrate Chemical compound [O-][N+](=O)OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O HWKQNAWCHQMZHK-UHFFFAOYSA-N 0.000 description 1
- LCPVBXOHXMBLFW-JSGCOSHPSA-N Trp-Arg Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)=CNC2=C1 LCPVBXOHXMBLFW-JSGCOSHPSA-N 0.000 description 1
- UYKREHOKELZSPB-JTQLQIEISA-N Trp-Gly Chemical compound C1=CC=C2C(C[C@H](N)C(=O)NCC(O)=O)=CNC2=C1 UYKREHOKELZSPB-JTQLQIEISA-N 0.000 description 1
- MYVYPSWUSKCCHG-JQWIXIFHSA-N Trp-Ser Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CO)C(O)=O)=CNC2=C1 MYVYPSWUSKCCHG-JQWIXIFHSA-N 0.000 description 1
- TYYLDKGBCJGJGW-WMZOPIPTSA-N Trp-Tyr Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)N)C(O)=O)C1=CC=C(O)C=C1 TYYLDKGBCJGJGW-WMZOPIPTSA-N 0.000 description 1
- LWFWZRANSFAJDR-JSGCOSHPSA-N Trp-Val Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C(C)C)C(O)=O)=CNC2=C1 LWFWZRANSFAJDR-JSGCOSHPSA-N 0.000 description 1
- DXYQIGZZWYBXSD-UHFFFAOYSA-N Tryptophyl-Proline Chemical compound C=1NC2=CC=CC=C2C=1CC(N)C(=O)N1CCCC1C(O)=O DXYQIGZZWYBXSD-UHFFFAOYSA-N 0.000 description 1
- YBRHKUNWEYBZGT-UHFFFAOYSA-N Tryptophyl-Threonine Chemical compound C1=CC=C2C(CC(N)C(=O)NC(C(O)C)C(O)=O)=CNC2=C1 YBRHKUNWEYBZGT-UHFFFAOYSA-N 0.000 description 1
- AOLHUMAVONBBEZ-STQMWFEESA-N Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AOLHUMAVONBBEZ-STQMWFEESA-N 0.000 description 1
- CGWAPUBOXJWXMS-HOTGVXAUSA-N Tyr-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 CGWAPUBOXJWXMS-HOTGVXAUSA-N 0.000 description 1
- BMPPMAOOKQJYIP-WMZOPIPTSA-N Tyr-Trp Chemical compound C([C@H]([NH3+])C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C([O-])=O)C1=CC=C(O)C=C1 BMPPMAOOKQJYIP-WMZOPIPTSA-N 0.000 description 1
- QZOSVNLXLSNHQK-UHFFFAOYSA-N Tyrosyl-Aspartate Chemical compound OC(=O)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 QZOSVNLXLSNHQK-UHFFFAOYSA-N 0.000 description 1
- 229940029983 VITAMINS Drugs 0.000 description 1
- YSGSDAIMSCVPHG-YUMQZZPRSA-N Val-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)C(C)C YSGSDAIMSCVPHG-YUMQZZPRSA-N 0.000 description 1
- VEYJKJORLPYVLO-RYUDHWBXSA-N Val-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 VEYJKJORLPYVLO-RYUDHWBXSA-N 0.000 description 1
- WPSXZFTVLIAPCN-UHFFFAOYSA-N Valyl-Cysteine Chemical compound CC(C)C(N)C(=O)NC(CS)C(O)=O WPSXZFTVLIAPCN-UHFFFAOYSA-N 0.000 description 1
- 241000721373 Variovorax dokdonensis Species 0.000 description 1
- 241000168661 Variovorax soli Species 0.000 description 1
- 241001659629 Virgibacillus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N Xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 244000150668 Zea mays subsp mays Species 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 239000005870 Ziram Substances 0.000 description 1
- 241000142944 Zoophthora radicans Species 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 230000036579 abiotic stress Effects 0.000 description 1
- 150000003869 acetamides Chemical class 0.000 description 1
- CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 239000002998 adhesive polymer Substances 0.000 description 1
- 230000035492 administration Effects 0.000 description 1
- 238000009632 agar plate Methods 0.000 description 1
- 108010008685 alanyl-glutamyl-aspartic acid Proteins 0.000 description 1
- 108010066829 alanyl-glutamyl-aspartylprolyine Proteins 0.000 description 1
- 108010039538 alanyl-glycyl-aspartyl-valine Proteins 0.000 description 1
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 1
- 108010069020 alanyl-prolyl-glycine Proteins 0.000 description 1
- 108010086434 alanyl-seryl-glycine Proteins 0.000 description 1
- 108010045350 alanyl-tyrosyl-alanine Proteins 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 1
- 108010009111 arginyl-glycyl-glutamic acid Proteins 0.000 description 1
- 108010038850 arginyl-isoleucyl-tyrosine Proteins 0.000 description 1
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 1
- 108010084758 arginyl-tyrosyl-aspartic acid Proteins 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 101700065210 asp1 Proteins 0.000 description 1
- 229960000892 attapulgite Drugs 0.000 description 1
- 125000000751 azo group Chemical group [*]N=N[*] 0.000 description 1
- 239000010905 bagasse Substances 0.000 description 1
- 238000002869 basic local alignment search tool Methods 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001559 benzoic acids Chemical class 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000037348 biosynthesis Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N boron Chemical class [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 235000010633 broth Nutrition 0.000 description 1
- 230000001680 brushing Effects 0.000 description 1
- 230000003139 buffering Effects 0.000 description 1
- 101700006045 cact Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229920005551 calcium lignosulfonate Polymers 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- FLKYBGKDCCEQQM-WYUVZMMLSA-M cefazolin sodium Chemical compound [Na+].S1C(C)=NN=C1SCC1=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 FLKYBGKDCCEQQM-WYUVZMMLSA-M 0.000 description 1
- 241000902900 cellular organisms Species 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000001427 coherent Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000001609 comparable Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 108010060199 cysteinylproline Proteins 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- BIXZHMJUSMUDOQ-UHFFFAOYSA-N dichloran Chemical compound NC1=C(Cl)C=C([N+]([O-])=O)C=C1Cl BIXZHMJUSMUDOQ-UHFFFAOYSA-N 0.000 description 1
- 229940004812 dicloran Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- KARVSHNNUWMXFO-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane;hydrate Chemical compound O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Al]O[Al]=O KARVSHNNUWMXFO-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000024346 drought recovery Effects 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- TUCNEACPLKLKNU-UHFFFAOYSA-N ethanone Chemical class C[C]=O TUCNEACPLKLKNU-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- HKIOYBQGHSTUDB-UHFFFAOYSA-N folpet Chemical compound C1=CC=C2C(=O)N(SC(Cl)(Cl)Cl)C(=O)C2=C1 HKIOYBQGHSTUDB-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Chemical class O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 241000957301 fungal endophyte Species 0.000 description 1
- 108010006664 gamma-glutamyl-glycyl-glycine Proteins 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 1
- 108010008237 glutamyl-valyl-glycine Proteins 0.000 description 1
- KZNQNBZMBZJQJO-YFKPBYRVSA-N gly pro Chemical compound NCC(=O)N1CCC[C@H]1C(O)=O KZNQNBZMBZJQJO-YFKPBYRVSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 230000003899 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 108010090037 glycyl-alanyl-isoleucine Proteins 0.000 description 1
- 108010000434 glycyl-alanyl-leucine Proteins 0.000 description 1
- 108010026364 glycyl-glycyl-leucine Proteins 0.000 description 1
- 108010051307 glycyl-glycyl-proline Proteins 0.000 description 1
- 108010066198 glycyl-leucyl-phenylalanine Proteins 0.000 description 1
- 108010079413 glycyl-prolyl-glutamic acid Proteins 0.000 description 1
- 108010043293 glycyl-prolyl-glycyl-glycine Proteins 0.000 description 1
- 108010048994 glycyl-tyrosyl-alanine Proteins 0.000 description 1
- 108010081551 glycylphenylalanine Proteins 0.000 description 1
- 229940097068 glyphosate Drugs 0.000 description 1
- 239000005431 greenhouse gas Substances 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002008 hemorrhagic Effects 0.000 description 1
- 244000038280 herbivores Species 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 108010045383 histidyl-glycyl-glutamic acid Proteins 0.000 description 1
- 108010092114 histidylphenylalanine Proteins 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000003864 humus Substances 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940079866 intestinal antibiotics Drugs 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 239000003621 irrigation water Substances 0.000 description 1
- 108010027338 isoleucylcysteine Proteins 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 238000011031 large scale production Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 108010083708 leucyl-aspartyl-valine Proteins 0.000 description 1
- 108010087810 leucyl-seryl-glutamyl-leucine Proteins 0.000 description 1
- 108010012058 leucyltyrosine Proteins 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229930013606 loline Natural products 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229920000940 maneb Polymers 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- NYGZLYXAPMMJTE-UHFFFAOYSA-M metanil yellow Chemical group [Na+].[O-]S(=O)(=O)C1=CC=CC(N=NC=2C=CC(NC=3C=CC=CC=3)=CC=2)=C1 NYGZLYXAPMMJTE-UHFFFAOYSA-M 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- 108010085203 methionylmethionine Proteins 0.000 description 1
- 108010068488 methionylphenylalanine Proteins 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 239000012569 microbial contaminant Substances 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- MEFBJEMVZONFCJ-UHFFFAOYSA-N molybdate Chemical compound [O-][Mo]([O-])(=O)=O MEFBJEMVZONFCJ-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N molybdenum Chemical class [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Chemical class 0.000 description 1
- 238000009343 monoculture Methods 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 230000000877 morphologic Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 229940042880 natural phospholipids Drugs 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate Chemical class [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000000018 nitroso group Chemical group N(=O)* 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N o-xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- UWVQIROCRJWDKL-UHFFFAOYSA-N oxadixyl Chemical compound CC=1C=CC=C(C)C=1N(C(=O)COC)N1CCOC1=O UWVQIROCRJWDKL-UHFFFAOYSA-N 0.000 description 1
- 125000000160 oxazolidinyl group Chemical class 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- AMEKQAFGQBKLKX-UHFFFAOYSA-N oxycarboxin Chemical compound O=S1(=O)CCOC(C)=C1C(=O)NC1=CC=CC=C1 AMEKQAFGQBKLKX-UHFFFAOYSA-N 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 229910052625 palygorskite Inorganic materials 0.000 description 1
- 230000003071 parasitic Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000003415 peat Substances 0.000 description 1
- 230000000149 penetrating Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000003209 petroleum derivative Substances 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 108010074082 phenylalanyl-alanyl-lysine Proteins 0.000 description 1
- 108010058453 phenylalanyl-glutamyl-glycine Proteins 0.000 description 1
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 1
- 108010024654 phenylalanyl-prolyl-alanine Proteins 0.000 description 1
- 108010073101 phenylalanylleucine Proteins 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- 108010051242 phenylalanylserine Proteins 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000000865 phosphorylative Effects 0.000 description 1
- 230000000243 photosynthetic Effects 0.000 description 1
- 230000003032 phytopathogenic Effects 0.000 description 1
- 231100000208 phytotoxic Toxicity 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 239000010908 plant waste Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920003245 polyoctenamer Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003389 potentiating Effects 0.000 description 1
- TVLSRXXIMLFWEO-UHFFFAOYSA-N prochloraz Chemical compound C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl TVLSRXXIMLFWEO-UHFFFAOYSA-N 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- FBQQHUGEACOBDN-UHFFFAOYSA-N quinomethionate Chemical compound N1=C2SC(=O)SC2=NC2=CC(C)=CC=C21 FBQQHUGEACOBDN-UHFFFAOYSA-N 0.000 description 1
- 230000018612 quorum sensing Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000000754 repressing Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 108091007521 restriction endonucleases Proteins 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000003620 semiochemical Substances 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 238000003530 single readout Methods 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000003068 static Effects 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000003319 supportive Effects 0.000 description 1
- 239000004546 suspension concentrate Substances 0.000 description 1
- 230000002195 synergetic Effects 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 125000001984 thiazolidinyl group Chemical class 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000003558 thiocarbamic acid derivatives Chemical class 0.000 description 1
- QGHREAKMXXNCOA-UHFFFAOYSA-N thiophanate-methyl Chemical group COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC QGHREAKMXXNCOA-UHFFFAOYSA-N 0.000 description 1
- 229960002447 thiram Drugs 0.000 description 1
- 150000003608 titanium Chemical class 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002103 transcriptional Effects 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- 150000003327 trichothecene derivatives Chemical class [H][C@]12O[C@]3([H])[C@H]([*])[C@@H]([*])[C@@](C)(C33CO3)C1(C[*])C([*])C([*])C(C)=C2 0.000 description 1
- 229930013292 trichothecenes Natural products 0.000 description 1
- RROQIUMZODEXOR-UHFFFAOYSA-N triforine Chemical compound O=CNC(C(Cl)(Cl)Cl)N1CCN(C(NC=O)C(Cl)(Cl)Cl)CC1 RROQIUMZODEXOR-UHFFFAOYSA-N 0.000 description 1
- 239000001974 tryptic soy broth Substances 0.000 description 1
- 108010080629 tryptophan-leucine Proteins 0.000 description 1
- 108010015666 tryptophyl-leucyl-glutamic acid Proteins 0.000 description 1
- 108010084932 tryptophyl-proline Proteins 0.000 description 1
- 108010044292 tryptophyltyrosine Proteins 0.000 description 1
- 238000005429 turbidity Methods 0.000 description 1
- 108010051110 tyrosyl-lysine Proteins 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 108010003885 valyl-prolyl-glycyl-glycine Proteins 0.000 description 1
- 108010009962 valyltyrosine Proteins 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011782 vitamin Chemical class 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamins Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 239000004563 wettable powder Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000005765 wild carrot Nutrition 0.000 description 1
- 241000228158 x Triticosecale Species 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 239000010925 yard waste Substances 0.000 description 1
- DUBNHZYBDBBJHD-UHFFFAOYSA-L ziram Chemical compound [Zn+2].CN(C)C([S-])=S.CN(C)C([S-])=S DUBNHZYBDBBJHD-UHFFFAOYSA-L 0.000 description 1
- SIGGQAHUPUBWNF-UHFFFAOYSA-N γ-glutamyl-Methionine Chemical compound CSCCC(C(O)=O)NC(=O)C(N)CCC(N)=O SIGGQAHUPUBWNF-UHFFFAOYSA-N 0.000 description 1
- UKKNTTCNGZLJEX-UHFFFAOYSA-N γ-glutamyl-Serine Chemical compound NC(=O)CCC(N)C(=O)NC(CO)C(O)=O UKKNTTCNGZLJEX-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01C—PLANTING; SOWING; FERTILISING
- A01C1/00—Apparatus, or methods of use thereof, for testing or treating seed, roots, or the like, prior to sowing or planting
- A01C1/06—Coating or dressing seed
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H5/00—Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H5/00—Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
- A01H5/10—Seeds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
-
- C—CHEMISTRY; METALLURGY
- C05—FERTILISERS; MANUFACTURE THEREOF
- C05G—MIXTURES OF FERTILISERS COVERED INDIVIDUALLY BY DIFFERENT SUBCLASSES OF CLASS C05; MIXTURES OF ONE OR MORE FERTILISERS WITH MATERIALS NOT HAVING A SPECIFIC FERTILISING ACTIVITY, e.g. PESTICIDES, SOIL-CONDITIONERS, WETTING AGENTS; FERTILISERS CHARACTERISED BY THEIR FORM
- C05G3/00—Mixtures of one or more fertilisers with additives not having a specially fertilising activity
- C05G3/60—Biocides or preservatives, e.g. disinfectants, pesticides or herbicides; Pest repellants or attractants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/04—Plant cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
Abstract
Disclosed is an isolated microbial strain of a Variovorax sp., wherein said microbial strain has suppressive activity against head blight disease. Also disclosed is a method for preventing, inhibiting or treating the development of Fusarium graminearum, wherein said method comprises growing the above-described microbial strain in a growth medium or soil of a host plant prior to or concurrent with host plant growth in said growth medium or soil. bove-described microbial strain in a growth medium or soil of a host plant prior to or concurrent with host plant growth in said growth medium or soil.
Description
COMPOSITIONS AND METHODS FOR CONTROLLING HEAD BLIGHT DISEASE
INCORPORATION OF SEQUENCE LISTING
The materialin the accompanying Sequence Listing is hereby incorporated by
reference in its entirety. The accompanying file, named “SG11520—1WO_ST25.txt”, was
created on July 24, 2012 and is 55 Kb. The file can be accessed using Microsoft Word on a
computer that uses Window OS.
FIELD OF THE INVENTION
The t invention relates to the biological control of phytopathogenic diseases.
cally, it relates to compositions and s useful for lling head blight disease
in cereal plants, such as Wheat and barley.
BACKGROUND OF THE INVENTION
Head blight, also known as head scab, pink mold, Whiteheads and tombstone scab,
is a devastating e afflicting wheat, barley, and l other cereal crops worldwide,
particularly in USA, Europe and China. This disease can reach epidemic levels and cause
extensive damage to grains, especially wheat and barley in humid and semi-humid cereal
growing areas of the world, including India, Russia, France, y, and the United
Kingdom. Particularly, wheat scab or head blight is one of the more damaging diseases of
wheat in the United States. Nationwide, this disease has caused the Wheat industry millions
of dollars in yield losses. In the Midwest and High Plains, wheat scab is the major obstacle to
wheat production in recent years. Head blight in addition to attacking Wheat also attacks and
reproduces on barley, oats, corn, and many other cereals.
This serious plant disease can be caused by several phytopathogens, but primarily
by several species in the flmgal genus Fusarz'um. For example, causal agents of the head
blight e in wheat include a number of different Fusarium species, e. g. F. culmorum, F.
graminearum (teleomorph, ella zeae), F. avenaceum (teleomorph, G. avenacea), F.
poae, as well as by non-Fusarium pathogens such as Microdochium nivale (teleomorph,
Monographella nivalz's), and ochium majus. In the United , Europe and most
agronomically important areas of the world, the predominant causative agent of head blight is
Fusarium graminearum (teleomorph, ella zeae sensu strict).
WO 16361
These ens typically survive on plant debris. They invade and damage the
spikelets of the grain head during flowering, thus preventing or partially impeding the
pment of grain in the grain head. As a result, the invading scab en can either
kill part of the grain head or the entire grain head. Some infected seeds are low in vigor and
often fail to ate. Infected seeds that germinate often die early in the ng stage due
to crown rot or root rot, causing poor stands in the following crop plant. Healthy seedlings
can also become infected at emergence. In addition to poor, unthrifty stand, yield losses due
to pathogen infestation can be quite high if ions are favorable for development of the
disease.
The fungal pathogens ofFusarz‘um genus spread across grain cultivating areas all
over the world, and are known to cause severe , particularly in areas With high rainfall
between flowering and grain filling. When Fusarium graminearum is the causative agent,
this disease is of y concern because it does not only reduce the commercial values of
the contaminated grains, in addition to yield losses, but because Fusarium infection can also
lead to the accumulation oftrichothecene xins in the grains thus threatening the health
ofhuman and livestock. Trichothecenes are major mycotoxin contaminants of cereals
worldwide, causing feed refusal, vomiting, ea and weight loss in non-ruminant animals
and posing a health threat to other animals and humans when exposure levels are high. This
threat has been exacerbated by the recent shift in the F. graminearum strains in the United
States towards greater toxin production and vigor. Most frequently found mycotoxins are
deoxynivalenol (DON, also known as xin) and zearalenone (ZEA). Deoxynivalenol in
particular is a very dangerous toxin, causing gastrointestinal disorders accompanied by
hemorrhagic conditions and the like in humans and animals that eat infected grains, leading
to death in some cases. Since deoxynivalenol is generally stable against changes in pH and
high temperature, detoxification can be very difficult. Therefore, grains contaminated
beyond a certain level cannot be used in any form ofbrewing, processing, or livestock feed,
and thus often need to be disposed of.
To date, various strategies have been deployed for controlling head blight in crop
plants. ing options include chemical measures, the development of resistant crop
cultivars, and ional practices of crop rotation and tillage of fields. Among these options,
chemical pesticides can be somewhat effective in reducing head blight infestation, but residue
concerns regarding the use of fungicides late in crop development, typically at flowering
stages only a few weeks before t, lessen their attractiveness. Advances in developing
resistant cultivars using traditional breeding and genetic engineering represent another
disease control alternative are also occurring. Reported examples of c engineering
advances include altering the production of a plant hormone or manipulating the plant
hormone signaling pathway. In recent years, considerable es in the area of traditional
breeding have been made in understanding the genetic basis of resistance to head blight
disease and a number of genes and quantitative trait loci (QTL) conferring resistance have
been reported. However, progress in improving crop resistance to head blight disease has
been slow, y because ofthe difficulty of studying this disease. In fact, relatively little is
currently understood about the mechanisms ed in resistance or susceptibility. In
on, the c ity ofFusarz'um species, which are the predominant causative
agents of the disease, often raises concerns regarding how durable the efficacy of chemical
fungicides and ant cultivars will be. As a result, practically all wheat cultivars tly
in large-scale production remain vulnerable to infection.
In addition, although some success in controlling head blight disease can be
expected by traditional practices such as plowing fields to bury crop residues infested with
ive agent, 6. g. F. gramz'nearum, after t, conventional tillage of fields after
harvesting is not compatible with the soil conservation practice ofminimum tillage.
Considering the potential of long distance inoculum dispersal and the e crops that can
act as alternative hosts of the pathogens, crop rotation is often an untenable on. In
addition to the problem of pesticide residues in the environment, reports of pesticide
resistance and instances ofDON t increases in grain can also be concerns with their
use. Further, costs and increasing concerns in the public and private sectors over pesticide
residues in the environment and food product safety render this disease control alternative
less attractive, and have led to requests for crop cultivation using as little pesticides as
possible.
In summary, despite considerable advances in developing techniques to control
head blight, reducing the impact of this devastating disease on grain production and quality
remains an intractable problem. ore, identification and development ofnew head
blight controlling techniques is essential in improving the production and quality ofmany
cereal crops. These problems require urgent solution not only in United States, but also
across the globe, ing the Asia and Europe.
Biological control ofhead blight disease has attracted considerable interest since
the mid 1990’s. Biological control agents (BCAs), though tly very limited in number,
could be an environmentally acceptable method for substantially decreasing the level of
disease incited by pathogens such as Fusarium. Public acceptance, compatibility with other
disease management measures, and durability are among favorable factors in support of
developing strategies for ically controlling head blight disease. Biological control
agents could play an important role in organic cereal production. In conventional production,
such agents may extend protection of spikes past the ng stage after chemical
fungicides can no longer be applied. To date, significant advances in the area of biological
control have been achieved. For example, certain s of spore-producing bacteria (such as
Bacillus and monas species) and yeasts (such as Cryptococcus s) show some
promise for the l of head blight disease and the reduction of mycotoxin contamination.
However, e these and other es, the need remains for improved microorganisms
for use in the biological control of head blight disease. Although BCAs have become a more
acceptable solution for plant pathogens and BCA products have been marketed to a greater
extent than ever before, to date there have been few attempts to develop strategies and
antagonistic rganism for biologically controlling head blight disease. rmore, the
life cycle ofFusarz'um spp. and other ive agents of head blight disease suggest that the
pathogens can potentially be susceptible to biocontrol techniques using antagonistic
microorganisms at different developmental stages. Thus, there is a need to identify new
biological control agents, preferably with different modes of actions, as well as biocontrol
methods that can help effectively prevent or suppress the development ofhead blight disease.
SUMMARY OF THE INVENTION
Compositions comprising iological strains and cultures are provided herein.
Certain strains, cultures, and compositions thereof are useful for the control of head blight
disease, for example, of various crop plants including wheat and other cereal plants.
ical control itions, and methods ofuse thereof to prevent, inhibit or treat the
development of plant pathogens or disease and for preserving plant yield, are also provided.
Also provided are methods for the use of such compositions as biological control agents in
combination with other agriculturally ive compounds or compositions for controlling
harmful plant pathogens.
In one aspect, the present invention provides isolated microbial s having
suppressive activity against head blight disease. The microbial strains in accordance to this
aspect of the present invention are selected from the group consisting of the genera
Microbacterium, Bacillus, Mycosphaerella, and Variovorax. In some preferred
embodiments, the microbial strains are selected from the group consisting of Mycosphaerella
sp. strain SGI H11 (deposited as NRRL , Microbacterium sp. strain SGI
C06 (deposited as NRRL B-50470), Microbacterium sp. strain SGIG08, Variovorax sp.
strain SGIG01 (deposited as NRRL B-50469), Bacillus sp. strain SGIF03
ited as NRRL B-50760), Bacillus sp. strain SGIH06 (deposited as NRRL B-
50761), and pesticidally active variants of any f. T he microbial strain in ance to
some other preferred embodiments can comprise a DNA sequence that exhibits at least 85%
sequence identity to any one of the nucleotide ces in the Sequence Listing. Further
provided are ically pure cultures and enriched cultures of the microbial strains
disclosed herein.
Also provided in another aspect of the present invention are compositions that
comprise a microbial strain of the ion or a culture thereof, and an agriculturally
effective amount of a compound or composition selected from the group consisting of an
acaricide, a bactericide, a fungicide, an insecticide, a microbicide, a nematicide, a pesticide,
and a izer. The compositions in some embodiments of this aspect may be prepared as a
formulation selected from the group consisting of an emulsion, a d, a dust, a granule, a
pellet, a , a spray, an emulsion, and a solution. In some other embodiments, the
compositions may be provided with a r. In some preferred embodiment, the carrier is
an agriculturally acceptable carrier. In some particularly preferred embodiment, the carrier is
a plant seed. In other preferred embodiments, the ition is a seed coating formulation.
Further provided in the present sure are seeds that are coated with a composition
according to the present invention.
In another aspect of the present invention, there are provided methods for
preventing, inhibiting or treating the development of a plant en. T he methods involve
growing a microbial strain of the invention or a culture thereof in a growth medium or soil of
a host plant prior to or concurrent with host plant growth in the growth medium or soil. In
some preferred embodiments of this aspect, the plant pathogen causes head blight disease. In
some particularly preferred embodiments, the plant pathogen is Fusarium graminearum.
In yet another aspect ofthe present invention, methods are provided for preventing,
inhibiting or treating the development of head blight e of a plant. The methods involve
applying to the plant, or to the plant's surroundings, an ive amount of a microbial strain
ofthe invention or a culture thereof. In one embodiment, such head blight disease is caused
by the fungus Fusarz'um gramz’nearum. In some embodiments ofthis aspect, the microbial
strain or a culture thereof is applied to soil, a seed, a root, a flower, a leaf, a portion of the
plant, or the whole plant. In a preferred embodiment, the plant is susceptible to Fusarz'um
graminearum. In some other preferred embodiments, the plant is wheat plant, a corn plant, a
barley plant, or an oat plant. In another preferred embodiment, the microbial strain of the
present invention or a culture thereof is established as an endophyte on the plant.
Another further aspect of the invention provides non-naturally occurring plants.
The turally occurring plants are artificially infected with a microbial strain of the
invention or a culture thereof. Further provided in some preferred ments of this
aspect are seed, reproductive , vegetative tissue, plant parts, and progeny of the non-
lly occurring plants.
Yet another aspect of the invention provides a method for preparing an agricultural
composition. The method es inoculating the microbial strain according to the present
invention or a e thereof into or onto a substratum and allowing it to grow at a
temperature of 1-37°C until obtaining a number of cells or spores of at least 102-103 per
milliliter or per gram.
These and other objects and es of the ion will become more fully
apparent from the following detailed description of the invention and the claims.
DETAILED DESCRIPTION OF THE INVENTION
Some definitions
Unless otherwise defined, all terms of art, notations and other scientific terms or
terminology used herein are intended to have the gs commonly understood by those of
skill in the art to which this invention pertains. In some cases, terms with commonly
tood meanings are defined herein for clarity and/or for ready reference, and the
inclusion of such definitions herein should not necessarily be construed to represent a
substantial difference over what is generally understood in the art. Many of the techniques
and procedures described or referenced herein are well tood and commonly employed
using conventional methodology by those d in the art.
The singular form “a”, “an”, and “the” include plural references unless the context
clearly dictates otherwise. For example, the term “a cell” includes one or more cells,
including mixtures thereof. By "comprising" is meant including, but not limited to, whatever
s the word "comprising".
The expressions onistic microorganism” and “microbial antagonist” are used
herein interchangeably in reference to a microorganism is intended to mean that the subject
strain exhibits a degree of inhibition of head blight disease exceeding, at a statistically
significant level, that of an untreated l.
Antibiotic: the term “antibiotic”, as used , refers to any substance that is able
to kill or inhibit the growth of a rganism. Antibiotics may be produced by any one or
more of the following: 1) a microorganism, 2) a synthetic process, or 3) a semisynthetic
process. An antibiotic may be a microorganism that secretes a volatile organic compound.
Furthermore, an antibiotic may be a volatile organic compound secreted by a microorganism.
icidal: the term “bactericidal”, as used herein, refers to the y of a
composition or substance to increase mortality or inhibit the growth rate of bacteria.
Inhibition of the growth rate of bacteria can be commonly quantified as the reduction of
viable bacterial cells over time.
Biological control: the term “biological control” and its abbreviated form
“biocontrol”, as used herein, is defined as control of a pathogen or insect or any other
rable organism by the use of at least a second organism other than man. An example
of a known mechanism ofbiological control is the use of microorganisms that control root rot
by out-competing fungi for space on the surface of the root, or microorganisms that either
inhibit the growth of or kill the pathogen. The “host plant” in the context of ical
control is the plant that is susceptible to disease caused by the pathogen. In the context of
isolation of an sm, such as a fungal species, from its l environment, the “host
plant” is a plant that supports the growth ofthe , for example, a plant of a species the
fungus is an endophyte of.
The term "cereal" as used herein is intended to refer to any cereal species that can
be susceptible to head blight disease. Cereals reported to be susceptible include wheat,
barley, oats, and triticale, though wheat and barley are the two crops in which this disease
ts a significant economic problem.
An "effective amoun " refers to an amount sufficient to affect beneficial or desired
results. In terms of disease management, treatment, inhibition or protection, an effective
amount is that amount sufficient to suppress, stabilize, reverse, slow or delay progression of
the target ion or disease states. As such, the expression “an effective amoun ” is used
herein in reference to that quantity of antagonist treatment which is necessary to obtain a
reduction in the level of pathogen pment and/or in the level of pathogenic disease
ve to that ing in an untreated l. Typically, an ive amount of a given
antagonist treatment provides a reduction of at least 20%; or more typically, between 30 to
40%; more typically, between 50—60%; even more typically, between 70 to 80%; and even
more typically, n 90 to 95%, relative to the level of disease and/or the level of
pathogen development occurring in an untreated control under suitable conditions of
treatment. An effective amount can be administered in one or more administrations. The
actual rate of application of a liquid formulation will usually vary from a minimum of about 1
X 103 to about 1 X 1010 Viable cells/mL and preferably from about 1 X 106 to about 5 X 109
Viable cells/mL. Under most conditions, the antagonistic microbial strains ofthe invention
described in the es below, would be optimally effective at application rates in the
range of about 1 X 106 to l X 109 Viable cells/mL, assuming a mode of application which
would e substantially uniform contact of at least about 50% of the plant tissues. If the
antagonists are applied as a solid formulation, the rate of application should be controlled to
result in a comparable number of viable cells per unit area ofplant tissue surface as obtained
by the aforementioned rates of liquid treatment. Typically, the biological control agents of
the present invention are biologically effective when delivered at a concentration in excess of
106 CFU/g (colony forming units per gram), preferably in excess of 107 CFU/g, more
preferably 108 CFU/g, and most ably at 109 CFU/g.
Further, the expression "effective microbial antagonist" used herein in reference to
a microorganism is intended to mean that the subject microbial strain exhibits a degree of
inhibition of head blight disease exceeding, at a tically significant level, that of an
untreated control. Typically, an effective microbial antagonist has the ability to effect a
reduction of at least 20%; or more typically, between 30 to 40%; more typically, between 50-
60%; even more typically, between 70 to 80%; and even more typically, between 90 to 95%,
relative to the level of disease and/or the level ofpathogen development occurring in an
untreated control under suitable conditions of treatment.
Composition: A “composition” is intended to mean a combination of active agent
and at least r compound, carrier or ition, inert (for example, a detectable agent
or label or liquid carrier) or active, such as a pesticide.
Isolated microbial strain, isolated culture, biologically pure culture, and enriched
culture: As used herein, the term “isolated” as d to a microorganism (e.g., bacterium or
ungus) refers to a microorganism which has been removed and/or d from an
environment in which it naturally occurs. As such, an “isolated strain “of a microbe as used
herein is a strain that has been removed and/or purified from its natural milieu. Thus, an
“isolated microorganism” does not include one residing in an environment in which it
naturally occurs. Further, the term "isolated" does not arily reflect the extent to which
the microbe has been purified. A "substantially pure e" of the strain of microbe refers
to a culture which ns substantially no other microbes than the desired strain or strains
of e. In other words, a substantially pure culture of a strain of microbe is substantially
free of other inants, which can include microbial contaminants as well as undesirable
chemical contaminants. Further, as used , a "biologically pure" strain is intended to
mean the strain separated from materials with which it is normally associated in nature. Note
that a strain associated with other strains, or with compounds or materials that it is not
normally found with in nature, is still defined as "biologically pure." A monoculture of a
particular strain is, of course, "biologically pure." As used herein, the term "enriched culture"
of an isolated microbial strain refers to a microbial culture that contains more than 50%, 60%,
70%, 80%, 90%, or 95% of the isolated strain.
As used herein, an "endophyte" is an endosymbiont that lives within a plant for at
least part of its life Without causing apparent disease. Endophytes may be transmitted either
vertically (directly from parent to offspring) or horizontally (from dual to ted
individual). Vertically-transmitted fungal endophytes are typically asexual and transmit from
the maternal plant to offspring via fungal hyphae penetrating the host's seeds. Bacterial
endophytes can also be transferred vertically from seeds to seedlings (Ferreira et al., 2008).
Conversely, horizontally-transmitted endophytes are typically sexual, and transmit via spores
that can be spread by Wind and/or insect vectors. Endophytes of crop plants have been
receiving considerable attention with respect to their ability to control both disease and insect
ation, as well as promoting plant growth.
Functionally comparable protein: The phrase ionally comparable protein” as
used herein describes those proteins that have at least one characteristic in common. Such
teristics include sequence similarity, biochemical ty, transcriptional pattern
similarity and phenotypic activity. Typically, the functionally comparable proteins share
some sequence similarity or at least one mical. Within this ion, homologs,
orthologs, paralogs and analogs are considered to be functionally comparable. In on,
functionally comparable proteins generally share at least one biochemical and/or phenotypic
activity. Functionally comparable proteins will give rise to the same characteristic to a
similar, but not necessarily the same, degree. Typically, onally comparable proteins
give the same characteristics where the quantitative measurement due to one ofthe
comparables is at least 20% of the other; more typically, between 30 to 40%; more typically,
between ; even more typically, between 70 to 80%; even more typically, between 90
to 95%; even more typically, between 98 to 100% ofthe other.
Fungicidal: As used herein, “fungicidal” refers to the ability of a composition or
substance to decrease the rate of growth of fimgi or to se the mortality of fimgi.
'um fungus: For purposes of this invention it is understood that the use of
term Fusarium fimgus is intended to include both the sexual (teleomorphic) stage of this
organism and also the l (anamorphic) stage, also referred to as the perfect and
imperfect fungal stages, respectively. For example, the anamorphic stage rium
graminearum is Gibberella zeae, a causative agent ofhead blight e. This e
typically occurs when the flower or seed head becomes inoculated with conidia produced by
the imperfect form or ascospores produced by the perfect form of this fimgus.
Mutant: As used , the term “mutant” or “varian ” in reference to a
rganism refers to a modification ofthe parental strain in which the desired biological
activity is similar to that expressed by the parental strain. For example, in the case of
Mcrobacterium the “parental strain” is defined herein as the original Microbacz‘erium strain
before mutagenesis. Mutants or variants may occur in nature without the intervention of
man. They also are obtainable by treatment with or by a variety of methods and
compositions known to those of skill in the art. For e, a parental strain may be treated
with a chemical such as N-methyl-N'-nitro-N—nitrosoguanidine, ethanesulfone, or by
irradiation using gamma, X-ray, or UV-irradiation, or by other means well known to those
practiced in the art.
Nematicidal: The term “nematicidal”, as used herein, refers to the y of a
substance or composition to increase mortality or t the growth rate of nematodes.
Pathogen: The term "pathogen" as used herein refers to an organism such as an
alga, an arachnid, a bacterium, a fungus, an insect, a nematode, a parasitic plant, yeast, a
protozoan, or a virus capable of producing a disease in a plant or animal. The term
"phytopathogen" as used herein refers to a pathogenic organism that infects a plant.
Percentage of percent identity: ntage of sequence identity”, as used herein, is
determined by comparing two optimally locally aligned sequences over a comparison
Window defined by the length of the local alignment n the two sequences. The amino
acid sequence in the comparison window may comprise additions or deletions (e. g., gaps or
overhangs) as compared to the reference sequence (which does not comprise additions or
deletions) for optimal alignment of the two sequences. Local alignment between two
ces only includes segments of each sequence that are deemed to be sufficiently similar
according to a criterion that depends on the algorithm used to perform the alignment (6. g.
BLAST). The tage identity is calculated by determining the number of positions at
which the identical nucleic acid base or amino acid residue occurs in both sequences to yield
the number of matched positions, dividing the number ofmatched positions by the total
number of positions in the window of comparison and multiplying the result by 100. Optimal
alignment of sequences for comparison may be conducted by the local homology algorithm
of Smith and Waterman (1981) Add. APL. Math. 2:482, by the global homology alignment
algorithm ofNeedleman and Wunsch (J. Mol. Biol. 48:443, 1970), by the search for
similarity method of Pearson and Lipman (Proc. Natl. Acad. Sci. USA 85: 2444, 1988), by
heuristic implementations of these algorithms (NCBI BLAST, WU-BLAST, BLAT, SIM,
), or by inspection. Given that two sequences have been identified for comparison,
GAP and BESTFIT are preferably employed to determine their l alignment.
Typically, the default values of 5.00 for gap weight and 0.30 for gap weight length are used.
The term “substantial sequence identity” between polynucleotide or polypeptide sequences
refers to polynucleotide or polypeptide comprising a sequence that has at least 50% ce
identity, ably at least 70%, preferably at least 80%, more preferably at least 85%, more
preferably at least 90%, even more preferably at least 95%, and most preferably at least 96%,
97%, 98% or 99% sequence identity compared to a reference sequence using the programs.
Query nucleic acid and amino acid ces can be searched t subject
nucleic acid or amino acid sequences residing in public or proprietary databases. Such
searches can be done using the National Center for Biotechnology Information Basic Local
Alignment Search Tool (NCBI BLAST v 2.18) program. The NCBI BLAST program is
available on the intemet from the National Center for Biotechnology Information
.ncbi.nlm.nih.gov/Blast.cgi). Typically the following parameters for NCBI BLAST can
be used: Filter options set to lt”, the ison Matrix set to "BLOSUM62”, the Gap
Costs set to “Existence: 11, Extension: 1”, the Word Size set to 3, the Expect (E threshold)
set to 16-3, and the minimum length of the local alignment set to 50% of the query ce
length. Sequence identity and similarity may also be determined using QuestTM
software (Gene-IT, Worcester Mass. USA).
The term “pesticidal”, as used , refers to the ability of a substance or
composition to decrease the rate of growth of a pest, i.e., an undesired organism, or to
se the mortality of a pest.
By “suppressive activity” of a biological control agent against a phytopathogen is
meant the ability of the agent to suppress, inhibit, stabilize, reverse, slow, or delay the
development ofthe pathogen , or the progression of the infection or disease states
caused by the pathogen.
Variant: A “varian ”, as used herein in nce to a microorganism, is a strain
having identifying characteristics of the s to which it belongs, While having at least one
nucleotide sequence variation or identifiably different trait with respect to the al strain,
where the trait is cally based (heritable). For example, for a Microbacterium sp. SGI-
SGI—Ol4-CO6 strain having fungicidal activity, identifiable traits include 1) the ability to
suppress the growth ofFusarium graminearum and its teleomorph Gibberella zeae; 2) the
ability to suppress the development of head blight disease; 3) having housekeeping genes
with greater than 95%, greater than 96%, greater than 97%, greater than 98%, or greater than
99% sequence identity to the housekeeping genes ofMicrobacterz'um sp. SGI-Ol4-CO6 can be
used to confirm a variant as Microbacterium sp. SGI—014-C06.
For nucleic acids and polypeptides, the term “varian ” is used herein to denote a
ptide, protein or polynucleotide molecule with some differences, generated
synthetically or naturally, in their amino acid or nucleic acid sequences as compared to a
nce polypeptide or polynucleotide, respectively. For example, these differences include
substitutions, insertions, deletions or any desired combinations of such changes in a reference
or polypeptide.
, polypeptide Polypeptide and protein variants can further t of changes
in charge and/or post-translational modifications (such as glycosylation, methylation,
phosphorylation, etc.)
All publications and patent applications mentioned in this specification are herein
incorporated by reference to the same extent as if each individual ation or patent
ation was specifically and individually indicated to be incorporated by reference.
No admission is made that any nce constitutes prior art. The discussion of
the references states What their authors , and the applicants reserve the right to
challenge the accuracy and pertinence of the cited documents. It will be clearly understood
that, although a number of prior art publications are referred to herein, this reference does not
constitute an admission that any of these documents forms part of the common general
knowledge in the art.
WO 16361 2012/048012
Methods for Taxonomic Identification
Microorganisms can often be guished based on direct microscopic is
(do all of the cells in a sample look the same on examination), staining characteristics, simple
lar analysis (such as a simply restriction fiagment length polymorphism (RFLP)
determination), and so forth. In addition to the illustrative examples of such taxonomic
analysis techniques as described at Examples 2-3 of the present sure, taxonomic
identification of a microorganism can involve up to several different levels of analysis, and
each analysis can be based on a different characteristic of the organism. Such taxonomic
analyses can include nucleic acid-based analysis (e.g., analysis of individual specific genes,
either as to their presence or their exact sequence, or expression of a particular gene or a
family of genes), protein-based analysis (e. g. , at a fimctional level using direct or indirect
enzyme assays, or at a structural level using irnmuno—detection techniques), and so forth.
a. Nucleic acid-based analysis: One of ordinary skill in the art will appreciate that a
wide variety of nucleic acid-based techniques are known and can be useful in obtaining the
taxonomic identification of a given microorganism. These ques can be used to identify
cells by gene sequence or to identify cells that have particular genes or gene families.
Common gene families useful for taxonomic studies include 168 gene family, actin gene
, and recombinase A (recA) gene . These methods typically include amplifying
and sequencing genes from very small numbers of cells, and therefore often me the
problems of concentrating cells and their DNA from dilute suspensions. The term “nucleic
acid amplification" generally refers to techniques that increase the number of copies of a
nucleic acid molecule in a sample or specimen. Techniques useful for nucleic acid
amplification are well known in the art. An example of c acid cation is the
polymerase chain reaction (PCR), in which a biological sample collected from a subject is
contacted with a pair of oligonucleotide primers, under conditions that allow for the
hybridization of the primers to nucleic acid template in the sample. The primers are ed
under suitable ions, dissociated fi'om the template, and then re-annealed, extended, and
iated to amplify the number of copies of the nucleic acid. Other examples of in vitro
amplification techniques include strand displacement amplification; transcription-free
isothermal amplification; repair chain reaction amplification; ligase chain reaction; gap filling
2012/048012
ligase chain reaction amplification; coupled ligase detection and PCR; and RNA
transcription-free amplification.
In addition to the illustrative example primers provided herein, see, e.g. Examples
2-3 and the Sequence Listing, primers have also been designed routinely, and new ones are
continually being designed, for individual species or phylogenetic groups of microorganisms.
Such narrowly targeted primers can be used with the methods described herein to screen
and/or identify specifically only the microorganisms of interest.
Methods for preparing and using nucleic acid primers are bed, for e,
in Sambrook et al. (In Molecular Cloning: A Laboratory , CSHL, New York, 1989),
Ausubel et al. (ed.) (In Current ols in Molecular Biology, John Wiley & Sons, New
York, 1998). cation primer pairs can be derived from a known sequence, for
example, by using computer programs intended for that purpose such as Primer (Whitehead
Institute for Biomedical Research, Cambridge, Mass). One of ordinary skill in the art will
appreciate that the specificity of a particular probe or primer increases with its length. Thus,
for example, a primer comprising 30 consecutive nucleotides of an rRNA-encoding
nucleotide or flanking region thereof will anneal to a target sequence With a higher specificity
than a corresponding primer of only 15 nucleotides. Thus, in order to obtain greater
specificity, probes and primers can be selected that comprise at least 20, 25, 30, 35, 40, 45, 50
or more consecutive nucleotides of a target nucleotide sequence such as the 168 rRNA.
Common techniques for the preparation of nucleic acids useful for nucleic acid
applications (6. g. , PCR) include phenol/chloroform extraction or use of one of the many
DNA extraction kits that are available on the . Another way that DNA can be
amplified is by adding cells directly to the nucleic acid amplification reaction mix and relying
on the denaturation step of the cation to lyse the cells and release the DNA.
The product ofnucleic acid cation reactions may be further characterized by
one or more of the standard techniques that are well known in the art, including
electrophoresis, restriction endonuclease cleavage patterns, oligonucleotide hybridization or
ligation, and/or nucleic acid sequencing. When in hybridization techniques are used for cell
identification purposes, a y ofprobe labeling s can be , including
cent labeling, radioactive labeling and non-radioactive labeling. When nucleic acid
sequencing techniques are used, homology search for the nucleotide sequence of the
amplified nucleic acid molecules can be conducted using various databases ofknown
sequences, including but not d to DDBJ/GenBank/EMBL databases.
b. Protein—based analysis: In addition to analysis of nucleic acids, microorganisms
can be taxonomically characterized and identified based on the ce (or e) of
specific proteins directly. Such analysis can be based on the activity of the specified protein,
e. g.
, through an enzyme assay or by the response of a co-cultured organisms, or by the mere
presence ofthe specified protein (which can for ce be determined using logic
methods, such as in situ immunofluorescent antibody staining).
Enzyme assays: By way of example, fluorescent or chromogenic substrate analogs
can be included into the growth media (e.g. microtiter plate cultures), followed by incubation
and screening for reaction products, thereby identifying cultures on a basis of their enzymatic
activities.
Co-cultivation response: In some embodiments of the present invention, the
activity of an enzyme carried by a microbial isolate can be d based on the response (or
degree of response) of a co-cultured organism (such as a reporter organism).
A variety ofmethods can also be used for identifying microorganisms selected and
isolated from a source environment by binding at least one dy or antibody—derived
molecule to a le, or more particularly an epitope of a molecule, ofthe microorganism.
Antijrrricroorganism n antibodies may be produced using standard
procedures bed in a number of texts, including Harlow and Lane (Antibodies, A
Laboratory Manual, CSHL, New York, 1988). The ination that a particular agent
binds substantially only to a n of the desired microorganism may y be made by
using or adapting routine procedures. One suitable in vitro assay makes use of the Western
blotting procedure (described in many standard texts, including Harlow and Lane
(Antibodies, A Laboratory Manual, CSHL, New York, 1988)).
Shorter fragments of antibodies (antibody-derived molecules, for instance, FAbs,
Fvs, and single-chain Fvs (SCFvs)) can also serve as c binding agents. Methods of
making these fragments are routine.
2012/048012
Detection of antibodies that bind to cells on an array ofthis invention can be
carried out using standard techniques, for instance ELISA assays that provide a detectable
signal, for instance a fluorescent or luminescent .
Isolated cultures of the invention
As described in more details in the Examples section of the present disclosure,
Applicants have discovered several agriculturally beneficial novel microorganisms, for
example, effective ssors ofhead blight disease. Particularly, these novel antagonistic
microorganisms are effective for reduction of head blight ty and for inhibition of the
growth ofFusarium graminearum, a primary causative agent of head blight disease in wheat.
The microbial nists were fied from a pool of approximately 5,000 microbial
strains obtained from Wild plant s collected from several locations in the United States.
Initial selection of antagonistic microorganism was based on the ability of the
rganisms to suppress the development of F. graminearum pathogen and that of its
teleomorph Gibberella zeae in an in vitro antagonism assay. Selected microbial antagonists
were then bio-assayed in a greenhouse study on wheat seedlings, which involved inoculation
of the seedlings with the microbial strains, followed by repeated inoculations of F.
graminearum , for the ability of the microbial strains to reduce the severity of fungal
ation and for their ability to preserve seed yield. The antagonistic rganisms
selected in this manner were found to be effective in ng the severity of head blight in
greenhouse trials.
Taxonomic analysis further determined that each ofthe antagonistic
microorganisms bed in the present disclosure are closely related either the bacterial
genus Microbacterium, the bacterial genus Bacillus, the bacterial genus Variovorax, or the
fungus genus Mycosphaerella.
The genus Microbacterium, the type genus of the family Microbacteriaceae, is
generally considered to accommodate Gram—positive, non-spore forming, rod-shaped bacteria
that were originally isolated during early studies on lactic acid-producing bacteria. Members
ofthe genus Microbacterium are originally characterized largely by their marked heat
resistance, presence in dairies, and production of small amounts of I..(+) lactic acid from
e. In contrast to other genera of the family Microbacterz'aceae in which species are
characterized by a coherent peptidoglycan type, species ofMicrobacterium possess omithine
or lysine either in the inter-peptide bridge or at position 3 of B-type peptidoglycan. In other
chemotaxonomic properties, such as isoprenoid quinones (MK-l l, MK-12, MK-l3), polar
lipids, fatty acids and base ition of DNA, members of the genus exhibit the usual
range of diversity found in other genera of Microbacteriaceae. Two bacterial genera
Microbacterium and Aureobacterz'um can be united according to some taxonomy studies. To
date, members ofthe genus Microbacterium comprise at least 33 species, which have been
isolated from a broad range of habitats, including soil, dairy products, plant galls, insects or
clinical specimens. s aspects of their y, phylogeny, taxonomy, culture methods,
and long-term preservation conditions have recently been summarized by Evtushenko and
Takeuchi (2006). One of skill in the art will readily appreciate that microorganism of the
genus Microbacterium can be mically identified largely by any ofthe taxonomic
identification ques bed above, including the chemotaxonomic analysis of the cell
wall oglycan and comparative 16S rDNA sequence analysis as described in
Evtushenko and Takeuchi (2006) and references cited therein, as well as in those described in
Examples 2-3 ofthe present disclosure. As discussed in detail below, to date several
naturally occurring microorganisms have been reported as having antagonistic activity
t head blight disease. However, there are no reports prior to the present invention that
be a microorganism ofthe genus Mycobacterium having such antagonistic activity.
r, prior to the t invention, the present inventors were not aware of any methods
or processes of using a bacterial strain of the genus Mycobacterz'um as biocontrol agent in
preventing, inhibiting or treating the development of a causative pathogen of head blight
disease.
The genus us is a genus of Gram-positive/variable, forming, rod-
shaped bacteria. rly to other genera associated with the early history of microbiology,
such as Pseudomonas or Vibrz’o, nearly 266 species members of the Bacillus genus are found
ubiquitously, and it is widely considered to be one of the genera with the t 168 diversity
and environmental diversity. Bacillus species can be obligate aerobes or facultative
anaerobes, and test positive for the enzyme catalase. Ubiquitous in nature, Bacillus includes
both iving and pathogenic species. Under stressful environmental conditions, the cells
produce oval endospores that can stay dormant for extended periods. These characteristics
originally defined the genus, but not all such species are closely related, and many have been
moved to other . In fact, several studies have tried to reconstruct the phylogeny of the
genus. The Bacillus-specific study with the most ity covered is by Xu and Cote [Int]. J
ofSyst. Evol. Microbiol. 53 (3): 695—704; 2003], using 16S and the ITS region, where they
divide the genus into 10 groups, which includes the nested genera Paenibacillus,
Brevibacillus, Geobacillus, Marinibacillus and Virgibacillus. However, according to more
recent studies, the genus us contains a very large number of nested taxa and ally
in both 168 and 23S it is considered to be paraphyletic to Lactobacillales (Lactobacillus,
Streptococcus, Staphylococcus, Listeria, eta), due to us coahuilensis and others (see,
e. g., Yarda et al., Syst. Appl. Microbiol. 31 (4): 241—250, 2008; Yarda et al., Syst. Appl.
Microbiol. 33 (6): 291—299, 2010]. One particular clade, formed by B. anthracis, B. cereus,
B. mycoz'des, B. pseudomycoz'des, B. thuringz‘ensis and B. weihenstephanensis under current
classification standards, should be a single species (within 97% 168 identity), but due to
medical reasons, they are considered separate species. In addition to the taxonomy analysis
methods described at Examples 2-3 ofthe present disclosure, the phylogenetic and taxonomic
analyses ofBacillus species can be med by a variety oftechniques, ing those
discussed in details in Xu and Cote, 2003; Yarda ez‘ al., 2008; Yarda et al., 2010..
The genus Variovorax was originally created by reclassification ofAlcaligenes
paradoxus as Variovorax paradoxus (Willems er al., 1991), which is widely consider as the
type species of this genus. V. paradoxus has been extensively studied as a model for novel
biodegradation agents, as well as e/microbe and e/plant interactions. Other
species include V. dokdonensis, V. soli (Kim et al., 2006), and V. borom’cumulans (Miwa et
al., 2008). Variovorax species are catabolically very diverse and engage in mutually
beneficial interactions with other bacterial species in many biodegradations, and therefore
s ecological importance and high application potential. For example, a soil
methanotroph, only when co—cultured together with a V. xus strain, exhibits high
y for methane (a potent greenhouse gas), and this trait is not usually observed in
tory cultures. Similarly, a close relative of Variovorax has been found to be the central,
non—photosynthetic partner within the phototrophic consortium ochromatz'um
aggregatum.” Some species of the genus Variovorax also have the ability to interfere with the
communication of other bacteria. Some yet other species of the genus Variovorax can
intimately interact with other biota (e.g. , plants) in various ecosystems. Moreover, some
Variovorax species, ng in the area just outside plant roots and/or inside a plant, have
been reported for being capable of promoting plant growth via the reduction of ethylene
levels, the repression of quorum-sensing-controlled pathogenesis, and the increase of
resistance to heavy metals, which greatly benefits phytoremediation. In addition to the
taxonomy analysis methods described at Examples 2-3 ofthe present disclosure, the
phylogenetic and taxonomic analyses of Variovorax species can be performed by a variety of
techniques, including those discussed in details elsewhere herein.
Mycosphaerella is a very large fiingus genus, with over 2,000 s names and at
least 500 species associated with more than 40 anamorph genera (especially Cercospora,
Pseudocercospora, Septoria, Ramularia, etc). In addition, l thousand anamorphs lack
telomorphs. The genus of Mycosphaerella includes species that are pathogens, saprobes,
endophytes, or mutualistic associations. Various aspects of their ecology, phylogeny,
taxonomy, culture methods, and long-term preservation conditions have ly been
reported (see, e. g. Crous et al., nia, 23:119-146,2009). One of skill in the art will
readily appreciate that microorganism ofthe genus Mycosphaerella can be mically
identified by any ofthe taxonomic techniques described above, or a combination thereof.
Most common techniques include comparative sequence analyses using 16S rDNA sequences
and the internal transcribed spacer regions as described in, for example, Crous et al.
, Studies
in Mycology, 55:235—253,2006; Crous et al., 2009, supra; Goodwin et al., athology 91:
648—65 8, 2001; and those described in es 2—3 of the present disclosure.
Deposit of Biological al
Purified cultures of microbial strains identified as having suppressive activity
against head blight disease were deposited in the ltural Research Service e
tion located at 1815 N. University Street, , IL 61604, USA (NRRL) in
accordance with the Budapest Treaty for the purpose ofpatent procedure and the regulations
thereunder est Treaty). Accession numbers for these deposits are as follows:
N ———
SGI—OlO-Hll NRRL 50471
SGIC06 NRRL 13—50470
SGIG01 NRRL B-50469
SGI-OlS-FO3 NRRL 0
SGI-OlS-H06 NRRL 1
The microbial strains have been deposited under conditions that ensure that access
to the culture will be available during the pendency of this patent application to one
determined by the Commissioner of Patents and Trademarks to be entitled thereto under 37
C.F.R. §1.14 and 35 U.S.C. §122. The deposits represent substantially pure cultures of the
deposited strains. The deposits are available as required by foreign patent laws in countries
wherein counterparts of the subject application or its progeny are filed. However, it should
be understood that the availability of a deposit does not constitute a license to practice the
subject invention in derogation of patent rights granted by governmental action.
red microorganisms of the present ion have all ofthe identifying
teristics of the deposited strains and, in particular, the identifying characteristics of
being able to suppress the development of head blight disease as described herein, and as
being able to suppress the development ofFusarz‘um gramz'nearum pathogen and its
teleomorph Gibberella zeae as described herein. In particular, the preferred microorganisms
ofthe present invention refer to the ted microorganisms as described above, and
mutants thereof.
Microbiological compositions
The microbiological compositions ofthe present invention that comprise isolated
microbial strains or cultures thereof can be in a y of forms, including, but not limited to,
still cultures, whole cultures, [stored stocks of cells, mycelium and/or hyphae (particularly
glycerol ), agar strips, stored agar plugs in glycerol/water, freeze dried stocks, and
dried stocks such as lisate or mycelia dried onto filter paper or grain seeds. As defined
elsewhere herein, “isolated culture” or grammatical lents as used in this disclosure and
in the art is understood to mean that the referred to culture is a culture fluid, pellet, scraping,
2012/048012
dried sample, lyophilate, or section (for example, hyphae or mycelia); or a support, container,
or medium such as a plate, paper, filter, matrix, straw, pipette or pipette tip, fiber, needle, gel,
swab, tube, vial, particle, etc. that contains a single type of organism. In the present
invention, an isolated e of a microbial antagonist is a culture fluid or a ng, pellet,
dried preparation, lyophilate, or section of the microorganism, or a support, container, or
medium that contains the microorganism, in the absence of other organisms.
The present disclosure further provides compositions that contain at least one
isolated microbial strains or cultures thereof of the t invention and a carrier. The
carrier may be any one or more of a number of carriers that confer a y of properties,
such as increased stability, wettability, dispersability, etc. Wetting agents such as natural or
synthetic surfactants, which can be nonionic or ionic surfactants, or a combination f
can be ed in a composition ofthe invention. Water-in—oil emulsions can also be used to
formulate a composition that includes at least one ed microorganism of the present
invention (see, for example, US. Patent No. 7,485,451, incorporated by reference herein).
le formulations that may be prepared include wettable powders, granules, gels, agar
strips or pellets, thickeners, and the like, microencapsulated particles, and the like, liquids
such as aqueous flowables, aqueous suspensions, water-in—oil emulsions, etc. The
formulation may include grain or legume products (e.g. or beans, broth or flour
, ground grain
derived from grain or beans), starch, sugar, or oil. The carrier may be an agricultural r.
In certain preferred embodiments, the carrier is a seed, and the composition may be applied
or coated onto the seed or allowed to saturate the seed.
In some embodiments, the agricultural carrier may be soil or plant growth .
Other agricultural carriers that may be used include water, izers, plant-based oils,
humectants, or ations thereof. Alternatively, the agricultural carrier may be a solid,
such as diatomaceous earth, loam, silica, alginate, clay, ite, vermiculite, seed cases,
other plant and animal products, or combinations, including granules, pellets, or suspensions.
Mixtures of any of the aforementioned ients are also contemplated as carriers, such as
but not limited to, pesta (flour and kaolin clay), agar or flour-based pellets in loam, sand, or
clay, etc. ations may include food sources for the cultured organisms, such as barley,
rice, or other biological materials such as seed, plant parts, sugar cane bagasse, hulls or stalks
from grain processing, ground plant material (e.g. “yard waste”) or wood from building site
refuse, sawdust or small fibers from recycling of paper, fabric, or wood. Other le
formulations will be known to those skilled in the art.
In the liquid form, 6. g. ons or suspensions, the microorganisms may be mixed
or suspended in water or in aqueous solutions. le liquid diluents or rs include
water, aqueous solutions, petroleum distillates, or other liquid rs.
Solid compositions can be prepared by dispersing the antagonist microorganisms
in and on an appropriately divided solid carrier, such as peat, wheat, bran, vermiculite, clay,
talc, bentonite, diatomaceous earth, fuller's earth, pasteurized soil, and the like. When such
formulations are used as wettable s, biologically compatible dispersing agents such as
non—ionic, anionic, amphoteric, or cationic dispersing and emulsifying agents can be used.
In a preferred embodiment, the compositions contemplated herein prevent attack
by head blight disease upon , particularly cereal plants, such as wheat, barley, oat, and
corn and, when used in sufficient amounts, to act as microbial antagonists. These
compositions, similarly to other biocontrol agents, have a high margin of safety because they
typically do not burn or injury the plant.
As described in great detail throughout the present disclosure, control of head
blight disease may be effected by application of one or more ofthe microbiological
compositions ofthe t ion to a host plant or parts ofthe host plant. The
compositions can be d in an amount effective to reduce the level of head blight relative
to that in an untreated control. The active constituents are used in a concentration sufficient
to inhibit plant pathogen development ofthe targeted plant pathogen when applied to the
cereal plant. As will be apparent to a skilled person in the art, effective concentrations may
vary depending upon such factors as: (a) the type of the plant or agricultural commodity; (b)
the logical condition ofthe plant or agricultural commodity; (c) the concentration of
pathogens affecting the plant or agricultural commodity; (d) the type of disease injury on the
plant or agricultural commodity; (e) weather conditions (e.g. temperature, humidity); and (f)
the stage of plant e. According to the invention, typical concentrations are those higher
than 1 X 102 CFU/mL of carrier. Preferred trations range from about 1 X 104 to
about 1 X 109 CFU/mL, such as the concentrations ranging from 1 X 106 to 1 X 108
CFU/mL. More preferred concentrations are those of from about 35 to about 150 mg dry
microbial mass per gram of r (dry formulation) or per milliliter of carrier (liquid
composition). In solid formulations, the rate of application should be controlled to result in a
comparable number of viable cells per unit area of plant tissue e as obtained by the
aforementioned rates of liquid ent. Typically, the biological control agents of the
present invention are biologically effective when delivered at a concentration in excess of 106
CFU/g (colony forming units per gram), ably in excess of 107 CFU/g, more ably
108 CFU/g, and most ably at 109 CFU/g.
In some embodiments, the amount of one or more ofthe biological l agents
' in the microbial compositions ofthe present invention can vary depending on the final
formulation as well as size or type of the plant or seed utilized. Preferably, the one or more
biological control agents in the ial itions are present in about 2% W/w/ to about
80% w/w ofthe entire formulation. More preferable, the one or more biological control
agents employed in the compositions is about 5% W/W to about 65% w/w and most preferably
about 10% w/w to about 60% w/w by weight ofthe entire formulation.
As it will be appreciated by those skilled in the art, the microbiological
compositions of the invention may be applied to the Wheat plant or other cereals using a
variety of conventional methods such as dusting, coating, injecting, rubbing, rolling, dipping,
spraying, or brushing, or any other appropriate technique which does not significantly injure
the wheat plant or other cereals to be treated. Particularly preferred is the spray method.
Typically, the compositions ofthe ion are chemically inert; hence they are
compatible with ntially any other constituents of the spray schedule. They may also be
used in combination with biologically compatible pesticidal active agents as for example,
herbicides, nematicides, fungicides, insecticides, and the like. They can also be used in
combination with plant grth affecting substances, such as fertilizers, plant growth
regulators, and the like, provided that such compounds or substances are biologically
compatible.
When used as pesticides or fungicide in their commercially available formulations
and in the use forms, prepared from these formulations, the active microbial antagonists and
compositions according to the present invention can furthermore be present in the form of a
mixture with synergists. Synergists are compounds by which the activity of the active
itions is increased without it being necessary for the synergist added to be active
itself.
When used as pesticides in their commercially available formulations and in the
use forms, prepared from these formulations, the active microbial antagonists and
compositions according to the invention can furthermore be present in the form of a mixture
with inhibitors which reduce the degradation of the active itions after application in
the habitat of the plant, on the surface of parts of plants or in plant tissues.
The active microbial antagonists and compositions according to the ion, as
such or in their formulations, can also be used as a mixture with known ides,
bactericides, fungicides, insecticides, icides, nematicides, pesticides, or combinations
thereof, for example in order to Widen the spectrum of action or to prevent the development
of resistances in this way. In many cases, synergistic effects result, 2'. e. the activity of the
mixture can exceed the activity of the individual components. A mixture with other known
active compounds, such as fertilizers, growth tors, safeners and/or semiochemicals is
also contemplated.
In a red embodiment ofthe present invention, the compositions may further
include at least one chemical or biological pesticide. The amount of at least one chemical or
biological pesticide employed in the compositions can vary depending on the final
ation as well as the size of the plant and seed to be treated. Preferably, the at least one
chemical or biological pesticide employed is about 0.1% w/w to about 80% w/w based on the
entire formulation. More preferably, the at least one al or ical pesticide is
present in an amount of about 1% w/w to about 60% w/w and most ably about 10%
w/w to about 50% w/w.
A variety of pesticides is apparent to one of skill in the art and may be used.
Exemplary chemical pesticides include those in the carbamate, organophosphate,
organochlorine, and prethroid classes. Also included are chemical control agents such as, but
not limited to, benomyl, borax, captafol, captan, halonil, formulations containing
copper; formulations containing dichlone, dicloran, iodine, zinc; fungicides that t
ergosterol biosynthesis such as but not limited to blastididin, cymoxanil, fenarimol,
flusilazole, folpet,, imazalil, ipordione, maneb, manocozeb, metalaxyl,oxycarboxin,
2012/048012
myclobutanil, oxytetracycline, PCNB, pentachlorophenol, prochloraz, propiconazole,
quinomethionate, sodium aresenite, sodium DNOC, sodium hypochlorite, sodium
phenylphenate, streptomycin, sulfur, tebuconazole, terbutrazole, thiabendazolel, thiophanate—
methyl, triadimefon, tricyclazole, triforine, validimycin, zolin, zineb, and ziram. A
variety of insecticidal compounds can be useful for the compositions ofthe invention,
including but not limited to those cited in U.S. Pat. Appl. No. 201 10033432A1.
The microbiological compositions ofthe present invention preferably include at
least one biological pesticide. Exemplary biological pesticides that are suitable for use herein
and can be included in a microbiological composition according to the present invention for
preventing a plant enic disease include microbes, animals, bacteria, fungi, genetic
material, plant, and l products of living organisms. In these itions, the
microorganism ofthe present invention is isolated prior to formulation with an additional
organism. For example, microbes such as but not limited to species ofAmpelomyces,
Aureobasidium, Bacillus, Beauverz'a, Candida, Chaetomium, Cordyceps, Cryptococcus,
Dabaryomyces, Erwim'a, Exophilia, Gliocladium, Mariannaea, Paecilomyces, acz'llus,
Pantoea, Pichia, Pseudomonas, Sporobolomyces, Talaromyces, and Trichoderma can be
provided in a composition with the antagonistic microorganisms of the present invention,
with fungal s of the Muscodor genus being particularly preferred. Use of the
microbiological compositions according to the t invention in combination with the
microbial antagonists sed in US Patent No. 7,518,040; US Patent No. 7,601,346; US
Patent No. 6,312,940 is also particularly preferred.
es of fungi that can be combined with microbial antagonists and
compositions ofthe present invention in a composition include, without limitation, Muscodor
species, Aschersonia aleyrodz's, Beauverz'a bassiana ("white muscarine"), Beauveria
brongniartii, sporium herbarum, eps clavulata, Cordyceps entomorrhiza,
Cordycepsfacis, Cordyceps gracilz's, Cordyceps melolanthae, Cordyceps militaris,
Cordyceps myrmecophz'la, eps ravenelz'i, Cordyceps sinensis, Cordyceps
sphecocephala, Cordyceps subsessz'lis, eps eralz's, Cordyceps variabilis,
Cordyceps washingtonensis, nomyces clavosporus, Entomophaga g‘ryllz', Entomophaga
maimaiga, Entomophaga , Entomophagapraxibulli, Entomophthoraplutellae,
Fusarz'um laterz'tium, Hirsutella citriformz's, Hirsutella om', Metarhizium anisopliae
("green muscarine"), Metarhizz'umflaviride, Muscodor albus, Neozygitesfloridana, Nomuraea
rileyz', Paecilomycesfarinosus, Paecz'lomycesfumosoroseus, Pandora neoaphz'dz's,
Tolypocladz'um cylindrosporum, Verticillz'um lecam'z', Zoophthora radicans, and mycorrhizal
species such as Laccarz'a bicolor. Other mycopesticidal species will be apparent to those
skilled in the art.
The present invention also provides methods of treating a plant by application of
any of a variety of customary formulations in an effective amount to either the soil (1'. e. , in-
furrow), a n of the plant (1'. e. , drench) or on the seed before ng (i.e., seed coating
or dressing). Customary ations include solutions, emulsifiable trate, wettable
powders, suspension concentrate, soluble powders, granules, suspension-emulsion
concentrate, natural and synthetic materials nated with active compound, and very fine
control release es in polymeric substances. In certain embodiments of the present
ion, the biological control compositions are formulated'in powders that are available in
either a ready-to-use formulation or are mixed together at the time of use. In either
embodiment, the powder may be admixed with the soil prior to or at the time of planting. In
an alternative embodiment, one or both of either the biological control agent or insect control
agent is a liquid formulation that is mixed together at the time of treating. One of ordinary
skill in the art understands that an effective amount of the inventive compositions depends on
the final ation of the composition as well as the size of the plant or the size of the seed
to be treated.
Depending on the final formulation and method of application, one or more
suitable additives can also be introduced to the itions of the present invention.
Adhesives such as carboxymethylcellulose and natural and synthetic polymers in the form of
powders, granules or latexes, such as gum , chitin, polyvinyl alcohol and polyvinyl
e, as well as natural phospholipids, such as cephalins and lecithins, and synthetic
phospholipids, can be added to the t compositions.
In a red embodiment, the microbiological compositions are formulated in a
single, stable solution, or emulsion, or suspension. For solutions, the active chemical
compounds (i. e., the pest control agents) are typically dissolved in solvents before the
biological control agent is added. Suitable liquid solvents include petroleum based aromatics,
such as xylene, e or alkylnaphthalenes, tic hydrocarbons, such as cyclohexane or
paraffins, f0r example eum ons, mineral and vegetable oils, alcohols, such as
butanol or glycol as well as their ethers and esters, ketones, such as methyl ethyl ketone,
methyl isobutyl ketone or cyclohexanone, strongly polar solvents, such as
dimethylformamide and dimethyl sulphoxide. For on or suspension, the liquid
medium is water. In one ment, the chemical control agent and biological control
agent are suspended in separate liquids and mixed at the time of application. In a preferred
embodiment of suspension, the insect control agent and biologic are combined in a to-
use formulation that exhibits a shelf-life of at least two years. In use, the liquid can be
sprayed or can be applied foliarly as an ed spray or in—furrow at the time of planting
the crop. The liquid composition can be introduced to the soil before germination of the seed
or directly to the soil in contact with the roots by utilizing a variety of techniques known in
the art including, but not limited to, drip irrigation, sprinklers, soil injection or soil drenching.
Optionally, stabilizers and buffers can be added, ing alkaline and alkaline
earth metal salts and organic acids, such as citric acid and ascorbic acid, inorganic acids, such
as hydrochloric acid or sulfuric acid. Biocides can also be added and can include
formaldehydes or formaldehyde- releasing agents and derivatives of benzoic acid, such as xybenzoic
acid.
Seed coating formulations
In some particularly preferred embodiments, the biocontrol compositions of the
t invention are formulated as a seed treatment. The seed treatment preferably
comprises at least one insect control agent and at least one biological control agent. It is
contemplated that the seeds can be substantially uniformly coated with one or more layers of
the biocontrol compositions disclosed herein using conventional s of mixing, spraying
or a combination thereof h the use of treatment application equipment that is
specifically designed and manufactured to accurately, safely, and efficiently apply seed
treatment products to seeds. Such equipment uses various types of coating technology such
as rotary coaters, drum coaters, fluidized bed techniques, spouted beds, rotary mists or a
combination thereof. Liquid seed ents such as those of the present invention can be
applied Via either a ng "atomizer" disk or a spray nozzle which evenly butes the
seed treatment onto the seed as it moves though the spray pattern. Preferably, the seed is then
mixed or tumbled for an additional period oftime to achieve additional treatment distribution
and drying. The seeds can be primed or ed before coating with the inventive
compositions to increase the uniformity of germination and emergence. In an alternative
embodiment, a dry powder formulation can be metered onto the moving seed and allowed to
mix until completely distributed.
Another aspect ofthe invention provides seeds d with the subject
microbiological compositions. One embodiment provides seeds having at least part ofthe
surface area coated with a microbiological composition according to the present invention. In
a specific embodiment, the microorganism-treated seeds have a spore concentration or
microbial cell concentration from about 106 to about 109 per seed. The seeds may also have
more spores or microbial cells per seed, such as, for example 1010, 1011 or 1012 spores per
seed. The microbial spores and/or cells can be coated freely onto the seeds or, preferably,
they can be formulated in a liquid or solid composition before being coated onto the seeds.
For example, a solid composition sing the microorganisms can be prepared by mixing
a solid r with a suspension of the spores until the solid carriers are impregnated with the
spore or cell suspension. This mixture can then be dried to obtain the desired particles.
In some other ments, it is plated that the solid or liquid biocontrol
compositions of the present invention further contain functional agents capable of ting
seeds from the harmful s of selective ides such as activated carbon, nutrients
(fertilizers), and other agents capable of improving the germination and quality of the
products or a combination thereof.
Seed g methods and compositions that are known in the art can be
particularly useful when they are modified by the addition of one of the embodiments ofthe
present invention. Such coating methods and apparatus for their application are disclosed in,
for example, U.S. Pat. Nos. 5,918,413; 5,554,445; 5,389,399; 4,759,945; and 4,465,017.
Various seed g compositions are disclosed, for example, in U.S. Pat. Appl. Nos.
US20110033432, US20100154299, U.S. Pat. Nos. 5,939,356; 5,876,739, 5,849,320;
,791,084, 5,661,103; 5,580,544, 5,328,942; 4,735,015; 4,634,587; 4,372,080, 4,339,456; and
4,245,432, among others. '
A variety of additives can be added to the seed treatment formulations sing
the inventive itions. Binders can be added and include those composed preferably of
an adhesive polymer that can be natural or synthetic without phytotoxic effect on the seed to
be coated. The binder may be selected from polyvinyl acetates; polyvinyl acetate
copolymers; ethylene vinyl acetate (EVA) copolymers; polyvinyl alcohols; polyvinyl alcohol
copolymers; celluloses, including ethylcelluloses, methylcelluloses,
hydroxymethylcelluloses, hydroxypropylcelluloses and carboxymethylcellulose;
polyvinylpyrolidones; polysaccharides, ing starch, modified starch, dextrins,
maltodextrins, alginate and chitosans; fats; oils; proteins, ing gelatin and zeins; gum
arabics; cs; Vinylidene chloride and dene de copolymers; calcium
lignosulfonates; acrylic copolymers; polyvinylacrylates; polyethylene oxide; acrylamide
polymers and copolymers; polyhydroxyethyl acrylate, methylacrylamide monomers; and
polychloroprene.
Any of a y of colorants may be employed, including organic chromophores
classified as nitroso; nitro; azo, including monoazo, bisazo and polyazo; acridine,
anthraquinone, azine, diphenyhnethane, indamine, indophenol, methine, oxazine,
phthalocyanine, thiazine, le, triarylmethane, xanthene. Other additives that can be
added include trace nts such as salts of iron, manganese, boron, copper, cobalt,
molybdenum and zinc. A polymer or other dust control agent can be applied to retain the
treatment on the seed surface.
In some specific embodiments, in addition to the microbial cells or spores, the
coating can fiirther comprise a layer of adherent. The adherent should be xic,
biodegradable, and adhesive. Examples of such materials include, but are not limited to,
polyvinyl es; polyvinyl acetate copolymers; polyvinyl alcohols; polyvinyl alcohol
mers; celluloses, such as methyl celluloses, hydroxymethyl celluloses, and
ymethyl propyl celluloses; dextrins; alginates; sugars; molasses; polyvinyl
pyrrolidones; polysaccharides; ns; fats; oils; gum arabics; gelatins; syrups; and starches.
More examples can be found in, for e, US. Pat. No. 7,213,367 and US. Pat. Appln.
No. US20100189693.
Various additives, such as adherents, dispersants, surfactants, and nutrient and
buffer ingredients, can also be included in the seed treatment formulation. Other
conventional seed treatment additives e, but are not limited to, coating agents, g
agents, buffering , and polysaccharides. At least one agriculturally acceptable carrier
can be added to the seed treatment formulation such as water, solids or dry powders. The dry
powders can be d from a variety ofmaterials such as calcium carbonate, gypsum,
vermiculite, talc, humus, activated charcoal, and various phosphorous compounds.
In some embodiment, the seed coating ition can comprise at least one filler
which is an organic or inorganic, natural or tic component with which the active
components are combined to facilitate its application onto the seed. Preferably, the filler is
an inert solid such as clays, natural or synthetic silicates, silica, resins, waxes, solid fertilizers
(for example um salts), natural soil minerals, such as kaolins, clays, talc, lime, ,
attapulgite, montmorillonite, ite or diatomaceous earths, or synthetic minerals, such as
silica, alumina or silicates, in particular aluminum or ium silicates.
The seed treatment formulation may further include one or more ofthe following
ingredients: other pesticides, including compounds that act only below the ground;
fimgicides, such as captan, thiram, metalaxyl, xonil, oxadixyl, and isomers of each of
those materials, and the like; herbicides, including compounds selected from glyphosate,
carbamates, thiocarbamates, acetamides, triazines, dinitroanilines, glycerol ethers,
pyridazinones, uracils, phenoxys, ureas, and benzoic acids; herbicidal safeners such as
benzoxazine, benzhydryl derivatives, N,N—diallyl dichloroacetamide, various dihaloacyl,
oxazolidinyl and thiazolidinyl compounds, ethanone, naphthalic anhydride compounds, and
oxime derivatives; fertilizers; and biocontrol agents such as other naturally-occmring or
inant bacteria and fungi from the genera Rhizobium, Bacillus, monas, Serratia,
Trichoderma, Glomus, Gliocladium and hizal fungi. These ients may be added
as a separate layer on the seed or atively may be added as part of the seed coating
composition ofthe invention.
Preferably, the amount of the novel composition or other ingredients used in the
seed treatment should not t germination of the seed, or cause phytotoxic damage to the
seed.
The microorganism-treated seeds may also be further enveloped with a film
overcoating to protect the coating. Such overcoatings are known in the art and may be
applied using fluidized bed and drum film coating techniques.
In principle, any plant seed capable of germinating to form a plant that is
susceptible to attack by nematodes and/or pathogenic fungi can be treated in ance with
the invention. Suitable seeds include those of cereals, coffee, cole crops, fiber crops, flowers,
fruits, legume, oil crops, trees, tuber crops, vegetables, as well as other plants of the
monocotyledonous, and dicotyledonous s. ably, crop seeds are coated which
include but are not limited to bean, carrot, corn, cotton, grasses, lettuce, , pepper,
potato, rapeseed, rice, rye, sorghum, soybean, sugar beet, sunflower, o, and tomato
seeds. Most preferably, barley or wheat g wheat or winter wheat) seeds are coated with
the present compositions.
Also provided, in r aspect of the present invention, is a novel cereal plant
created by artificially introducing a microbial yte ofthe invention into a cereal plant
that is free of ytic microorganisms. In some embodiments ofthis aspect, the microbial
endophyte introduced into the cereal plant may be an endophytic antagonist having
suppressive activity against head blight disease or a causative agent of head blight disease.
Furthermore, the endophytic antagonist introduced into the cereal plant may be the fungal
strain SGI—OlO-Hl l. A variety ofmethods previously found ive for the introduction of
a microbial endophyte into cereal grass species are known in the art. Examples of such
methods include those described in US. Pat. Appl. No. 20030195117A1, US. Pat. Appl. No.
20010032343Al, and US Pat. No. 7,084,331, among others. It will become nt to
those skilled in the art that many of the aforementioned methods can be useful for the making
of a novel cereal plant of the invention.
After artificial infection, it is preferred that DNA ofthe isolated endophytic
antagonist is amplified by PCR and the antagonist is confirmed by carrying out a homology
search for the DNA ed. Further it is preferred that a foreign gene that expresses an
identifiable means is introduced into the above-mentioned endophytic antagonist, and the
presence of the colonization of the above—mentioned endophytic antagonist infecting the plant
is confirmed by the above-identifiable means using the foreign gene.
Preparing the biocontrol compositions according to the present invention
Cultures ofthe microbial antagonists may be prepared for use in the biocontrol
compositions ofthe invention using standard static drying and liquid fermentation techniques
known in the art. Growth is commonly effected in a bioreactor.
A bioreactor refers to any device or system that supports a biologically active
environment. As bed herein a bioreactor is a vessel in which microorganisms including
the microbial antagonists of the invention can be grown. A bioreactor may be any
appropriate shape or size for growing the microorganisms. A bioreactor may range in size
and scale from 10 mL to s to cubic meters and may be made of stainless steel or any
other appropriate material as known and used in the art. The bioreactor may be a batch type
ctor, a fed batch type or a continuous-type bioreactor (e.g. , a continuous stirred
r). For example, a bioreactor may be a chemostat as known and used in the art of
microbiology for growing and harvesting bacteria. A bioreactor may be obtained from any
commercial supplier (See also Bioreactor System Design, Asenjo & Merchuk, CRC Press,
1995).
For small scale operations, a batch ctor may be used, for example, to test and
develop new processes, and for processes that cannot be converted to continuous operations.
rganisms grown in a bioreactor may be suspended or immobilized. Growth
in the bioreactor is lly under aerobic conditions at suitable temperatures and pH for
growth. For the organisms of the invention, cell growth can be achieved at temperatures
between 5 and 37°C, with the preferred temperature being in the range of 15 to 30°C, 15 to
28°C, 20 to 30°C, or 15 to 25°C. The pH ofthe nutrient medium can vary between 4.0 and
9.0, but the preferred operating range is usually slightly acidic to neutral at pH 4.0 to 7.0, or
4.5 to 6.5, or pH 5.0 to 6.0. Typically, l cell yield is obtained in 20-72 hours after
inoculation.
Optimal conditions for the ation of antagonists of this ion will, of
in the
, depend upon the particular strain. However, by virtue of the conditions applied
selection s and general requirements of most microorganisms, a person of ordinary
skill in the art would be able to determine essential nutrients and conditions. The microbial
antagonists would typically be grown in aerobic liquid cultures on media which contain
2012/048012
sources of carbon, nitrogen, and nic salts that can be assimilated by the microorganism
and supportive of efficient cell growth. Preferred carbon sources are hexoses such as
glucose, but other s that are readily assimilated such as amino acids, may be
substituted. Many nic and naceous als may be used as nitrogen sources in
the growth process. Preferred nitrogen sources are amino acids and urea but others include
gaseous ammonia, inorganic salts of nitrate and ammonium, vitamins, purines, pyrimidines,
yeast extract, beef extract, proteose e, soybean meal, hydrolysates of casein, distiller's
solubles, and the like. Among the inorganic minerals that can be incorporated into the
nutrient medium are the customary salts e of yielding calcium, zinc, iron, manganese,
magnesium, copper, cobalt, potassium, sodium, molybdate, phosphate, sulfate, chloride,
borate, and like ions. Without being limited thereto, use of potato dextrose liquid medium for
fungal antagonists and R2A broth premix for bacterial strains is red.
Throughout this disclosure, various information sources are referred 'to and
incorporated by reference. The information sources include, for example, scientific journal
articles, patent documents, textbooks, and World Wide Web browser—inactive page addresses.
The reference to such information sources is solely for the purpose ofproviding an indication
of the general state of the art at the time of filing. While the contents and teachings of each
and every one ofthe information sources can be relied on and used by one of skill in the art to
make and use embodiments of the invention, any discussion and comment in a specific
information source should in no way be considered as an admission that such comment was
widely accepted as the general opinion in the field.
The discussion of the l methods given herein is intended for illustrative
purposes only. Other ative s and embodiments will be apparent to those of skill
in the art upon review of this disclosure, and are to be included within the spirit and purview
ofthis application.
It should also be understood that the following examples are offered to illustrate,
but not limit, the invention.
EXAMPLES
EXAMPLE 1: Discoveg of the antagonistic microorganisms e of suppressing the
development rz'um gramz'naerum and Gibberella zeae, causative agents of head blight
disease.
This example describes a high-throughput process of collecting and screening
candidate microorganisms that has been developed internally at Synthetic Genomics, Inc. to
isolate s of microorganisms having suppressive activity against causative agents ofhead
blight disease, particularly against Fusarium graminearum. Novel microbial antagonistic
strains were isolated from plant tissue samples collected from several locations across the
United States. The bacterial strains SGIC06, SGI—Ol4-G01, SGI-OlS-F03, and SGI—
015-H06 were isolated from plant root tissues collected from Eagle Peak Preserve near
Julian, CA. The fungal strain O-Hll and the bacterial strain SGI-OOS-GOS were
isolated from stem tissues oftwo different plant s collected from San Elijo Lagoon,
Encinitas, CA.
The rganisms were isolated as follows. For bacterial strain isolation, plant
root tissues were sonicated and subjected to serial dilutions on 2><YT (yeast extract and
tryptone) and N—free agar medium plates. Individual colonies were then selected based on
morphological characteristics, and individually ed in liquid broth medium. For fimgal
isolation, plant tissue was first surface-sterilized by dipping in 70% l and briefly
passing through a flame. The tissue was then dissected and placed on potato dextrose agar
(PDA) medium, followed by incubation at room temperature. When mycelial growth was
observed, a t of mycelial growth was then transferred to another PDA plate. Strains
of microorganisms were isolated, purified and preserved at —80°C in 15% glycerol at for
ial s and on dried barley seed for fungal s.
Strains ofmicroorganisms isolated as bed above were thereafter d for
their ability to suppress mycelial growth ofE graminearum in an in vitro antagonism test,
which was performed on agar plates containing potato dextrose agar (PDA) growth medium
according to a high-throughput screening procedure described in US. Pat. Appl. No.
U820120107915A1, which is incorporated by reference herein, with minor modifications.
Briefly, isolated strains ofmicroorganisms were grown on one-fifth strength Tryptic soy
broth agar (TSBA/S) for 24 hours prior to use. Conidial um of F. gmmz'nearum
NRRL—S883 was ed by hyphal tipping an actively growing colony ofthe fungus and
transferring the hyphal s to PDA agar medium. After incubating the plates for 7 days at
°C using a 12 h/day photoperiod, conidia were washed from PDA plates using a weak
phosphate buffer (0.004% phosphate buffer, pH 7.2, with 0.019% MgClz). A suspension of
conidia of F. graminearum in the weak phosphate buffer (1 X 105 conidia/m1) was then
ately spread over the agar surface, and the plates were then ted at 25°C for 48-
72 hours. To initiate the antagonism test, cells of ed microbial strains were point-
inoculated at equal distances inside the perimeter of the plate. After five days, the strains
were scored as antibiosis ve when a visibly clear area that lacked mycelial growth
existed around the perimeter of the microbial colonies.
More than 4,000 microbial strains were ed and assayed by the procedure
described above. Ofthose, six strains were found to significantly suppress the mycelial
growth ofF. gramz‘nearum NRRL—5883 on PDA medium. These new microbial antagonists
are identified as SGI—005-G08, SGI-OlO-Hl 1, SGI—014-CO6, SGI—014-G01, SGI-OlS-F03,
and SGI-Ol 5—H06.
Antagonism test was also performed for the new microbial antagonists for their
ability to suppress the growth of fungal pathogen Gibberella zeae, which is a teleomorphic
species ofFusarz'um graminearum. All procedures were identical to those described above,
except that the pathogen strain tested in this assay was a pathogenic strain of the fungus
Gibberella zeae. Of these six microbial antagonists, four strains SGI—OlO-Hl 1, SGI—014-
C06, SGI—015-F03, and SGI—015-H06 were found to significantly suppress the al
growth of Gibberella zeae.
EXAMPLE 2: DNA extraction, Sequencing and Taxonomy
Fungal Cell Lysis and Acquiring 88 rDNA Sequence Information
The fungal biomass was transferred to a 96—well PCR microplate containing 50 ul
of a 2 X lysis buffer (100 mM Tris HCL, pH 8.0, 2 mM EDTA, pH 8.0, 1% SDS, 400 ug/ml
Proteinase K). Lysis conditions were as follows: 55°C for 60 minutes, 94°C for 4 minutes.
An aliquot ofthe lysis product was used as the source oftemplate DNA for PCR
amplification. The ITS-5.88 rDNA sequence was amplified via PCR using two primers
M13-ITSI (SEQ ID NO: 15) and ITS4 iled (SEQ ID NO: 16).
For cation ofthe ITS-5.88 rDNA region, each PCR mixture was prepared in
a 20-ul final volume on containing 4 ul from the flmgal lysis reaction, 0.2 uM of each
primer (ITSl/ITS4), 6% Tween-20, and 10 ul of 2X ImmoMix (Bioline USA Inc, Taunton,
MA). PCR ions were as follows: 94°C for 10 minutes; 94°C for 30 seconds, 52°C for
seconds, 72°C for 75 seconds for 30 cycles; 72°C for 10 minutes. A 2-ul aliquot ofthe
PCR product was run on a 1.0% agarose gel to confirm a single band ofthe expected size.
Positive bands were sent r Sanger sequencing in the forward and reverse directions
using M13 primers. Sequence of the 5.88 enic region (ITS) of the fungal strain SGI-
OlO-Hll is provided in the Sequence Listing as SEQ ID NO: 11. Homology search for the
determined nucleotide sequence ofthe 5.88 intergenic region (ITS) was conducted using the
DDBJ/GenBank/EMBL database. Subsequently, the phylogenetic relationship of the
nucleotide sequence of the 5.88 intergenic region (ITS) was analyzed among the ed
fungal antagonist SGI-OlO—Hll described herein, rganisms of the genera and species
that exhibit high sequence homologies to the isolated fungal antagonist SGI-OlO-Hl 1, and
other wide varieties of microorganism genera and, species, using the ClustalW phylogenetic
tree building program. The fimgal strain SGI-OlO-Hll is considered to be related to the
family of Mycosphaerellaceae based upon ~97% similarity of its ITS-5.88 rDNA sequence to
those ofMycosphaerella punctiformz‘s (GenBank EU343182) and rz'a pratensz's
(GenBank EU019284), whose 5.8S ITS sequences show clear relatedness to
Mycosphaerellaceae.
Bacterial Cell Lysis and Acquiring 16S rRNA Sequence Information
A 20-ul aliquot of cell suspension was transferred to a 96-well PCR plate
containing 20 pl of a 2)< lysis buffer (100 mM Tris HCL, pH 8.0, 2 mM EDTA, pH 8.0, 1%
SDS, 400 ug/ml Proteinase K). Lysis conditions were as s: 55°C for 30 s, 94°C
for 4 minutes. An aliquot of the lysis product was used as the source of template DNA for
PCR amplification. The 16S rRNA sequence was amplified via PCR using M13—27F (SEQ
ID NO: 17) and 1492R M13-tailed (SEQ ID NO: 18) primers.
For amplification of 16S rRNA region, each PCR mixture was prepared in a 20—u1
final volume reaction ning 4 pl from the bacterial lysis reaction, 2 uM of each primer
492R), 6% Tween-20, and 10 ul of 2X ImmoMix (Bioline USA Inc, Taunton, MA).
PCR conditions were as follows: 94°C for 10 s; 94°C for 30 seconds, 52°C for 30
s, 72°C for 75 seconds for 30 cycles; 72°C for 10 minutes. A 2-ul aliquot ofthe PCR
product was run on a 1.0% agarose gel to confirm a single band ofthe expected size. Positive
bands were sent out for Sanger sequencing in the forward and reverse directions using M13
primers. ces of the 16S rRNA ofthe bacterial strains SGIC06, SGI-OOS-GOS,
SGI—014-G01, SGIF03, and SGI—OlS—H06 are approximately 1.4—Kb in length and are
provided in the Sequence Listing as SEQ ID NOS: 1, 10, 12, 13, and 14 respectively.
Homology search for the determined nucleotide sequence was conducted using the
DDBJ/GenBank/EMBL se. Subsequently, the phylogenetic relationship of the
nucleotide sequence ofthe 16 rRNA genes was analyzed among the isolated bacterial
antagonists described , bacteria of the genera and species that exhibit high sequence
homologies to the isolated bacterial antagonists, and other wide varieties of bacterial genera
and species, using the ClustaIW phylogenetic tree building program. Sequence identity and
similarity were also determined using GenomeQuestTM software (Gene-1T, Worcester Mass.
USA). The sequence is result revealed that the bacterial isolate SGI—014—G01 can be
ered to be related to the genus of Variovorax based upon ~99% rity of its 16S
rRNA sequence to those of several Variovorax species, including Variovorax sp. R—21938
(GenBank AJ786799) and Variovoraxparadoxus (GenBank GU186109), whose 16S rRNA
sequences show clear relatedness to Variovorax sp. Further, the sequence analysis result also
ed that the two bacterial isolates SGI-015—F03 and SGI—015-H06 can be considered to
be related to the family ofBacillaceae, based upon >99% rity of their respective 168
sequences to those of several Bacillus spp.
The sequence analysis result revealed that the two bacterial isolates SGI—014-C06
and SGIG08 can be considered to be related to the family of Microbacteriaceae based
upon >99% similarity of their tive l6S sequences to those of several Microbacz‘erz’um
spp. Notably, the 1430-nt sequence ofthe 16S rRNA gene of 4-C06 (SEQ ID NO: 1)
is identical to the 16S rRNA gene of a Microbacterium oxydcms strain DSM 20578 and
several other Mcrobacterium sp. strains (e.g.
, GenBank sequences Y17227.1, 06,
EU086800, and EU714335) over its entire 1430-nt length.
In particular, among the thousands ofmicrobial strains that were isolated and
tested for the ability to suppress Fusarium pment in antagonism
assays as described in
Example 1, a total of eighty—eight strains was subsequently identified as Microbacterz'um
species based upon the sequence similarity of their 168 sequences to those n
Microbacterium spp. However, Applicants have found that SGI—014-C06 and SGI—OSS-GOS
were the only two Microbacterium s that sed suppressive activity against
Fusarium graminearum. To date, as discussed above, several naturally occurring microbes
have been reported as having antagonistic activity against head blight disease. However,
there are no reports prior to the present invention that describe a microorganism of the
genus
Mycobacterium having such nistic activity. Further, prior to the present invention, the
present inventors were not aware of any methods or processes of using a bacterial strain of
the genus cterz'um as biocontrol agent in preventing, ting or treating the
development of a causative pathogen ofhead blight disease.
EXAMPLE 3: Sequence Analysis of Housekeeping Genes from the Isolate SGI—Ol4-C06
A phylogenetic study of several housekeeping genes from 27 species of the
genus
Microbacterz'um has been reported recently by Richert et al. (Syst. App]. ol. 30: 102-
108, 2007). The study concluded that although the merits of the 16S rRNA sequence analysis
for systematic taxonomy are unsurpassed, sole emphasis on a single taxonomic parameter
' should
not guide systematic conclusions. As disclosed above, the nucleotide sequence ofthe
16S rRNA gene of SGIC06 (SEQ ID NO: 1) is identical to the 16S rRNA
gene of
several Microbacterium sp. strains, including the nucleotide sequence of a 16S rRNA
gene of
a Microbacterium oxydans strain DSM 20578 that was included in Richert et al. (2007) study
nk Accession Y17227.1). Applicants proceeded to perform a phylogenetic is
on four housekeeping genes ofthe isolate SGIC06, which are DNA gyrase subunit B
(gyrB), RNA-polymerase t B (rpoB), recombinase A (recA), and polyphosphate kinase
(ppk). Toward this end, the entire genome of the isolate SGI-014—C06 was shot—gun
sequenced, assembled and annotated by using procedures bed in PCT Patent
Application No. W02010115156A2. Genomic DNA was prepared from a fresh culture of
SGIC06. Cell pellet was used for high lar weight DNA extraction using the
U1traC1ean® Mega Soil DNA Isolation Kit (Cat. No 10) from MO BIO Laboratories,
Inc. according to the manufacture’s recommended protocol. The genomic DNA from SGI—
014-C06 was then prepared for shotgun 454-pyrosequencing. Genomic DNA (7.5ug) was
used for library construction according to the recommended protocol (454 Life Sciences) for
single long reads. The sequences were generated by two GS FLX Titanium series cing
111113.
The sequences of four housekeeping genes gyrB, rpoB, recA, andppk ofthe isolate
SGIC06 are provided in the Sequence g. Homology search for the determined
nucleotide sequences was conducted using the DDBJ/GenBank/EMBL database. Sequence
identity and similarity were also determined using GenomeQuestTM re (Gene-IT,
Worcester Mass. USA). As discussed in details below, the result of sequence analysis ofthe
housekeeping genes revealed that the isolate SGIC06 described in the present disclosure
is a novel bacterial strain and can be considered to be related to the family of
acteriaceae.
The polynucleotide sequence ofthe gyrB gene of SGI-Ol4-C06 has the st
sequence identity with a gyrB gene ofMicrobacterium eum having GenBank ion
number AP012052 (82.69% over a 936/2172 nucleotide alignment). When ed to the
gyrB gene ofthe Microbacterium oxydans strain DSM 20578 (GenBank AM181493; Richert
et al., 2007), the sequence homologies between the two genes were ~62% identical at the
nucleotide level and ~37% identical at the amino acid level.
The polynucleotide sequence of the rpoB gene of 4-CO6 has the greatest
sequence identity with an rpoB gene ofMicrobacterium maritypz‘cum having GeneBank
accession number AM181582 (96.98% over a 1093/3504 nucleotide alignment). When
compared to the rpoB gene of the Microbacz‘erium oxydans strain DSM 20578 (GenBank
AM181583; t et al., 2007), the sequence homologies between the two genes were
~96% identical at the nucleotide level and 99% identical at the amino acid level.
The polynucleotide sequence of the recA gene of SGI-014—C06 has the greatest
sequence ty with a recA gene ofMicrobacterium testaceum having GeneBank ion
number AP012052 (85.45% over a 962/1188 nucleotide alignment). When ed to the
recA gene ofthe Microbacterium oxydans strain DSM 20578 (GenBank AM181527; Richert
et al., 2007), the sequence homologies between the two genes were ~92% identical at the
nucleotide level and 100% identical at the amino acid level.
The cleotide sequence of theppk gene of SGI—Ol4-C06 has the greatest
sequence ty with appk gene ofMicrobacterium luteolum having GenBank accession
number AM181554 (91.38% over a 1380/2175 tide alignment). When compared to
the ppk gene ofthe Microbacterium oxydans strain DSM 20578 nk AM181556;
Richert et al., 2007), the sequence homologies between the, two genes were ~91% identical at
the nucleotide level and ~98% identical at the amino acid level.
EXAMPLE 4: Protection of wheat from Fusarium earum infection using the microbial
antagonists Microbacterium Sp. [ERRL B-50470) Mycophaerella sp. (N BBL 50471 1, and
Variovorax sp. [EBB]: B-50469)
Microbial strains that were found positive for antibiosis in the antagonism screen
described in Example 1 were further evaluated through a plant-based bioassay in which cells
of the microbial strains were applied directly onto seeds of a susceptible cereal cultivar,
followed by inoculation with conidial spores of F. grarninearum. The microbial s were
grown to a sufficient turbidity and diluted in water. Two gram ofwheat seeds of a
susceptible wheat ar (Hank; WestBred LLC, Bozeman, MT) were sown in one-liter pots
containing pasteurized soil medium. After , 20 mL ofthe ial e dilution
was transferred on top of sown seeds. The wheat seeds were allowed to germinate in
ouse conditions under fluorescent lighting with a 14 hour photoperiod. At the onset of
wheat flowering, the wheat heads were challenged by spraying with F. graminearum NRRL
5883 conidial spores. Conidial spores were ted from five day old PDA plates by
pouring water with 0.01% Tween20 on plates and scraping spores into suspension. After
spraying spores, wheat plants were transferred to a mist chamber with 100% humidity for
three days to allow for infection. The treatments were:
l. Untreated: no microbial or chemical fungicide treatment + Fusarium challenge.
. 2. Non-infected: no microbial or chemical fungicide treatment, no Fusarz’um
challenge.
3. SGI—Ol O-Hl 1: fimgal treatment + Fusarium challenge.
4. SGI—014-G01: ial treatment + Fusarz'um challenge.
5. SGI-Ol4-C06: bacterial treatment + Fusarium challenge.
Twenty days after infection, watering was stopped and wheat plants were allowed
to dry for three weeks before harvesting. dual wheat heads were harvested and
collected. Disease severity was determined for each head showing head blight disease
symptoms. Disease severity was calculated as the number of diseased spikelets divided by
the total number of spikelets per heads. The s (TABLE 2) ed that wheat plants
treated with each of the three microbial antagonists tested, SGI-014—C06 (NRRL B-50470),
SGI—OlO-Hll (NRRL 50471), and SGI—014-G01 (NRRL 9), had significantly lower
severity and incidence ofFusarz'um graminearum infestation 'when compared to the
“untreated” control growing in the same conditions 5).
The seeds from each head were harvested by hand and the seed mass was weighed.
The average seed weight per pot in each ofthe ents was calculated. As ed in
TABLE 3, each ofthe microbial antagonists was found to significantly reduce yield loss
caused by head blight infestation.
TABLE 2. Efficacy ofthe microbial antagonists in reducing head blight incidence in Wheat.
Percent severity (%) STDEV
SGI—OlO—Hll 0.0219 0.0005
SGI—014-G01 0.0315 0.0001
SGI—014-C06 0.0225 0.0004
TABLE 3. Efficacy of the microbial antagonists in preserving seed yield in wheat plants
having head blight disease.
0.8438i0.1633 0.0191
SGI—OlO-Hll 0.6200 i 0 1844 0.7025
SGI—Ol4-G01 0.7963 3: 0 2032 0.5277
SGI—014-C06 7
0.6744 :i: 0.0948 0.0551
EXAMPLE 5: Growth inhibition ofFusarz'um graminearum by microbial antagonists on
Was.
The microbial strains found to possess suppressive activity against F. graminearum
in antagonism plate assay were investigated further for their ability to reduce the incidence of
head blight in wheat. Seeds of a susceptible wheat cultivar (Hank; WestBred LLC, Bozeman,
MT) were sown in l-Liter pots each containing pasteurized soil medium in 20 cm diameter
plastic pots. Microbial cell suspensions were prepared as follows.2YT, or similar growth
medium, broth cultures were inoculated from isolate glycerol stocks or streak plates.
Typically, cultures were initiated 48 - 72 hours prior to use in the growth chamber,
greenhouse or field allowing the culture to reach late exponential phase. Isolates that have
longer doubling times were initiated further in advance. Cultures were incubated at 30°C on
a rotary shaker at 200 rpm. After growth, the cells were pelleted at 10,000 x g for 15 min at
4°C and re-suspended in 10 mM MgSO4 buffer (pH 7.0). Cell densities were normalized for
each isolate on a CFU/mL basis (cell performing units per milliliter). Typically, ~109 CFU/
mL suspensions were prepared for each isolate and transported to the inoculation site on ice.
Inoculations were med by diluting these cell suspensions 1/20 in irrigation water to a
final density 5 X 107 . For 1-L pot trials, 20 mL of this dilute cell sion was
distributed evenly over the e of each replicate pot. For trial pots, cell
suspensions were not diluted and 1 mL of each 109 CFU/mL suspension was pipetted directly
onto the surface of each replicate pot as soil drench on top of the submerged seeds. The
seeds and plants were maintained in a ouse at room temperature with a 14 h
photoperiod of light.
Mycelium of the Fusarium gramz’nearum strain NRRL-5883 was grown on PDA
plates for 5 days under constant light. Hyphae and conidia were harvested by g a few
mL of sterile water (0.01% Tween 20) on the plates and ng the agar surface with a
sterile a. The concentration of spores in the inoculum was approximately 2><105
spores/mL, but hyphal fragment concentration was not determined.
Inoculation with F. earum began after shoot emerging from the seeds and
continued every other evening for 10 days. The inoculum of F. nearum was applied
with a sprayer at about 30 mL per pot. Immediately after each inoculation, the plants were
misted with overhead mister. When chemical ide was used, the fungicide (Banner
Maxx, Syngenta) was prepared by diluting 2 mL of fungicide stock in IL of distilled water,
and was applied with a sprayer at about 30 mL per pot.
Head blight was ted by the severity ofFusarium infestation, as determined
by the number ofFusarium -forming units per gram ) ofplant tissues. All
treatments were performed in four blocks with four replicate pots. The treatments were:
1. ted: no microbial or chemical fungicide treatment, + 'um challenge.
2. fected: no microbial or chemical fungicide treatment, no Fusarium
challenge.
3. Fungicide: chemical fungicide treatment + Fusarium challenge.
4. SGI-OlO-Hl 1: fungal treatment + Fusarium challenge.
5. SGIG01: ial treatment + Fusarz’um challenge.
6. SGI-014—C06: bacterial treatment + Fusarium challenge.
The results, as reported in TABLE 4, revealed that all three microbial treatments
provided a significant decrease in FHB severity as compared to the infected control. In
particular, two microbial antagonists, SGIC06 and SGI—OlO-Hl 1, significantly reduced
the ation of Wheat plants by Fusarium gramz’nearum when compared to the untreated
control grown in the same ions. The protection of Wheat plants from Fusarz'um
infestation effected by each of the two microorganisms 4-C06 and SGI-OlO-Hll was
statistically comparable to the protection effected by the commercial chemical fungicide.
When the microorganism SGIG01 was applied, the observed protection of wheat plants
from Fusarz'um infestation was much less conspicuous and its effectiveness varied greatly
among the replicate pots.
WO 16361
TABLE 4: Effect ofmicrobial antagonists on Fusarz'um infestation.
Treatment CFU/g
Untreated 487 :l: 600
Non-infected <.0001
Chemical fungicide 290 i 146 <.0001
SGI-OlO—Hll 671 i 450 0.0077
SGI—Ol4-G01 1246 i 465 0.8387
SGI—014-C06 367 i 234 0.0001
EXAMPLE 6: Growth and stora e of the microbial anta onists
Mycosphaerella sp.: Several methods were used to store the isolated fungus as a
pure culture, one of which was the filter paper technique. The fungus was also allowed to
grow on PDA, and then it was cut into small squares which were placed into vials containing
% glycerol and stored at —70°C. The fungus was also stored at 4°C by a similar method,
using distilled water rather than glycerol. However, one of the preferred methods of storage
was on infested sterile barley seed at -80°C.
Bacillus sp., Microbacterz'um Sp. and Variovorax sp.: The ed bacteria were
stored as a pure culture. A bacterial colony was transferred to a vial containing R2A broth
liquid medium ova) and allowed to grow at 30°C with shaking at 250 rpm for two
days. The e was then transferred into vials containing 15% glycerol and stored at —
80°C.
EXAMPLE 7: Spore production and seed coating treatments
Spore tion: In a typical spore production procedure, one liter of2XYT
growth medium (16 g/L Tryptone, 10 g/L yeast extract, 5 g/L NaCl) was inoculated with 5
mL starter culture or petri dish ng and incubated overnight at 30°C in a rotating shaker
that was set at 225 rpm. Bacterial cells were pelleted by centrifugation, and washed 1x with
PBS buffer (8 g/L NaCl; 0.2 g/L KCI; 1.44 g/L NazHPO4; 0.24g of ; pH 7.4). Cells
were ended in CDSM medium (Hageman et al., J Bacteriol., 43 8-441, 1984), and
were grown for four additional nights at 30°C in the rotating shaker. Sporulation in the
bacterial culture was monitored daily by using phase contrast microscope until the entire
culture was virtually made up of free-floating spores. The incubation time typically took less.
than four days or more than six days depending on the s. Under phase contrast
microscope, ores were detected within cells as bright white oblate spheroids. Bacterial
spores were pelleted by centrifugation at 10,000 X g for 15 minutes, washed two times with
sterile dH20 and, if necessary, concentrated down to 50 mL and could either be used
immediately or refrigerated for later use. Spore concentration was measured at 0D600. This
procedure typically produced at least 2000 OD's of bacterial spores.
In particular, several bacterial strains of the present invention, e.g. Bacillus sp.
SGIF03, could conveniently produce large amounts of spores after 4 days of incubation
with a simple inoculation of a large overnight starter culture (~15 ml.) in to 1 liter of 2>< SG
growth medium, followed by a 4-day incubation at appropriate temperature in a rotating
shaker set at 225 rpm. The recipe of the 2x SG growth medium was as follows: 16 g/L
Nutrient Broth; 0.25 g/L MgSO4; 2.0 g/L KCl; 0.15 g/L CaC12.2H20; 0.025 g/L MnC12.2H20;
0.28 mg/L 7H20; 1.0 g/L Dextrose.
Seed coating treatments ofwheat and corn seeds: Small-scale seed treatment
experiments were conducted by following a procedure described in a et al. , 2009 with
minor modifications. Typically, a biopolymer stock solution was made by adding 6 gram of
gum Arabic powder (MP Biomedical) to 36 mL water in a 50 mL Falcon tube, which was
subsequently mixed to homogeneity by using a wheel mixer. A stir plate was used for
mixing when larger quantities of coated seeds were needed.
When vegetative cells were used, turbid cultures of actively growing microbial
cells were washed with PBS and adjusted to an OD600 of ~5.0. Alternatively, microbial spore
suspensions were prepared as described above. Bacterial spores and/or vegetative cells were
thoroughly resuspended in ~32 mL gum Arabic biopolymer stock solution ed as
described above, and ing suspension was mixed thoroughly in a 1 L bottle.
imately 400 g of seeds (either wheat or corn) were added to the bottle and usly
shaken or vortexed to ensure a uniform distribution ofthe ll suspension. Coated seeds
were then spread across a sterile plastic weigh boats to dry in a laminar flow hood until no
longer tacky, generally 3-6 hours with ic mixing. In some ces, seeds coated with
spores could be dried overnight. However, seeds coated with vegetative cultures were
typically stored away before they completely desiccated. Viability test performed
ically on the microbes used in seed coating formulation showed that the microbes
ed viable for at least three months. ation rate ofthe coated seeds was
determined to be essentially identical to control uncoated seeds.
EXAMPLE 8: Effect of microbial seed treatments on the development of Fusarium head
blight in wheat
Seeds of a FHB-susceptible wheat cultivar (RB07) were coated with each ofthe
microorganisms SGI-014—C06; SGI—OlS-F03, and SGI-OlS-HOG, in accordance with the
procedure described in Example 8. Coated seeds were subsequently sown in one-liter pots
containing pasteurized soil medium omix—Mix 200; Scotts-Sierra Horticultural
ts, Marysville, OH; and 3 gram of fertilizer 14—14—14 (N-P—K)]. Pots were seeded at
7-8 plants per pot and subsequently thinned to 5 plants per pot at the 3—leaf stage. Pots were
arranged in randomized blocks with 5 pots per treatments. The coated seeds were then
allowed to germinate in greenhouse conditions under cent lighting with 16 hours of
lighting per day. At the onset of wheat flowering (anthesis), the wheat heads were challenged
by spraying with F. graminearum NRRL 5883 macroconidial spores at a concentration of
100,000 spores/mL. After ng spores, wheat plants were transferred to a dew r
with 100% humidity for three days to allow for infection. The treatments were:
1. Untreated: no ial or chemical fungicide treatment + Fusarz'um challenge.
2. SGIC06: bacterial seed treatment + Fusarium challenge.
3. SGI—Ol 5-F03: bacterial seed treatment + Fusarium challenge.
4. SGI-OlS-H06: bacterial seed treatment + Fusarium challenge.
Severity of head blight disease was assessed visually at ten days and twenty-one
days after infection. Disease severity was determined for each spike g head blight
disease symptoms, and calculated as the percentage of symptomatic spikelets; i. e. the number
of spikelets displaying FHB symptoms divided by the total number of spikelets. The results
(TABLE 5) ed that wheat seeds coated with each of the three microbial antagonists
tested, 4-C06; SGI-OlS—FO3, and SGI-OlS-H06, had significantly lower severity of
Fusarz'um graminearum infestation when compared to the “untreated” control growing in the
same conditions (P<0.05).
WO 16361
Table 5: Development of head blight symptoms in wheat following seed treatments with
antagonistic microorganisms
_10 days post-infection
SGI-014—C06 2.08
SGI-OlS-F03 23.12
EXAMPLE 9: Biocontrol ofhead-blight disease of wheat in greenhouse trials
Each of the microorganisms SGICO6; SGI—OlS-FO3, and SGI—OlS-H06 were
further tested at larger-scale greenhouse trials. The trials were conducted in a “plant growth
containment room” (PGCR) located at Synthetic Genomics, Inc., and included the following
control treatments: infected control, fected l, as well as four commercial
fungicide benchmarks. The benchmarking chemical fungicides were Banner MAXX®
nta) at a concentration of 2 ml/L and Prosaro® (Bayer CropScience) at a concentration
of 3 ml/L, each d as a foliar spray, following cturers’ recommendation. The
benchmarking biological firngicides were Actinovate® (Natural Industries) and RhizoVital®
P GmbH), each applied as a soil drench as per instruction s recommended by
manufacturers.
The microbial treatments were prepared and applied either as a soil drench or as a
seed coat. When microbial treatments were applied as a soil drench, cell suspensions of each
of the microorganisms were individually applied to the seeds before covering the seeds with
more growth medium. For this purpose, freshly prepared cultures were pelleted to remove
growth media and resuspended in 10 mM ium sulfate (MgSO4) buffer. Cell
suspensions were then added by ing and distributing 20 milliliters evenly across the
seeds at a total cell number of ~1 09 cells per pot. When microbial treatments were d as
a seed coating, microorganism cells/spores were essentially prepared as described in Example
8 above. Coated seeds were produced by incorporating cell suspensions with a gum Arabic
solution to form a tacky coating mixture that was subsequently applied to the seeds. The
microbial seed coating was then allowed to dry to form a hard but water soluble biopolymer
entrapping the microorganism cells/spores. The goal was to reach a cell titer in the range of at
least 106 — 107 viable cells/seed. In this greenhouse trial experiment, the seed coatings were
prepared the day prior to the sowing ofthe seeds.
Each treatment had four replicates that were positioned in a Randomized Complete
Block Design (RCBD) on three leveled racks arranged in two rows along the sides of a
growth room. The racks were equipped with fluorescent lights (Agrosun, 5850K) that
generated on average 800 umole of light intensity as measured at the pot e. Each
replicate consisted of four l-liter pots contained in a half flat. The pots were filled with a
synthetic growth medium consisted of a 3:1 ratio (V/v) of Arabidopsis Growth Medium AIS
(Lehle Seeds) to sand (Washed Coarse). In each pot, two grams of spring wheat seeds (Hank,
WestBred) were scattered on the surface ofthe growth medium. The pots were bottom
watered by g ~2 cm water at their base and observed for germination and growth.
At flowering stage (Feekes ) the wheat heads were ed by spraying with
a Fusarium gramz'nearum conidial spore suspension. For this greenhouse trial experiment,
fungal spores were prepared by plating homogenized mycelia ofF. gramz'nearum strain
NRRL 5883 onto large PDA plates, followed by five-day incubation under constant light at
room temperature. The fungal spores were then harvested by flooding the plates with
magnesium sulfate buffer (10 mM MgSO4; 0.01% Tween 20) and gently scraping the agar
surface with a sterile spatula. The spore concentration was adjusted and imately
50,000 conidial spores were applied per head with a pressurized hand sprayer. The growth
room relative humidity was increased to 90% for three days ng for infection before
again being normalized. After wheat seeds had set, watering was stopped and the wheat
heads were allowed to dry completely. Individual wheat heads were harvested and collected.
Disease severity was determined for each wheat head showing head blight disease ms.
Disease severity was calculated as the number of diseased ets divided by the total
number of ets per head. The results (TABLE 6) revealed that wheat d with each
ofthe three microbial antagonists tested, SGIC06; SGI-OlS-F03, and SGI-OlS-HO6, had
significantly lower severity and incidence ofFusarz'um graminearum infestation when
compared to the “untreated” control g in the same conditions (P<0.05).
WO 16361
TABLE 6. Efficacy of the microbial antagonists in reducing head blight incidence in wheat.
Infection severity (%) ion protection%
——-u-
SGI-OlS-H06 26.6 i 7.4 34.00
To determine seed yield, wheat heads were dually threshed by hand, the
seeds collected and cleaned of chaff and other detritus, counted, and weighed. The total seed
yield was determined as the total seed mass produced by 16 pots of each ofthe treatments.
As reported in TABLE 7 each ofthe three microbial antagonists tested was found to
significantly protect the seed yield; 1'. e. the yield loss caused by head blight infestation was
significantly reduced.
TABLE 7. y ofthe microbial antagonists in ving seed yield in wheat plants
having head blight disease.
——-a-
SGI—OlS-FO3
SGI-OlS-H06
Thus, treatments of wheat plants with each of the tested microorganisms
significantly preserved the wheat plants against yield loss caused by Fusarz‘um infestation. In
particular, wheat plants treated with either 4-C06 or SGI-OlS-F03 showed a
significant improvement in total seed yield; z'.e. 110% and 120% respectively, when
compared to non-infected control. In contrast, the benchmarking fungicides Actinovate®,
RhizoVital®, and Prosario® did not appear to significantly protect the treated Wheat plants
from yield loss caused by Fusarium head blight ation.
E 10: Biocontrol ofwheat scab under field conditions.
Microorganism antagonists that were found having suppressive activity against the
pathogen F. graminearum and head blight disease in in vitro antagonism assays and
greenhouse studies, as described in Examples 4-9, are r evaluated in a series field
experiments at ent geographical locations throughout the United States. Some
experiments are d out in agricultural areas which are used for microbiological control of
wheat scab, where natural disease infection occurs. The wheat variety used in the test is a F.
graminearum susceptible variety. Generally, Wheat plants with each treatment were sown in
plots of 12 rows, about 3-meters long. The space between rows is about 20 cm. Treated
plots in each experiment are arranged in a randomized block design. The efficacy of various
WO 16361
wettable powder compositions ning the microbial antagonists ofthe present invention
in reducing head blight severity and incidence are also assessed. In these experiments, the
microbial antagonists are ted either individually or in combination.
In these tests, microorganism antagonists are evaluated in various seed-coating
treatments and/or field tests where microbial suspensions are applied directly onto flowering
wheat heads. In each ofthe experiments, the rganisms are assessed in replicated plots.
Antagonist, pathogen, and plant production methods as described in Examples 4 -9 can be
used in these experiments.
Seed-coating treatment — In addition to the seed coating method described in
Example 7 above, a variety oftechniques and seed-coating formulations known in the art can
be ed for the treatment ofwheat seeds with microbial antagonists, such as those
described previously by Fernando et al., 2002; Bello et al.
, 2002; and Kim et al, 1997. In
general, wheat seeds are pre-moistened and stored at room ature to promote
germination. Germinated seeds can be then immersed into microbial suspensions before
seeding. The pathogen spores can be inoculated either before or after bacterial ation.
Antagonist, pathogen, and plant tion methods as described in Examples 4 and 5 can be
used for these seed treatments.
Disease severity and yield assessment — The antagonists are subjected to further
evaluation in ouse and field evaluation for their suppressive activity against head
blight disease on wheat and barley at flowering stages, by using a variety of methods and
procedures, typically those described in, e.g., Schisler, Plant Disease, Vol 86(12), 1350—1356,
2002; Schisler et al. Biological Control, 39:497—506, 2006; and Khan and Doohan, Biological
Control, 48:42-47, 2009. In one of such ments, inoculums of G. zeae are prepared on
sterile, yellow dent corn as described by Khan et al. (Biological l, 29:245-255, 2004).
Fully colonized lipid cultures ur culture) of microbial s are diluted to one-quarter
strength with phosphate buffer. Final CFU per mL counts for antagonist treatments are
between 1 X 109 CFU/mL and 6 X 109 CFU/mL. Treatment suspensions are then applied to
flowering wheat heads using a C02 backpack sprayer. Treatments are typically applied after
sunset to minimize potential UV degradation of nist cells. There are 5 replicates per
treatment which are arranged in a randomized block design. The primary control treatment
consists of plants d with a buffer on. A second control consists of untreated
plants. Field assessments of head blight disease and incidence are made by evaluating 60
heads per replicate (i. e. 300 heads/treatment) When plant development reaches between mid-
milk and soft dough pment. Wheat heads are harvested by hand and threshed using an
Almaco single plant and head thresher (Almaco, IA) when grains reach full maturity. Grain
samples obtained fiom each replicate row are evaluated for rnel weight. Disease
ty, incidence, and 100-kernel weight data are analyzed using one-way analysis of
variance (ANOVA).
The itions containing the microbial antagonists ofthe invention, either
individually or in combination, are found to significantly diminish the disease incidence.
These s show that the biological control measures using these active microbial agents
can play an important role in the management of scab on cereal plants such as wheat plants.
EXAMPLE 11: Development ofnon-naturally occurring cultivars and breeding program
Endophytic microorganisms ofthe present invention are introduced into crop
plants, including cereals, of varying genotypes and geographic , lacking such
ytic microorganisms, to create endophyte combinations with improved
agronomic characteristics, using procedures analogous to those known in the art, including
those described in US. Pat. Appl. No. 20030195117A1; US. Pat. Appl. No.
32343A1; and U.S. Pat. No. 7,084,331, among . Thus, given synthetic plant-
endophyte combinations may be created and selected in a breeding/cultivar development
program based on their ability to form and maintain a mutualistic combination that results in '
an agronomic benefit. Rating of agronomic teristics of the combination may also be
utilized in such a ng program. These characteristics may include, without limitation,
drought tolerance, biomass accumulation, resistance to insect infestation, bility to
ock (e.g. herbivores), ease of reproduction, and seed yield, among others. Such
combinations may differ in levels of accumulation of microbial metabolites that are toxic to
pests and weeds, including ergot alkaloid levels, loline levels, peramine levels, or lolitrem
levels, while displaying desired agronomic characteristics of crop plants, including ance
to insect feeding or infestation, resistance to abiotic stress, palatability to livestock, biomass
accumulation, ease of reproduction, and seed yield, among other traits.
A number ofembodiments of the invention have been described. Nevertheless, it
will be understood that elements of the embodiments described herein can be combined to
make additional embodiments and various modifications may be made without departing
from the spirit and scope of the invention. Accordingly, other embodiments, alternatives and
equivalents are within the scope of the invention as described and claimed .
Headings within the application are solely for the convenience of the reader, and
do not limit in any way the scope of the ion or its ments.
All ations and patent applications mentioned in this specification are herein
incorporated by reference to the same extent as if each individual publication or patent
application was specifically can individually indicated to be incorporated by reference.
5555
BUDAPEST TREATY ON THE INTERNATIONAL
RECOGNITION OF THE DEPOSIT OF MICROORGANISMS
FOR THE PURPOSE OF PATENT URES
ATIONAL FORM
TO RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT
Patent Dept. issued pursuant to Rule 7.1 by the
Synthetic Genomics INTERNATIONAL TARY AUTHORITY
1 1149 North Torrey Pines Rd. identified at the bottom of this page
Lajolla, CA 92037
NANIE AND ADDRESS OF DEPOSITOR
I. IDENTIFICATION OF THE MICROORGANISM
Identification reference given by the DEPOSITOR: Accessmn number given by the
[wimp/Jamfla 1}). INTERNATIONAL DEPOSITARY AUTHORITY:
010 H11 NRRL 50471
II. SCIENTIFIC DESCRIPTION AND/OR ED TAXONOMIC DESIGNATION
The microorganism identified under I. above was accompanied by:
E] 1a scientific description
Eda proposed taxonomic designation
III RECEIPT AND ACCEPTANCE
This International Depositary Authority accepts the microorganism identified under I above, which was received byit
February 18, 2011(date of the original deposit)z
IV. RECEIPT OF RE. UEST FOR CONVERSION
The microorganism identified under I above, was received by this International Depositary Authority
on_—
(date of the original deposit) and a t to convert the al deposit to a deposit under the Budapest——Treaty was received
byit on (date of receipt of t for conversion).
V. INTERNATIONAL DEPOSITARY AUTHORITY
Name: Agricultural Research Culture Signature(s) of person(s) haying the power to represent the
Collection (NRRL) International Depositary Authority or of authorized official(s):
International Depositary Authority
s: 1815 N. University Street / ' Peoria, Illinois 61604 USA. Date: 7—3—(1
1 Mark with
a cross the applicable box.
2 \Where Rule 6.4(d) applies, such date is the date
on which the status of ational tary authority was acquired.
5656
BUDAPEST TREATY ON THE INTERNATIONAL
RECOGNITION OF THE DEPOSIT OF MICROORGANISMS
FOR THE PURPOSE OF PATENT PROCEDURES
INTERNATIONAL FORM
TO RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT
Patent Dept. issued pursuant to Rule 7.1 by the
Synthetic Genomics INTERNATIONAL DEPOSITARY ITY
11149 North Torrey Pines Rd. identified at the bottom of this page
a, CA 92037
NAME AND ADDRESS OF DEPOSITOR
I. IDENTIFICATION OF THE MICROORGANISM
Identification reference given by the DEPOSITOR: Accessmn number g1ven by the
orax 119. INTERNATIONAL DEPOSITARY AUTHORITY:
014 G01 NRRL B-50469
II. SCIENTIFIC DESCRIPTION AND/OR PROPOSED TAXONOMIC ATION
The microorganism identified under I. above was accompamed by:
E] 1a ific description
[:l 1a ed taxonomic designation
III. RECEIPT AND ACCEPTANCE
This International Depositary Authority accepts the rganism identified under I. above, which was received by1t on
February 18, 2011(date of the original deposit)2
IV. RECEIPT OF RE. UEST FOR CONVERSION
The microorganism identified under I. above, was received by this ational Depositary Authority
on_____
(date of the original deposit) and a request to convert the original deposit to a deposit under the Budapest__——Treaty was received
byIt on (date of receipt of request for conversion).
V. INTERNATIONAL DEPOSITARY AUTHORITY
Name: Agricultural Research Culture Signature(s) of person(s) having the power to represent the
Collection (NRRL) International Depositary Authority or of authorized official(s):
International Depositary Authority
Address: 1815 N. sity Street
, Illinois 61604 U.S.A. Date: file
3 6"”
1 Mark with
a cross the applicable box.
2 Where Rule 6.4(d) applies, such date is the date
on which the status of international depositary authority was acquired.
5757
BUDAPEST TREATY ON THE INTERNATIONAL
RECOGNITION OF THE DEPOSIT OF MICROORGANISMS
FOR THE PURPOSE OF PATENT PROCEDURES
INTERNATIONAL FORM
TO RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT
Patent Dept. issued pursuant to Rule 7.1 by the
Synthetic cs INTERNATIONAL DEPOSITARY ITY
11149 North Torrey Pines Rd. identified at the bottom of this page
La Jolla, CA 92037
NAME AND ADDRESS OF DEPOSITOR
I. IDENTIFICATION OF THE MICROORGANISM
Identification reference given by the DEPOSITOR: Access1on number given by the
Mimbacterium {2). INTERNATIONAL DEPOSITARY AUTHORITY:
014 C06 NRRL B-50470
II. SCIENTIFIC DESCRIPTION AND/OR PROPOSED TAXONOMIC DESIGNATION
The microorganism identified under I. above was accompanied by:
D 1a scientific description
Eda proposed taxonomic designation
III RECEIPT AND ACCEPTANCE
This International Depositary ity accepts the microorganism identified under I. above, which was ed by1t on
February 18, 2011(date of the al deposit)2
IV. RECEIPT OF RE. UEST FOR CONVERSION
The microorganism identified under I. above, was received by this International Depositary Authority
on____
(date of the original deposit) and a request to convert the original deposit to a t under the Budapest—_—Treaty was received
by1t on (date of receipt of t for. conversion).
V. INTERNATIONAL DEPOSITARY AUTHORITY
Name: Agricultural Research Culture Signature(s) of person(s) havlng the power to represent the
tion (NRRL) International Depositary Authority or of authorized offlcial(s):
International tary Authority
Address: 1815 N. University Street éfi
Peoria, Illinois 61604 USA. Date:
} 5’ ‘/
1Mark with a cross the applicable box.
2 Where Rule 6.4(d) applies, such date is the date
on which the status of international depositary authority was acquired.
5858
BUDAPEST TREATY ON THE INTERNATIONAL RECOGNITION OF THE DEPOSIT
OF MICROORGANISMS FOR THE PURPOSE OF PATENT PROCEDURES
INTERNATIONAL FORM
VIABILITY STATEMENT
Patent Dept.
Synthetic cs, Inc. issued pursuant to Rule 10.2 by the
11149 North Torrey Pines Rd. INTERNATIONAL DEPOSITARY AUTHORITY
La Jolla, CA 92037 identified at the bottom of this page
NAIVIE AND ADDRESS OF THE PARTY TO WHOM
THE ITY STATEMENT IS ISSUED
I. DEPOSITOR II. IDENTIFICATION OF THE MICROORGANISM
Name: Dr. Spehar Depositor’s taxonomic designation and accession number
Synthetic Genomics, Inc. given by the INTERNATIONAL DEPOSITARY
11149 North Torrey Pines Rd. AUTHORITY
Address: LaJolla, CA 92037 Bari/[m z'qmyfim'em
NRRL B—50760
Date of: June 21, 2012
aOriginal Deposit
E] New Deposit
[:1 Repropagation of Original Deposit
III. (a) VIABILITY STATEMENT
Deposit was found:
WViable D zNonviable on une 23 2012 (Date)
International Depositary ity's preparation was found viable on lune 30, 2012 (Date)3
III. . DEPOSITOR'S EOUIVALENCY ATION
Depositor determined the International tary Authority's preparation was
% ZEquivalent 2Not equivalent to deposit on (Date)
SignatureofDeposr'tor I‘LL/f /I/Z 91/4”),.,.
IV. CONDITIONS UNDER WHICH THE VIABILITY TEST WAS PERFORMED D e ositors/De osita 4
V. INTERNATIONAL DEPOSITARY ITY
Name: Agricultural Research Culture Signature(s) of person(s) having the power to represent the
Collection (NRRL) International Depositary Autho ‘ty or of authorized official(s):
International Depositary Authority
Address: 1815 N. University Street 2
Peoria, Illinois 61604 U.S.A. Date: 8““ »D
‘ Indicate the date of the al deposit
or when a new deposit has been made.
2 Mark with
a cross the able box.
3 In the
cases referred to in Rule 10.2(a)(ii) and (iii), refer to the most recent viability test.
‘ Fill in if the information has been requested.
5959
BUDAPEST TREATY ON THE INTERNATIONAL RECOGNITION OF THE DEPOSIT
OF MICROORGANISMS FOR THE PURPOSE OF PATENT PROCEDURES
INTERNATIONAL FORM
VIABILITY STATEMENT
Patent Dept.
Synthetic Genomics, Inc. issued pursuant to Rule 10.2 by the
11149 North Torrey Pines Rd. INTERNATIONAL DEPOSITARY AUTHORITY
Lajolla, CA 92037 identified at the bottom of this page
NAME AND ADDRESS OF THE PARTY TO WHOM
THE ITY STATEMENT IS ISSUED
I. DEPOSITOR II. IDENTIFICATION OF THE RGANISM
Name: Dr. Spehar Depositor’s taxonomic designation and accession number
Synthetic Genomics, 1110- given by the INTERNATIONAL DEPOSITARY
11149 North Torrey Pines Rd. AUTHORITY
Address: Lajolla, CA 92037 Bad/1m ”(Mi/1';
NRRL B-50761
Date of: June 21, 2012
Original Deposit
New Deposit
El Repropagation of Original Deposit
III. (a) VIABILITY STATEMENT
Eyosit was found:2Viable E] 2Nonviable on une 23 2012 (Date)
International Depositary Authority's preparation was found viable on lune 30, 2012 (Date)3
III. - TOR'S EUIVALENCY ATION
Depositor determined the International Depositary Authority's preparation was
%_ ZEquivalent2Not equivalent to deposit on (Date)
Signature of Depositor ; /
/’ L 0/2
IV. IONS UNDER WHICH THE VIABILITY TEST WAS PERFORMED I e- 051tors/De .osna
V. INTERNATIONAL DEPOSITARY AUTHORITY
Name: Agricultural Research Culture ure(s) of person(s) having the power to represent the
Collection (NRRL) ational Depositary Au hority or of authorized official(s):
International Depositary Authority
s: 1815 N. University Street /
Peoria, Illinois 61604 USA. Date: 310 ‘11,
' Indicate the date of the original deposit or when
a new deposit has been made.
2 Mark with
a cross the applicable box.
3 In the
cases ed to in Rule 10.2(a)(ii) and (iii), refer to the most recent viability test
4 Fill in if the information has been requested.
SEQUENCE LISTING
<110> SYNTHETIC GENOMICS, INC.
GRANDLIC, CHRISTOPHER J.
GREEN, WAYNE A.
KEROVUO, JANNE S.
MCCANN, RYAN T.
<120> ITIONS AND METHODS FOR CONTROLLING HEAD BLIGHT DISEASE
<130> SGI1520-1WO
<150> US 61/511,467
<151> 201125
<160> 18
<170> PatentIn version 3.5
<210> 1
<211> 1430
<212> DNA
<213> acterium sp.
<220>
<221> misc_feature
<223> SGI bacterial isolate SGIC06
<220>
<221> misc_feature
<223> encodes a 16S ribosomal RNA
<400> 1
acgctggcgg cgtgcttaac acatgcaagt gtga agct tgctctgtgg
gatcagtggc gaacgggtga gtaacacgtg agcaacctgc ccctgactct gggataagcg
ctggaaacgg cgtctaatac tggatatgtg ccgc atggtctgcg tctggaaaga
atttcggttg gggatgggct cgcggcctat cagcttgttg gtgaggtaat ggctcaccaa
ggcgtcgacg ggtagccggc ctgagagggt gaccggccac actgggactg agacacggcc
cagactccta cgggaggcag cagtggggaa tattgcacaa tgggcgcaag cctgatgcag
cgcg tgagggacga cggccttcgg gttgtaaacc tcttttagca gggaagaagc
gaaagtgacg gtacctgcag aaaaagcgcc ggctaactac gtgccagcag ccgcggtaat
ggcg caagcgttat ccggaattat tgggcgtaaa gagctcgtag gcggtttgtc
gcgtctgctg tgaaatccgg aggctcaacc tccggcctgc tacg ggcagactag
gtag gggagattgg aattcctggt gtagcggtgg aatgcgcaga tatcaggagg
aacaccgatg gcgaaggcag atctctgggc cgtaactgac gagc gaaagggtgg
ggagcaaaca ggcttagata ccctggtagt cgta aacgttggga actagttgtg
gggtccattc cacggattcc gtgacgcagc taacgcatta agttccccgc ctggggagta
cggccgcaag gctaaaactc aaaggaattg acggggaccc gcgg cggagcatgc
ggattaattc gatgcaacgc gaagaacctt accaaggctt gacatatacg agaacgggcc
agaaatggtc aactctttgg acactcgtaa acaggtggtg catggttgtc gtcagctcgt
1020
gtcgtgagat gttgggttaa gtcccgcaac gagcgcaacc ctcgttctat gttgccagca
1080
cgtaatggtg ggaactcatg ggatactgcc ggggtcaact cggaggaagg tggggatgac
1140
gtcaaatcat catgcccctt atgtcttggg cttcacgcat gctacaatgg ccggtacaaa
1200
gggctgcaat accgcgaggt aatc ccaaaaagcc ggtcccagtt cggattgagg
1260
tctgcaactc gacctcatga agtcggagtc gctagtaatc gcagatcagc aacgctgcgg
1320
cgtt cccgggtctt accg cccgtcaagt catgaaagtc ggtaacacct
1380
gaagccggtg gcctaaccct tgtggaggga gccgtcgaag tcgg
1430
<210> 2
<211> 2172
<212> DNA
<213> Microbacterium sp.
<220>
<221> misc_feature
<223> SGI bacterial isolate SGIC06
<220>
<221> misc_feature
<223> SGI Gene ID G850682
<220>
<221> eature
<223> encodes the peptide sequence at SED ID NO 3
<400> 2
gtgtctgcgg ccggagagcg gctgtcgaga atagactcgg agattgtgaa tgccgagtat
tccgcccatc aggt gcttgagggg ctcgaagctg tccgcaagcg cccgggcatg
tacatcgggt cgaacggctc gccgggcctc atgcactgcc agat catcgacaac
tctgtcgacg aggcggtggc aggcaacggc atcg acatcatcct gcactccgac
ggcagcgtcg aggtgcacga ccgcggtcgc ggcatccctg tcgacgtcga gccgcgcacc
ggtctcaccg gtgtcgaggt cgtctacacc aagctgcacg ccggaggaaa gttcggcggc
ggctcgtacg cggcatccgg tggactgcac ggtgtcggcg tcgt gaacgcgctc
cgcc tcgacgtcga ggtcgaccgc gggggcaaga cctacgcgat gtcgttccat
cgcggtgagc ccggcatctt cacggactcc ggcgagaagc ggccggacgc cacg
ccgttcgagg gcga gctgcgcgtc atcggcaagg cgccgcgtgg cgtgaccggc
acccgggtgc gctactgggc cgaccggcag atcttcacca aggatgcggc gttccagctc
tcggagctcg agacccgcgc acgccagacg gcgttcctcg ttcccggtct cgagatcgtc
gtcaaggacg cacgggcggc cggtcaggtc atccccgtcc cggactccga cggcgagacg
accgtcgtcg ggaccgatga gacctcgtac gagg gcggcatctc cgagttcgtc
gagtacctcg ccatcgaccc tcccgtgacc tggc gtatccaggg cgagggcatg
ttcaaggaga ccgtgcccgt ggca caca tggtcgccac cgaggtggag
cgtgtgtgcg ccgtcgacat cgcgctgcgc tgggggaccg gctacgacac ccgtgtgcgc
1020
tccttcgtga acatcatcgc gacgcccaag ggcggaaccc accagcaggg cttcgagcag
1080
gagctcctga aggtgctgcg ctcccaggtc gagcagaacg cccgccgtct gaaggtcggc
1140
aacgacaagc tggagaagga cgacgtcctc gccggcctca ccgccgtgct cacggtcaac
1200
gtgccggagc cgcagttcga gacc aaggaagtgc tcggcacccc gcgg
1260
cagatcgtgg cgcaggtgat ccgtaaggat ctggcgcagc gcttcagctc gaccaagcgc
1320
gacgacaaga accaggccac acagctgctc gacaagatcg tctccgagat gaaggcccgt
1380
gtctcggcgc gcgcccacaa ggagacgcag aaga acgcgctgga gtcgtcgacg
1440
ctgccgacca agctcgtcga cacg aacgaggtcg agcgcagcga gctcttcatc
1500
gtggagggcg actcggctct cggcaccgcc aagaacgcgc gcaacagcga gttccaggcg
1560
ctgctcccga tccgagggaa gatcctcaac gtgcagaagg cctctgtcgg cgacatgctg
1620
tcgaacaccg agtgcgcgtc gatcatccag gtgatcggcg ccggatccgg acgcaccttc
1680
gacatcgatg cggcgcgcta cggcaaggtg atcctgatga ccga tgtcgacggc
1740
gcgcacatcc gtaccctgct gctg ttcttccgct acatgcgacc gctgatcgag
1800
cacgggcgtg tgttcgccgc ggtgccgccg cggg tgatcgtgat gaacccgggg
1860
ccga acgagacgat ctacacctac agcgagcagg agatgcacgc gctgctggcg
1920
aagctccgca aggccggcaa gcgctggcac gagccgatcc agcgctacaa gggtctcggt
1980
gagatggacg cggaacagct cgcgaacacc accatggacc gctccggccg tctgctgcgc
2040
cgtgtgcgca tggaagacgc cgaggccgcc ggtcgcgtgt tcgagctgct gatgggcaac
2100
gaggtcgcgc cgcgccgcga gttcatcatc gactcctccg accggttgtc gtcc
2160
atcgacgcct ga
2172
<210> 3
<211> 723
<212> PRT
<213> Microbacterium sp.
<220>
<221> misc_feature
<223> SGI bacterial isolate SGIC06
<220>
<221> misc_feature
<223> SGI peptide ID SG1MICT850682
<220>
<221> misc_feature
<223> gyrase subunit B
<400> 3
Met Ser Ala Ala Gly Glu Arg Leu Ser Arg Ile Asp Ser Glu Ile Val
1 5 10 15
Asn Ala Glu Tyr Ser Ala His His Leu Gln Val Leu Glu Gly Leu Glu
25 30
Ala Val Arg Lys Arg Pro Gly Met Tyr Ile Gly Ser Asn Gly Ser Pro
40 45
Gly Leu Met His Cys Leu Trp Glu Ile Ile Asp Asn Ser Val Asp Glu
50 55 60
Ala Val Ala Gly Asn Gly Thr Lys Ile Asp Ile Ile Leu His Ser Asp
65 70 75 80
Gly Ser Val Glu Val His Asp Arg Gly Arg Gly Ile Pro Val Asp Val
85 90 95
Glu Pro Arg Thr Gly Leu Thr Gly Val Glu Val Val Tyr Thr Lys Leu
100 105 110
His Ala Gly Gly Lys Phe Gly Gly Gly Ser Tyr Ala Ala Ser Gly Gly
115 120 125
Leu His Gly Val Gly Ala Ser Val Val Asn Ala Leu Ser Glu Arg Leu
130 135 140
Asp Val Glu Val Asp Arg Gly Gly Lys Thr Tyr Ala Met Ser Phe His
145 150 155 160
Arg Gly Glu Pro Gly Ile Phe Thr Asp Ser Gly Glu Lys Arg Pro Asp
165 170 175
Ala Pro Phe Thr Pro Phe Glu Glu Asn Ser Glu Leu Arg Val Ile Gly
180 185 190
Lys Ala Pro Arg Gly Val Thr Gly Thr Arg Val Arg Tyr Trp Ala Asp
195 200 205
Arg Gln Ile Phe Thr Lys Asp Ala Ala Phe Gln Leu Ser Glu Leu Glu
210 215 220
Thr Arg Ala Arg Gln Thr Ala Phe Leu Val Pro Gly Leu Glu Ile Val
225 230 235 240
Val Lys Asp Ala Arg Ala Ala Gly Gln Val Ile Pro Val Pro Asp Ser
245 250 255
Asp Gly Glu Thr Thr Val Val Gly Thr Asp Glu Thr Ser Tyr Leu Tyr
260 265 270
Glu Gly Gly Ile Ser Glu Phe Val Glu Tyr Leu Ala Ile Asp Pro Pro
275 280 285
Val Thr Asp Thr Trp Arg Ile Gln Gly Glu Gly Met Phe Lys Glu Thr
290 295 300
Val Pro Val Leu Gln Ala Asp Gly His Met Val Ala Thr Glu Val Glu
305 310 315 320
Arg Val Cys Ala Val Asp Ile Ala Leu Arg Trp Gly Thr Gly Tyr Asp
325 330 335
Thr Arg Val Arg Ser Phe Val Asn Ile Ile Ala Thr Pro Lys Gly Gly
340 345 350
Thr His Gln Gln Gly Phe Glu Gln Glu Leu Leu Lys Val Leu Arg Ser
355 360 365
Gln Val Glu Gln Asn Ala Arg Arg Leu Lys Val Gly Asn Asp Lys Leu
370 375 380
Glu Lys Asp Asp Val Leu Ala Gly Leu Thr Ala Val Leu Thr Val Asn
385 390 395 400
Val Pro Glu Pro Gln Phe Glu Gly Gln Thr Lys Glu Val Leu Gly Thr
405 410 415
Pro Ala Val Arg Gln Ile Val Ala Gln Val Ile Arg Lys Asp Leu Ala
420 425 430
Gln Arg Phe Ser Ser Thr Lys Arg Asp Asp Lys Asn Gln Ala Thr Gln
435 440 445
Leu Leu Asp Lys Ile Val Ser Glu Met Lys Ala Arg Val Ser Ala Arg
450 455 460
Ala His Lys Glu Thr Gln Arg Arg Lys Asn Ala Leu Glu Ser Ser Thr
465 470 475 480
Leu Pro Thr Lys Leu Val Asp Cys Arg Thr Asn Glu Val Glu Arg Ser
485 490 495
Glu Leu Phe Ile Val Glu Gly Asp Ser Ala Leu Gly Thr Ala Lys Asn
500 505 510
Ala Arg Asn Ser Glu Phe Gln Ala Leu Leu Pro Ile Arg Gly Lys Ile
515 520 525
Leu Asn Val Gln Lys Ala Ser Val Gly Asp Met Leu Ser Asn Thr Glu
530 535 540
Cys Ala Ser Ile Ile Gln Val Ile Gly Ala Gly Ser Gly Arg Thr Phe
545 550 555 560
Asp Ile Asp Ala Ala Arg Tyr Gly Lys Val Ile Leu Met Ser Asp Ala
565 570 575
Asp Val Asp Gly Ala His Ile Arg Thr Leu Leu Leu Thr Leu Phe Phe
580 585 590
Arg Tyr Met Arg Pro Leu Ile Glu His Gly Arg Val Phe Ala Ala Val
595 600 605
Pro Pro Leu His Arg Val Ile Val Met Asn Pro Gly Ser Lys Pro Asn
610 615 620
Glu Thr Ile Tyr Thr Tyr Ser Glu Gln Glu Met His Ala Leu Leu Ala
625 630 635 640
Lys Leu Arg Lys Ala Gly Lys Arg Trp His Glu Pro Ile Gln Arg Tyr
645 650 655
Lys Gly Leu Gly Glu Met Asp Ala Glu Gln Leu Ala Asn Thr Thr Met
660 665 670
Asp Arg Ser Gly Arg Leu Leu Arg Arg Val Arg Met Glu Asp Ala Glu
675 680 685
Ala Ala Gly Arg Val Phe Glu Leu Leu Met Gly Asn Glu Val Ala Pro
690 695 700
Arg Arg Glu Phe Ile Ile Asp Ser Ser Asp Arg Leu Ser Arg Glu Ser
705 710 715 720
Ile Asp Ala
<210> 4
<211> 3504
<212> DNA
<213> Microbacterium sp.
<220>
<221> misc_feature
<223> SGI bacterial e SGIC06
<220>
<221> misc_feature
<223> SGI Gene ID SG1MICG850290
<220>
<221> misc_feature
<223> encodes the peptide ce at SEQ ID NO 5
<400> 4
ttggctgctg acgc atccacatcc accaccacca agaacggacg cggagcttcc
cgtctttcgt tcgccaagat ctccgacacg ctgacggtcc ctgaccttct cgccctgcag
accgaatcct tcggttggct ggtcggcaac gacgcctgga aggcgcgcgt ggccgaggcc
aagaagcagg ggcgcaccga cgtcaacgag aacagcggtc tgggcgagat cttcgaggag
atctctccga tcgaggacct cggcgagacg ctgt cgttcacgaa cccctacctc
gagccggaga agtactccat cgaggagtgc aaggagcgtg ccta cgccgctccg
ctgtacgtcg aggccgagtt catgaaccac ctcacgggtg agatcaagac ccagacggtc
ggcg acttcccgct cgac aagggaacgt tcatcatcaa cggctccgag
cgcgtcgtcg tctcgcagct ggtgcgttcg cccggtgtct acttcgacaa gacccccgac
aagacgtccg acaaggacat cgtctcggca cgcgtcatcc cgagccgtgg tgcctggctc
gagttcgaga tcgacaagcg cgaccaggtc ggcgtgcgcg tcgaccgcaa gcgcaagcag
tcggtcacgg tcttcctcaa ggcgctgggc atgaccagcg aggagatcct cgccgagttc
gccggctaca cctcgatcga ggagacgctc gaca cgatcgtcac gaaggaagat
cgcg acatctaccg caagctccgt ccgggcgagc aggtcgccgc cgaggccgcc
cgcgcgctcc tggacaactt ctacttcaac ccgaagcgct tggc caaggtcggt
cgctacaaga tcaaccacaa gctgggcctg gaccagccgc tgaactcgtc ggtcctgacc
gtcgaagaca tcgtggccac gatcaagtac ctggtgcgtc tgcacgccgg caccgaggag
1020
acgg gcatccgcgg tggtaagaag gccgagatcc gtctcgcgac cgacgacatc
1080
gacaacttcg gcaaccgtcg catccgcgcg gtcggcgagc tgatccagaa ccaggtccgc
1140
accggtctct cccgcatgga cgtc cgcgagcgca tgaccacgca cgag
1200
gcgatcacgc cgcagaccct gatcaacgtg cgccccgtcg cgat caaggagttc
1260
ttcggaacgt cgcagctgtc gcagttcatg gaccagaaca acccgctcgc gggtctgacg
1320
aacaagcgtc gtctgtctgc gctcggcccc ggtggtctct cgcgagaccg cgtc
1380
gaggtccgtg acgtccaccc ctcgcactac atgt gcccgatcga gactccggaa
1440
ggcccgaaca tcggtctgat cggtgctctc gcgaccttcg cgcgcatcaa ctcgttcgga
1500
ttcatcgaga ccccgtaccg caaggtcgtc gacggtgtcg tgaccgacca gatcgactac
1560
gctt ccgaagaggt cgacttcaac atcgcgcagg ccaacgcccc gctcgatgcc
1620
aagggtcgct tccgcgagag ccacgtcctg gcccgcccca agggtggcag cggcgaggtc
1680
gacctgttcg tccccgagga gatcggctac atcgacgtct ccccgcgcca gatggtgtcg
1740
gtcgcgacct cgctcgtgcc cttcctcgag cacgacgacg cacagcgcgc cctcatgggt
1800
gccaacatgc agcgtcaggc tgtgccgctg ctgcgcagcg actcgccgct cgtcggaacc
1860
ggtatggagg gctacacggc catcgacgcc ggtgacgtgc tcaccgccga gaaggccggt
1920
gtcgtctccg aggtctccgc agaccgcgtc gtcgtcatgc tcgacgaggg cggaacgcag
1980
gagtaccacc tgcgcaagtt cgaccgctcc aaccagggca cgtcgtacaa ccagaaggtc
2040
accg ccggtgagcg cgtcgaggtc gtca tcgccgatgg ccccgccacc
2100
gagaacggcg agctggccct cggaaagaac ctcctcgtcg cgttcatgac gtgggagggc
2160
tacaacttcg aggacgcgat catcctgagc caggacctgg acga caccctctcc
2220
caca tcgaggagta cgaggtcgat gctcgcgaca ccaagctcgg caaggaggag
2280
cgtg acctccccaa cgtcagcccg gagctgctga aggacctcga cgagcgcggc
2340
cgca tcggtgccga ggtccgccct ggcgacatcc tcgtcggcaa ggtcacgccg
2400
aagggtgaga ccgagctgtc ggccgaggag cgcctgctcc gcgcgatctt caacgagaag
2460
agccgcgaag acac ctcgctgaag gtgccccacg gtgagcaggg cacgatcatc
2520
gccgtcaagg agttcaacgc tgaggacggc gacgacgagc tcggctccgg cgtcaaccgc
2580
cgcgtcgtgg tctacatcgc ccagaagcgc aagatcaccg agggtgacaa gctcgccggc
2640
cgtcacggca acaagggtgt catcgcgaag atcctcccga tcgaggacat gccgttcctt
2700
tcggacggta ccccggtcga catcgtgctg aacccgctcg gtatccccgg tcgaatgaac
2760
ttcggtcagg tcctggagac cggg gcga agcagggctg gaaggtcgag
2820
ggcaacccgg ctgt gaagctcccg aaggacgcat tcgaggccgc cacg
2880
aaggtcgcca ccccggtgtt cgacggtgcg agcgaggagg agatcgctgg tctcctcgac
2940
gcgaccaccc cgacccgtga cggcgtccgc ctgatcgact cgagcggcaa gacgcagctg
3000
ttcgacggtc gttcgggtga cccg gcgccgatct ccgtgggcta catgtacatc
3060
ctgaagctgc accacctggt cgacgacaag atccacgcac gttccacggg tccgtactcg
3120
atgatcaccc agcagccgct cggtggtaag gcgcagttcg gtggacagcg cttcggtgag
3180
atggaggtgt gggccctcga ggcctacggc gccgcatacg agga gctcctcacg
3240
tccg acgacatcct cggccgcgtc aaggtgtacg aggcgatcgt caagggcgag
3300
aacatccagg agcccggcat ccccgagtcg gtgc agga gatgcagtcg
3360
ctctgcctga acgtcgaggt cctctcggcc gacggcacgc tggtcaacct ccgcgacacc
3420
gacgacgagg cgttccgcgc cgcggaagag ctcggtatca acatctccag ccgcttcgag
3480
tcga tcgacgagat ctaa
3504
<210> 5
<211> 1167
<212> PRT
<213> Microbacterium sp.
<220>
<221> misc_feature
<223> SGI bacterial isolate SGIC06
<220>
<221> misc_feature
<223> SGI peptide ID T850290
<220>
<221> misc_feature
<223> RNA-polymerase subunit B
<400> 5
Met Ala Ala Ala Arg Asn Ala Ser Thr Ser Thr Thr Thr Lys Asn Gly
1 5 10 15
Arg Gly Ala Ser Arg Leu Ser Phe Ala Lys Ile Ser Asp Thr Leu Thr
25 30
Val Pro Asp Leu Leu Ala Leu Gln Thr Glu Ser Phe Gly Trp Leu Val
40 45
Gly Asn Asp Ala Trp Lys Ala Arg Val Ala Glu Ala Lys Lys Gln Gly
50 55 60
Arg Thr Asp Val Asn Glu Asn Ser Gly Leu Gly Glu Ile Phe Glu Glu
65 70 75 80
Ile Ser Pro Ile Glu Asp Leu Gly Glu Thr Met Gln Leu Ser Phe Thr
85 90 95
Asn Pro Tyr Leu Glu Pro Glu Lys Tyr Ser Ile Glu Glu Cys Lys Glu
100 105 110
Arg Gly Lys Thr Tyr Ala Ala Pro Leu Tyr Val Glu Ala Glu Phe Met
115 120 125
Asn His Leu Thr Gly Glu Ile Lys Thr Gln Thr Val Phe Met Gly Asp
130 135 140
Phe Pro Leu Gln Thr Asp Lys Gly Thr Phe Ile Ile Asn Gly Ser Glu
145 150 155 160
Arg Val Val Val Ser Gln Leu Val Arg Ser Pro Gly Val Tyr Phe Asp
165 170 175
Lys Thr Pro Asp Lys Thr Ser Asp Lys Asp Ile Val Ser Ala Arg Val
180 185 190
Ile Pro Ser Arg Gly Ala Trp Leu Glu Phe Glu Ile Asp Lys Arg Asp
195 200 205
Gln Val Gly Val Arg Val Asp Arg Lys Arg Lys Gln Ser Val Thr Val
210 215 220
Phe Leu Lys Ala Leu Gly Met Thr Ser Glu Glu Ile Leu Ala Glu Phe
225 230 235 240
Ala Gly Tyr Thr Ser Ile Glu Glu Thr Leu Ala Lys Asp Thr Ile Val
245 250 255
Thr Lys Glu Asp Ala Leu Arg Asp Ile Tyr Arg Lys Leu Arg Pro Gly
260 265 270
Glu Gln Val Ala Ala Glu Ala Ala Arg Ala Leu Leu Asp Asn Phe Tyr
275 280 285
Phe Asn Pro Lys Arg Tyr Asp Leu Ala Lys Val Gly Arg Tyr Lys Ile
290 295 300
Asn His Lys Leu Gly Leu Asp Gln Pro Leu Asn Ser Ser Val Leu Thr
305 310 315 320
Val Glu Asp Ile Val Ala Thr Ile Lys Tyr Leu Val Arg Leu His Ala
325 330 335
Gly Thr Glu Glu Thr Phe Thr Gly Ile Arg Gly Gly Lys Lys Ala Glu
340 345 350
Ile Arg Leu Ala Thr Asp Asp Ile Asp Asn Phe Gly Asn Arg Arg Ile
355 360 365
Arg Ala Val Gly Glu Leu Ile Gln Asn Gln Val Arg Thr Gly Leu Ser
370 375 380
Arg Met Glu Arg Val Val Arg Glu Arg Met Thr Thr Gln Asp Ile Glu
385 390 395 400
Ala Ile Thr Pro Gln Thr Leu Ile Asn Val Arg Pro Val Val Ala Ala
405 410 415
Ile Lys Glu Phe Phe Gly Thr Ser Gln Leu Ser Gln Phe Met Asp Gln
420 425 430
Asn Asn Pro Leu Ala Gly Leu Thr Asn Lys Arg Arg Leu Ser Ala Leu
435 440 445
Gly Pro Gly Gly Leu Ser Arg Asp Arg Ala Gly Val Glu Val Arg Asp
450 455 460
Val His Pro Ser His Tyr Gly Arg Met Cys Pro Ile Glu Thr Pro Glu
465 470 475 480
Gly Pro Asn Ile Gly Leu Ile Gly Ala Leu Ala Thr Phe Ala Arg Ile
485 490 495
Asn Ser Phe Gly Phe Ile Glu Thr Pro Tyr Arg Lys Val Val Asp Gly
500 505 510
Val Val Thr Asp Gln Ile Asp Tyr Leu Thr Ala Ser Glu Glu Val Asp
515 520 525
Phe Asn Ile Ala Gln Ala Asn Ala Pro Leu Asp Ala Lys Gly Arg Phe
530 535 540
Arg Glu Ser His Val Leu Ala Arg Pro Lys Gly Gly Ser Gly Glu Val
545 550 555 560
Asp Leu Phe Val Pro Glu Glu Ile Gly Tyr Ile Asp Val Ser Pro Arg
565 570 575
Gln Met Val Ser Val Ala Thr Ser Leu Val Pro Phe Leu Glu His Asp
580 585 590
Asp Ala Gln Arg Ala Leu Met Gly Ala Asn Met Gln Arg Gln Ala Val
595 600 605
Pro Leu Leu Arg Ser Asp Ser Pro Leu Val Gly Thr Gly Met Glu Gly
610 615 620
Tyr Thr Ala Ile Asp Ala Gly Asp Val Leu Thr Ala Glu Lys Ala Gly
625 630 635 640
Val Val Ser Glu Val Ser Ala Asp Arg Val Val Val Met Leu Asp Glu
645 650 655
Gly Gly Thr Gln Glu Tyr His Leu Arg Lys Phe Asp Arg Ser Asn Gln
660 665 670
Gly Thr Ser Tyr Asn Gln Lys Val Val Val Thr Ala Gly Glu Arg Val
675 680 685
Glu Val Gly Glu Val Ile Ala Asp Gly Pro Ala Thr Glu Asn Gly Glu
690 695 700
Leu Ala Leu Gly Lys Asn Leu Leu Val Ala Phe Met Thr Trp Glu Gly
705 710 715 720
Tyr Asn Phe Glu Asp Ala Ile Ile Leu Ser Gln Asp Leu Val Lys Asp
725 730 735
Asp Thr Leu Ser Ser Ile His Ile Glu Glu Tyr Glu Val Asp Ala Arg
740 745 750
Asp Thr Lys Leu Gly Lys Glu Glu Ile Thr Arg Asp Leu Pro Asn Val
755 760 765
Ser Pro Glu Leu Leu Lys Asp Leu Asp Glu Arg Gly Ile Ile Arg Ile
770 775 780
Gly Ala Glu Val Arg Pro Gly Asp Ile Leu Val Gly Lys Val Thr Pro
785 790 795 800
Lys Gly Glu Thr Glu Leu Ser Ala Glu Glu Arg Leu Leu Arg Ala Ile
805 810 815
Phe Asn Glu Lys Ser Arg Glu Val Arg Asp Thr Ser Leu Lys Val Pro
820 825 830
His Gly Glu Gln Gly Thr Ile Ile Ala Val Lys Glu Phe Asn Ala Glu
835 840 845
Asp Gly Asp Asp Glu Leu Gly Ser Gly Val Asn Arg Arg Val Val Val
850 855 860
Tyr Ile Ala Gln Lys Arg Lys Ile Thr Glu Gly Asp Lys Leu Ala Gly
865 870 875 880
Arg His Gly Asn Lys Gly Val Ile Ala Lys Ile Leu Pro Ile Glu Asp
885 890 895
Met Pro Phe Leu Ser Asp Gly Thr Pro Val Asp Ile Val Leu Asn Pro
900 905 910
Leu Gly Ile Pro Gly Arg Met Asn Phe Gly Gln Val Leu Glu Thr His
915 920 925
Leu Gly Trp Ile Ala Lys Gln Gly Trp Lys Val Glu Gly Asn Pro Glu
930 935 940
Trp Ala Val Lys Leu Pro Lys Asp Ala Phe Glu Ala Ala Pro Gly Thr
945 950 955 960
Lys Val Ala Thr Pro Val Phe Asp Gly Ala Ser Glu Glu Glu Ile Ala
965 970 975
Gly Leu Leu Asp Ala Thr Thr Pro Thr Arg Asp Gly Val Arg Leu Ile
980 985 990
Asp Ser Ser Gly Lys Thr Gln Leu Phe Asp Gly Arg Ser Gly Glu Pro
995 1000 1005
Phe Pro Ala Pro Ile Ser Val Gly Tyr Met Tyr Ile Leu Lys Leu
1010 1015 1020
His His Leu Val Asp Asp Lys Ile His Ala Arg Ser Thr Gly Pro
1025 1030 1035
Tyr Ser Met Ile Thr Gln Gln Pro Leu Gly Gly Lys Ala Gln Phe
1040 1045 1050
Gly Gly Gln Arg Phe Gly Glu Met Glu Val Trp Ala Leu Glu Ala
1055 1060 1065
Tyr Gly Ala Ala Tyr Ala Leu Gln Glu Leu Leu Thr Ile Lys Ser
1070 1075 1080
Asp Asp Ile Leu Gly Arg Val Lys Val Tyr Glu Ala Ile Val Lys
1085 1090 1095
Gly Glu Asn Ile Gln Glu Pro Gly Ile Pro Glu Ser Phe Lys Val
1100 1105 1110
Leu Met Lys Glu Met Gln Ser Leu Cys Leu Asn Val Glu Val Leu
1115 1120 1125
Ser Ala Asp Gly Thr Leu Val Asn Leu Arg Asp Thr Asp Asp Glu
1130 1135 1140
Ala Phe Arg Ala Ala Glu Glu Leu Gly Ile Asn Ile Ser Ser Arg
1145 1150 1155
Phe Glu Ala Ala Ser Ile Asp Glu Ile
1160 1165
<210> 6
<211> 1188
<212> DNA
<213> acterium sp.
<220>
<221> misc_feature
<223> SGI bacterial isolate SGIC06
<220>
<221> misc_feature
<223> SGI Gene ID SG1MICG851004
<220>
<221> misc_feature
<223> encodes the peptide sequence at SEQ ID NO 7
<400> 6
ttgccgactc gatgtcggtg gcctctccta cggtggaaaa caagccgaag agccattacg
ccttgtcgga gagttgctcc caaccgggag cgccgcgaca gcctacaggc ggcaccacgc
gcgcagaagg agcacatcat gccatcaccc cgcg agaagtccct cgagaccgcc
ctcgcccaga tcgaccgcca gttcggaaag ggctcggtca tgcggctggg cagcgatgag
cgcgcccccg tggccgtcat ccccaccggc tccatcgccc tcgacgtcgc cctcggcgtc
ggaggactcc cgcgtggtcg catcgtcgag atctacggac cggagtcctc cggtaagacg
acgctcaccc tgcacgcgat cgcgaacgca cagcgtgccg gtggcatcgc catc
gacgccgagc acgcgctcga ccccgactac gccgccaagc tcggcgtcga catcgatgcg
ctcctggtct cgcagcccga cacgggtgag caggcgctcg agatcgccga catgctcgtg
cgctccggtg cgatcgacct catcgtcatc gactccgtcg cggccctcgt gccgcgcgcc
gagg gcgagatggg tgactcgcac gtcggtctgc aggctcgcct catgtcgcag
gcgctgcgaa agctcaccgg tggtctgaac aaca ccacgatgat cttcatcaac
cgcg agaagatcgg tgtcttcttc ccgg agaccactgc cggcggtaag
gcgctcaagt tctacgcctc catg cgtc gtatcgagac ggac
ggtactgacg ctgtcggtaa ccgcaccagg gtcg tcaagaacaa gatggctccg
aagc aggccgagtt cgacatcctc tacggcgtcg gcatctcgcg cgagggaagc
ctgatcgact tcggtgtcga gcatgcgatc gtcaagaagt ccggttcctg gtatacgtac
1020
gacggtgacc agctgggtca gggcaaggag aacgcgcgga cgttcctgct caacaacccc
1080
gacatcgcgc tggcgatcga gacgcagatc aagcagaagc tcggcatcgg cggtcccgcc
1140
gcggcgcctg ctgcggcaga cgagctcgct gagcgtcgtc cggcctga
1188
<210> 7
<211> 395
<212> PRT
<213> Microbacterium sp.
<220>
<221> misc_feature
<223> SGI ial isolate SGIC06
<220>
<221> misc_feature
<223> SGI peptide ID SG1MICT851004
<220>
<221> misc_feature
<223> recombinase A
<400> 7
Met Pro Thr Arg Cys Arg Trp Pro Leu Leu Arg Trp Lys Thr Ser Arg
1 5 10 15
Arg Ala Ile Thr Pro Cys Arg Arg Val Ala Pro Asn Arg Glu Arg Arg
25 30
Asp Ser Leu Gln Ala Ala Pro Arg Ala Gln Lys Glu His Ile Met Pro
40 45
Ser Pro Ala Asp Arg Glu Lys Ser Leu Glu Thr Ala Leu Ala Gln Ile
50 55 60
Asp Arg Gln Phe Gly Lys Gly Ser Val Met Arg Leu Gly Ser Asp Glu
65 70 75 80
Arg Ala Pro Val Ala Val Ile Pro Thr Gly Ser Ile Ala Leu Asp Val
85 90 95
Ala Leu Gly Val Gly Gly Leu Pro Arg Gly Arg Ile Val Glu Ile Tyr
100 105 110
Gly Pro Glu Ser Ser Gly Lys Thr Thr Leu Thr Leu His Ala Ile Ala
115 120 125
Asn Ala Gln Arg Ala Gly Gly Ile Ala Ala Phe Ile Asp Ala Glu His
130 135 140
Ala Leu Asp Pro Asp Tyr Ala Ala Lys Leu Gly Val Asp Ile Asp Ala
145 150 155 160
Leu Leu Val Ser Gln Pro Asp Thr Gly Glu Gln Ala Leu Glu Ile Ala
165 170 175
Asp Met Leu Val Arg Ser Gly Ala Ile Asp Leu Ile Val Ile Asp Ser
180 185 190
Val Ala Ala Leu Val Pro Arg Ala Glu Ile Glu Gly Glu Met Gly Asp
195 200 205
Ser His Val Gly Leu Gln Ala Arg Leu Met Ser Gln Ala Leu Arg Lys
210 215 220
Leu Thr Gly Gly Leu Asn Gln Thr Asn Thr Thr Met Ile Phe Ile Asn
225 230 235 240
Gln Leu Arg Glu Lys Ile Gly Val Phe Phe Gly Ser Pro Glu Thr Thr
245 250 255
Ala Gly Gly Lys Ala Leu Lys Phe Tyr Ala Ser Val Arg Met Asp Ile
260 265 270
Arg Arg Ile Glu Thr Leu Lys Asp Gly Thr Asp Ala Val Gly Asn Arg
275 280 285
Thr Arg Val Lys Val Val Lys Asn Lys Met Ala Pro Pro Phe Lys Gln
290 295 300
Ala Glu Phe Asp Ile Leu Tyr Gly Val Gly Ile Ser Arg Glu Gly Ser
305 310 315 320
Leu Ile Asp Phe Gly Val Glu His Ala Ile Val Lys Lys Ser Gly Ser
325 330 335
Trp Tyr Thr Tyr Asp Gly Asp Gln Leu Gly Gln Gly Lys Glu Asn Ala
340 345 350
Arg Thr Phe Leu Leu Asn Asn Pro Asp Ile Ala Leu Ala Ile Glu Thr
355 360 365
Gln Ile Lys Gln Lys Leu Gly Ile Gly Gly Pro Ala Ala Ala Pro Ala
370 375 380
Ala Ala Asp Glu Leu Ala Glu Arg Arg Pro Ala
385 390 395
<210> 8
<211> 2175
<212> DNA
<213> acterium sp.
<220>
<221> misc_feature
<223> SGI bacterial isolate 4-C06
<220>
<221> misc_feature
<223> SGI Gene ID SG1MICG849768
<220>
<221> misc_feature
<223> encodes the peptide sequence at SEQ ID NO 9
<400> 8
atgtacccca tgatcgatcc cgcactcgcc gacgccggcc tcggtgacgc cgac
gacttcgacg ccatcgagtc tcccgactcc cagctcccgg accaccgcta cctggatcgc
gagctgagct cctt caaccagcgc gtaatggagc tcgccgagga tccgtcactg
cccgaactcg agcgggcgaa cttcctggcg atcttcgcca tcga cgagttcttc
atggtgcgcg tcgccggcct caagcgccgc atcatgaccg gcctggccgt gccgacgaac
atcggccgct cccccgtcga cgcgctcgcc gacatctccc gcgaagcgca cgccctgcag
cacg ccgaggcctg gacctcgctc gtgcgccccg ccga ctccggcatc
gagatcacgg actggtccga gctgaccgac gacgagcgct ccggattgtc cgagtacttc
cagctccagg tcttcccggt gctgatgccg ctcgcggtcg acccggcgca tccgttcccc
tacatctccg gcctgtcgct gaacctcgcg atccgcatcc gcaatgcccg gcgc
caggagttcg cgcgcctcaa ggtgccgccc atgctccccc gcttcgtgga gggc
ggcggcgaga tcaagcgctt cctgcgcctg gaggaactga tcgcgaacca cctcggcgac
ctgttccccg gcatggaggt gctcgaccac cacgcgttcc gcctcacccg caacgaagac
gtggagatcg aggaagacga gagcgagaac ctcatccagg cgctcgaggc cgagctgctg
cgccgtcgat tcggcccgcc gatccgcctc gagatcacgg tgga cgaggtcacg
atggacctgc tcgtccgcga gctcgacatc accgacctgg accg cctccccggt
ccgctcgacc tgcgcggact gttcgatctg tcccgcatcg accgtcccga cctgcgctac
1020
ccgccgcacc tgcccaccac ggccgtggcc ttccagcccg caggatcgag cgcc
1080
gacatcttca aagcgatccg caagtcggat gtgctcgtgc accacccgta gttc
1140
acgaccagcg tgcaggcgtt cctcgaacag gccgcccgcg acccgcacgt gctcgccatc
1200
aagcagaccc gcac ctcgggcgac agcccggtcg tgcaggcgct gatcgacgcg
1260
gccgaagccg gcaagcaggt gctggccctc gtcgaggtga aggcccgttt cgacgaggcc
1320
aacaacatcg cacg caagctcgag aaggccggcg tgcacgtggt ctacggtctc
1380
gtcggactca actg caagctcgcc ctcgtcatcc gcgaggaaga ggggatgctg
1440
cgccactact cgcacgtcgg caccggcaac tacaacccca agaccagccg catctacgag
1500
gacttcggtc tgttcaccgc agacgcgcag gtcggcaaag acctgacacg cctgttcaac
1560
gagctcagcg gctacgcgat gaag ttcaagcgcc tgctggtcgc cccgctgcac
1620
ctgcgcaagg gcctcatccg ccagatcgac gccgagcgca ggaacgccga gatc
1680
cccgcgcaca tccgcatcaa ggtgaactcg atggtcgatg aggagatcat cgacgcgctc
1740
taccgcgcga gcgcggccgg ggtgaaggtc gacgtgtggg gcat ctgcagcctg
1800
cgcaccgacc tcgacggcat caac atcacggtgc gcagcatcct cggccgctac
1860
ctcgagcact cccgcatctt cgcgttcgag aacgccggcg acccgcaggt gtacatcggc
1920
agcgccgaca tgatgcaccg cgac cgtcgtgtgg aggcgctggt gcgcgtcacc
1980
gacgccgacc acctcaagga actgcaggcg ttcttcgacc tcgcgatgga cgacggaacc
2040
tcgtcgtggc atctcggcgc cggcggcgtc tgggagcgcc acgccgtgaa cgccgacggc
2100
aagccgctga tcgacctgca ggataagacc atggggttga tccagcggcg ccgccgcgcg
2160
cgggcggttc gatga
2175
<210> 9
<211> 724
<212> PRT
<213> acterium sp.
<220>
<221> misc_feature
<223> SGI bacterial isolate SGIC06
<220>
<221> misc_feature
<223> SGI peptide ID SG1MICT849768
<220>
<221> misc_feature
<223> polyphosphate kinase
<400> 9
Met Tyr Pro Met Ile Asp Pro Ala Leu Ala Asp Ala Gly Leu Gly Asp
1 5 10 15
Ala Glu Asp Asp Asp Phe Asp Ala Ile Glu Ser Pro Asp Ser Gln Leu
25 30
Pro Asp His Arg Tyr Leu Asp Arg Glu Leu Ser Trp Leu Ala Phe Asn
40 45
Gln Arg Val Met Glu Leu Ala Glu Asp Pro Ser Leu Pro Glu Leu Glu
50 55 60
Arg Ala Asn Phe Leu Ala Ile Phe Ala Ser Asn Leu Asp Glu Phe Phe
65 70 75 80
Met Val Arg Val Ala Gly Leu Lys Arg Arg Ile Met Thr Gly Leu Ala
85 90 95
Val Pro Thr Asn Ile Gly Arg Ser Pro Val Asp Ala Leu Ala Asp Ile
100 105 110
Ser Arg Glu Ala His Ala Leu Gln Leu Arg His Ala Glu Ala Trp Thr
115 120 125
Ser Leu Val Arg Pro Ala Leu Ala Asp Ser Gly Ile Glu Ile Thr Asp
130 135 140
Trp Ser Glu Leu Thr Asp Asp Glu Arg Ser Gly Leu Ser Glu Tyr Phe
145 150 155 160
Gln Leu Gln Val Phe Pro Val Leu Met Pro Leu Ala Val Asp Pro Ala
165 170 175
His Pro Phe Pro Tyr Ile Ser Gly Leu Ser Leu Asn Leu Ala Ile Arg
180 185 190
Ile Arg Asn Ala Arg Thr Gly Arg Gln Glu Phe Ala Arg Leu Lys Val
195 200 205
Pro Pro Met Leu Pro Arg Phe Val Glu Val Pro Gly Gly Gly Glu Ile
210 215 220
Lys Arg Phe Leu Arg Leu Glu Glu Leu Ile Ala Asn His Leu Gly Asp
225 230 235 240
Leu Phe Pro Gly Met Glu Val Leu Asp His His Ala Phe Arg Leu Thr
245 250 255
Arg Asn Glu Asp Val Glu Ile Glu Glu Asp Glu Ser Glu Asn Leu Ile
260 265 270
Gln Ala Leu Glu Ala Glu Leu Leu Arg Arg Arg Phe Gly Pro Pro Ile
275 280 285
Arg Leu Glu Ile Thr Asp Asp Met Asp Glu Val Thr Met Asp Leu Leu
290 295 300
Val Arg Glu Leu Asp Ile Thr Asp Leu Glu Val Tyr Arg Leu Pro Gly
305 310 315 320
Pro Leu Asp Leu Arg Gly Leu Phe Asp Leu Ser Arg Ile Asp Arg Pro
325 330 335
Asp Leu Arg Tyr Pro Pro His Leu Pro Thr Thr Ala Val Ala Phe Gln
340 345 350
Pro Ala Gly Ser Ser Asn Arg Ala Asp Ile Phe Lys Ala Ile Arg Lys
355 360 365
Ser Asp Val Leu Val His His Pro Tyr Glu Ser Phe Thr Thr Ser Val
370 375 380
Gln Ala Phe Leu Glu Gln Ala Ala Arg Asp Pro His Val Leu Ala Ile
385 390 395 400
Lys Gln Thr Leu Tyr Arg Thr Ser Gly Asp Ser Pro Val Val Gln Ala
405 410 415
Leu Ile Asp Ala Ala Glu Ala Gly Lys Gln Val Leu Ala Leu Val Glu
420 425 430
Val Lys Ala Arg Phe Asp Glu Ala Asn Asn Ile Val Trp Ala Arg Lys
435 440 445
Leu Glu Lys Ala Gly Val His Val Val Tyr Gly Leu Val Gly Leu Lys
450 455 460
Thr His Cys Lys Leu Ala Leu Val Ile Arg Glu Glu Glu Gly Met Leu
465 470 475 480
Arg His Tyr Ser His Val Gly Thr Gly Asn Tyr Asn Pro Lys Thr Ser
485 490 495
Arg Ile Tyr Glu Asp Phe Gly Leu Phe Thr Ala Asp Ala Gln Val Gly
500 505 510
Lys Asp Leu Thr Arg Leu Phe Asn Glu Leu Ser Gly Tyr Ala Ile Glu
515 520 525
Lys Lys Phe Lys Arg Leu Leu Val Ala Pro Leu His Leu Arg Lys Gly
530 535 540
Leu Ile Arg Gln Ile Asp Ala Glu Arg Arg Asn Ala Glu Ala Gly Ile
545 550 555 560
Pro Ala His Ile Arg Ile Lys Val Asn Ser Met Val Asp Glu Glu Ile
565 570 575
Ile Asp Ala Leu Tyr Arg Ala Ser Ala Ala Gly Val Lys Val Asp Val
580 585 590
Trp Val Arg Gly Ile Cys Ser Leu Arg Thr Asp Leu Asp Gly Ile Ser
595 600 605
Asp Asn Ile Thr Val Arg Ser Ile Leu Gly Arg Tyr Leu Glu His Ser
610 615 620
Arg Ile Phe Ala Phe Glu Asn Ala Gly Asp Pro Gln Val Tyr Ile Gly
625 630 635 640
Ser Ala Asp Met Met His Arg Asn Leu Asp Arg Arg Val Glu Ala Leu
645 650 655
Val Arg Val Thr Asp Ala Asp His Leu Lys Glu Leu Gln Ala Phe Phe
660 665 670
Asp Leu Ala Met Asp Asp Gly Thr Ser Ser Trp His Leu Gly Ala Gly
675 680 685
Gly Val Trp Glu Arg His Ala Val Asn Ala Asp Gly Lys Pro Leu Ile
690 695 700
Asp Leu Gln Asp Lys Thr Met Gly Leu Ile Gln Arg Arg Arg Arg Ala
705 710 715 720
Arg Ala Val Arg
<210> 10
<211> 1390
<212> DNA
<213> Microbacterium sp.
<220>
<221> misc_feature
<223> SGI bacterial isolate SGIG08
<220>
<221> misc_feature
<223> encodes a 16S ribosomal RNA
<220>
<221> misc_feature
<222> (29)..(36)
<223> n is a, c, g, t, or other
<220>
<221> misc_feature
<222> (38)..(41)
<223> n is a, c, g, t, or other
<400> 10
aacggtgaac acggagcttg ctctgtggnn nnnnnngnnn ncgggtgagt aacacgtgag
caacctgccc ctgg gataagcgct ggaaacggcg tctaatactg gatacgagta
gcgatcgcat ctac tggaaagatt ttttggttgg ggatgggctc gcggcctatc
agcttgttgg aatg gctcaccaag gcgtcgacgg gtagccggcc tgagagggtg
accggccaca ctgggactga gacacggccc agactcctac gggaggcagc agtggggaat
attgcacaat gggcggaagc ctgatgcagc aacgccgcgt tgac ggccttcggg
ttgtaaacct gcag ggaagaagcg aaagtgacgg tacctgcaga aaaagcgccg
gctaactacg cagc cgcggtaata cgtagggcgc tatc cggaattatt
gggcgtaaag agctcgtagg cggtttgtcg cgtctgctgt gaaatcccga ggctcaacct
cgggcctgca gtgggtacgg gcagactaga gtgcggtagg ggagattgga attcctggtg
tagcggtgga atgcgcagat atcaggagga acaccgatgg cgaaggcaga tctctgggcc
gtaactgacg ctgaggagcg aaagggtggg gagcaaacag gcttagatac cctggtagtc
caccccgtaa acgttgggaa ctagttgtgg ttcc acggattccg tgacgcagct
aacgcattaa gttccccgcc tggggagtac ggccgcaagg ctaaaactca ttga
cggggacccg cacaagcggc ggagcatgcg gattaattcg atgcaacgcg aagaacctta
ccaaggcttg acatatacga gaacgggcca gaaatggtca actctttgga cactcgtaaa
caggtggtgc atggttgtcg tcagctcgtg tcgtgagatg ttgggttaag tcccgcaacg
1020
accc tatg ttgccagcac gtaatggtgg gaactcatgg gatactgccg
1080
gggtcaactc ggaggaaggt ggggatgacg tcaaatcatc atgcccctta tgtcttgggc
1140
ttcacgcatg ctacaatggc cggtacaaag ggctgcaata ccgtgaggtg gagcgaatcc
1200
caaaaagccg gtcccagttc ggattgaggt ctgcaactcg acctcatgaa gtcggagtcg
1260
ctagtaatcg cagatcagca acgctgcggt gttc cttg tacacaccgc
1320
agtc atgaaagtcg gtaacacctg aagccggtgg cctt gtggagggag
1380
ccgtcgaagg
1390
<210> 11
<211> 532
<212> DNA
<213> Mycosphaerella sp.
<220>
<221> misc_feature
<223> SGI bacterial isolate SGIH11
<220>
<221> misc_feature
<223> Internal transcribed spacer 1_5.8S ribosomal DNA
<220>
<221> misc_feature
<222> (43)..(43)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (526)..(526)
<223> n is a, c, g, or t
<400> 11
cggagggatc attaatgagt gagggggcca cccccaacct ccnacccttt gtgaacgcat
catgttgctt cgggggcgac cctgccgttc gcggcattcc ccccggaggt catcaaaaca
ctgcattctt acgtcggagt aaaaagttaa tttaataaaa ctttcaacaa cggatctctt
ggttctggca tcgatgaaga cgaa atgcgataag taatgtgaat tgcagaattc
agtgaatcat cgaatctttg aacgcacatt gcgccccctg gtattccggg gggcatgcct
gttcgagcgt catttcacca cctc gcttggtatt gggcgtcgcg agtctctcgc
gcgcctcaaa gtctccggct gttcggttcg tctcccagcg ttgtggcaac tatttcgcag
tggagtacga gtcgtggcgg aatc tttcaaaggt cgga tcaggtaggg
atacccgctg aacttaagca tatcaataag cggaggaggt catagntgtt tc
<210> 12
<211> 1431
<212> DNA
<213> Variovorax sp.
<220>
<221> misc_feature
<223> SGI bacterial isolate SGIG01
<220>
<221> misc_feature
<223> encodes a 16S mal RNA
<400> 12
tgccttacac atgcaagtcg aacggcagcg cgggagcaat cctggcggcg agtggcgaac
gggtgagtaa ggaa cgtgcccaat ggat aacgcagcga aagctgtgct
aataccgcat acgatctacg gatgaaagca cgca tgcg cgaatggagc
ggccgatggc agattaggta gttggtgagg taaaggctca ccaagccttc gatctgtagc
tggtctgaga ggacgaccag ccacactggg actgagacac ggcccagact cctacgggag
gcagcagtgg ggaattttgg acaatgggcg aaagcctgat ccagccatgc cgcgtgcagg
atgaaggcct tgta aactgctttt gtacggaacg aaacggcctt ttctaataaa
gagggctaat gacggtaccg taagaataag caccggctaa ctacgtgcca gcagccgcgg
taatacgtag ggtgcaagcg ttaatcggaa ttactgggcg taaagcgtgc gcaggcggtt
atgtaagaca gttgtgaaat ccccgggctc ggaa ctgt gactgcatag
ctagagtacg gtagaggggg atggaattcc gcgtgtagca gtgaaatgcg tgcg
gaggaacacc gatggcgaag ccct ggacctgtac tgacgctcat gcacgaaagc
gtggggagca aacaggatta gataccctgg tagtccacgc cctaaacgat gtcaactggt
tgttgggtct tcactgactc agtaacgaag ctaacgcgtg aagttgaccg cctggggagt
acggccgcaa ggttgaaact caaaggaatt gacggggacc cgcacaagcg gtggatgatg
tggtttaatt cgatgcaacg cgaaaaacct tacccacctt tgacatgtac ggaattcgcc
agagatggct tagtgctcga aagagaaccg taacacaggt gctgcatggc tgtcgtcagc
1020
tcgtgtcgtg agatgttggg ttaagtcccg caacgagcgc aacccttgtc attagttgct
1080
acattcagtt gggcactcta atgagactgc cggtgacaaa ccggaggaag gtggggatga
1140
cgtcaagtcc tcatggccct tataggtggg cacg tcatacaatg gctggtacaa
1200
agggttgcca acccgcgagg gggagctaat cccataaaac cagtcgtagt ccggatcgca
1260
gtctgcaact cgactgcgtg aagtcggaat cgctagtaat cgtggatcag aatgtcacgg
1320
tgaatacgtt cccgggtctt gtacacaccg cccgtcacac agcg ggttctgcca
1380
gtta gcttaaccgc aaggagggcg attaccacgg cagggttcgt g
1431
<210> 13
<211> 1424
<212> DNA
<213> Bacillus iquefaciens
<220>
<221> misc_feature
<223> SGI bacterial e SGIF03
<220>
<221> misc_feature
<223> encodes a 16S ribosomal RNA
<400> 13
ctggcggcgt gcctaataca tgcaagtcga gcggacagat gggagcttgc tccctgatgt
tagcggcgga cgggtgagta acacgtgggt cctg taagactggg ccgg
gaaaccgggg ctaataccgg atggttgtct catg gttcagacat aaaaggtggc
ttcggctacc acttacagat ggacccgcgg cgcattagct agttggtgag gtaacggctc
gcga cgatgcgtag ccgacctgag agggtgatcg gccacactgg gactgagaca
cggcccagac tcctacggga ggcagcagta gggaatcttc cgcaatggac gaaagtctga
cggagcaacg gagt gatgaaggtt ttcggatcgt aaagctctgt tgttagggaa
gaacaagtgc cgttcaaata gggcggcacc ttgacggtac ctaaccagaa agccacggct
aactacgtgc cagcagccgc ggtaatacgt aggtggcaag cgttgtccgg aattattggg
cgtaaagggc tcgcaggcgg tttcttaagt ctgatgtgaa agcccccggc tcaaccgggg
agggtcattg gaaactgggg aacttgagtg cagaagagga gagtggaatt ccacgtgtag
aatg cgtagagatg tggaggaaca ccagtggcga aggcgactct ctggtctgta
actgacgctg aggagcgaaa gcgtggggag cgaacaggat tagataccct ggtagtccac
gccgtaaacg atgagtgcta aggg ggtttccgcc ccttagtgct gcagctaacg
cattaagcac tccgcctggg gagtacggtc gcaagactga aactcaaagg aattgacggg
ggcccgcaca agcggtggag catgtggttt aagc aacgcgaaga accttaccag
gtcttgacat cctctgacaa tcctagagat aggacgtccc cttcgggggc agagtgacag
1020
gtggtgcatg gttgtcgtca gctcgtgtcg tgagatgttg gtcc cgcaacgagc
1080
gcaacccttg atcttagttg ccagcattca cact tgac tgccggtgac
1140
aaaccggagg aaggtgggga tgacgtcaaa tcatcatgcc ccttatgacc tgggctacac
1200
acgtgctaca atggacagaa caaagggcag cgaaaccgcg agcc aatcccacaa
1260
atctgttctc agttcggatc gcagtctgca actcgactgc gtgaagctgg aatcgctagt
1320
aatcgcggat cagcatgccg cggtgaatac gttcccgggc cttgtacaca ccgcccgtca
1380
caccacgaga gtttgtaaca cccgaagtcg gtgaggtaac cttt
1424
<210> 14
<211> 1425
<212> DNA
<213> Bacillus subtilis
<220>
<221> misc_feature
<223> SGI ial isolate SGIH06
<220>
<221> misc_feature
<223> encodes a 16S ribosomal RNA
<400> 14
gctggcggcg tgcctaatac atgcaagtcg agcggacaga tgggagcttg ctccctgatg
gcgg acgggtgagt aacacgtggg taacctgcct gtaagactgg gataactccg
ggaaaccggg gctaataccg gatggttgtt tgaaccgcat ggttcagaca gtgg
ctac cacttacaga tggacccgcg tagc tagttggtga ggtaacggct
caccaaggca acgatgcgta gccgacctga gagggtgatc ggccacactg ggactgagac
acggcccaga ctcctacggg aggcagcagt agggaatctt ccgcaatgga cgaaagtctg
acggagcaac gccgcgtgag tgatgaaggt atcg taaagctctg ttgttaggga
agaacaagtg ccgttcaaat agggcggcac cttgacggta cctaaccaga aagccacggc
taactacgtg ccagcagccg cggtaatacg taggtggcaa tccg gaattattgg
gcgtaaaggg ctcgcaggcg gtttcttaag tctgatgtga aagcccccgg ctcaaccggg
gagggtcatt ggaaactggg gaacttgagt gcagaagagg agagtggaat tgta
gcggtgaaat gcgtagagat gtggaggaac accagtggcg aaggcgactc tctggtctgt
aactgacgct gaggagcgaa agcgtgggga gcgaacagga ttagataccc tggtagtcca
cgccgtaaac gatgagtgct tagg gggtttccgc cccttagtgc tgcagctaac
gcattaagca ctccgcctgg ggagtacggt cgcaagactg aaactcaaag gaattgacgg
gggcccgcac aagcggtgga gcatgtggtt taattcgaag caacgcgaag aaccttacca
ggtcttgaca tcctctgaca atcctagaga taggacgtcc ccttcggggg gaca
1020
ggtggtgcat ggttgtcgtc agctcgtgtc gtgagatgtt gggttaagtc ccgcaacgag
1080
cgcaaccctt agtt gccagcattc agttgggcac tctaaggtga ctgccggtga
1140
caaaccggag gaaggtgggg atgacgtcaa atgc cccttatgac ctgggctaca
1200
cacgtgctac caga acaaagggca gcgaaaccgc gaggttaagc caatcccaca
1260
aatctgttct cagttcggat cgcagtctgc aactcgactg cgtgaagctg gaatcgctag
1320
taatcgcgga tcagcatgcc gcggtgaata cgttcccggg ccttgtacac accgcccgtc
1380
acaccacgag agtttgtaac acccgaagtc gtaa ccttt
1425
<210> 15
<211> 37
<212> DNA
<213> Artificial sequence
<220>
<223> PCR primer S1
<400> 15
tgtaaaacga gttt cgtaggtgaa cctgcgg
<210> 16
<211> 38
<212> DNA
<213> Artificial sequence
<220>
<223> PCR primer ITS4-M13
<400> 16
caggaaacag ctatgacctc ctccgcttat tgatatgc
<210> 17
<211> 39
<212> DNA
<213> Artificial sequence
<220>
<223> PCR primer M13-27F Bac
<400> 17
tgtaaaacga cggccagtta gagtttgatc ctggctcag
<210> 18
<211> 37
<212> DNA
<213> Artificial sequence
<220>
<223> PCR primer 1492R-M13 Bac
<400> 18
caggaaacag ccgg ttaccttgtt acgactt
Claims (23)
1. An isolated microbial strain of a Variovorax sp., wherein said microbial strain has suppressive activity against head blight e.
2. An isolated microbial strain according to claim 1, wherein said microbial strain is Variovorax sp. strain SGIG01 (deposited as NRRL B-50469), and pesticidally active variants thereof.
3. An isolated ial strain according to claim 1 or 2, wherein said microbial strain comprises a DNA ce exhibiting at least 85% sequence identity to any one of the nucleotide sequences in the Sequence Listing.
4. A biologically pure culture of a microbial strain according to claim 1.
5. An enriched culture of a ial strain according to claim 1.
6. A composition comprising a microbial strain or culture thereof of any one of claims 1- 5, and an agriculturally effective amount of a compound or composition selected from the group consisting of an acaricide, a icide, a fungicide, an insecticide, a microbicide, a nematicide, a pesticide, and a izer.
7. A composition comprising a microbial strain or culture thereof of any one of claims 1- 5, and a r.
8. A composition according to claim 7, wherein said carrier is an agriculturally acceptable carrier.
9. A composition according to claim 7, n said carrier is a plant seed.
10. A composition according to claim 7, wherein said composition is prepared as a formulation selected from the group consisting of an emulsion, a colloid, a dust, a granule, a pellet, a , a spray, an emulsion, and a solution.
11. A composition according to claim 7, wherein said composition is a seed coating formulation.
12. A seed having a coating comprising a composition according to claim 7.
13. A method for preventing, inhibiting or ng the development of a plant pathogen, n said method ses growing a microbial strain or culture thereof of any one of claims 1-5 in a growth medium or soil of a host plant prior to or concurrent with host plant growth in said growth medium or soil.
14. A method according to claim 13, wherein said plant pathogen causes head blight disease.
15. A method according to claim 14, wherein said plant pathogen is Fusarium graminearum.
16. A method for preventing, inhibiting or treating the development of head blight disease of a plant, wherein said method comprises applying to the plant, or to the plant's surroundings, an effective amount of a microbial strain or culture thereof of any one of claims 1-5.
17. A method according to claim 16, wherein said microbial strain or culture thereof is applied to soil, a seed, a root, a , a leaf, a portion of the plant, or the whole plant.
18. A method according to claim 16, n said plant is susceptible to Fusarium graminearum.
19. A method ing to claim 16, wherein said plant is a wheat plant, a corn plant, a barley plant, or an oat plant.
20. A method according to claim 16, wherein said microbial strain or culture thereof is established as an yte on said plant.
21. A turally occurring plant that is a plant artificially infected with a microbial strain or culture f of any one of claims 1-5.
22. Seed, reproductive tissue, vegetative tissue, plant parts, or progeny of a non-naturally occurring plant of claim 21.
23. A method for preparing an agricultural composition, wherein said method comprises inoculating a microbial strain or culture thereof according to any one of claims 1-5 into or onto a substratum and allowing said microbial strain or culture thereof to grow at a temperature of 1-37°C until obtaining a number of cells or spores of at least 102-103 per milliliter or per gram.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ712059A NZ712059B2 (en) | 2011-07-25 | 2012-07-24 | Compositions and methods for controlling head blight disease |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161511467P | 2011-07-25 | 2011-07-25 | |
US61/511,467 | 2011-07-25 | ||
NZ620577A NZ620577B2 (en) | 2011-07-25 | 2012-07-24 | Compositions and methods for controlling head blight disease |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ709801A NZ709801A (en) | 2015-09-25 |
NZ709801B2 true NZ709801B2 (en) | 2016-01-06 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2018267535B2 (en) | Compositions and methods for controlling head blight disease | |
CN112867784A (en) | Methods and compositions for improved phosphate solubilization | |
CN107980058A (en) | Plant growth promotes microorganism, composition and purposes | |
MX2014007070A (en) | Plant growth-promoting microbes and uses therefor. | |
KR20230105465A (en) | Development of a multifunctional biopesticide controlling anthracnose and bacterial diseases with plant growth stimulating effects | |
RU2777606C2 (en) | Compositions and methods for fusarium control | |
NZ709801B2 (en) | Compositions and methods for controlling head blight disease | |
NZ712059B2 (en) | Compositions and methods for controlling head blight disease | |
NZ704721B2 (en) | Compositions and methods for controlling head blight disease | |
NZ620577B2 (en) | Compositions and methods for controlling head blight disease | |
NZ715042B2 (en) | Compositions and methods for controlling head blight disease | |
ADETUNJI et al. | Production of phytotoxic metabolite using biphasic fermentation system from strain C1136 of Lasiodiplodia pseudotheobromae, a potential bioherbicidal agent | |
Tshabuse | Identification of rhizospheric microorganisms associated with sorghum | |
NZ625835B2 (en) | Plant growth-promoting microbes and uses therefor |